[
    {
        "question": "A 78-year-old male patient presents to your clinic for a routine check-up. He has a history of hypertension and recently experienced a transient ischemic attack. He does not have diabetes or congestive heart failure. He is not currently prescribed warfarin. Based on these factors, what is the estimated stroke rate per 100 patient-years without antithrombotic therapy for this patient?",
        "choices": {
            "A": "1.9",
            "B": "2.8",
            "C": "4.0",
            "D": "5.9",
            "E": "8.5"
        },
        "answer": "E",
        "pmid": "11401607"
    },
    {
        "question": "An 85-year-old patient with a history of congestive heart failure, hypertension, and diabetes presents to your clinic. The patient has no history of stroke or transient ischemic attack. The patient is not currently prescribed warfarin. Based on these factors, what is the estimated stroke rate per 100 patient-years without antithrombotic therapy for this patient?",
        "choices": {
            "A": "1.9",
            "B": "2.8",
            "C": "4.0",
            "D": "5.9",
            "E": "8.5"
        },
        "answer": "E",
        "pmid": "11401607"
    },
    {
        "question": "A 70-year-old patient with a history of nonrheumatic atrial fibrillation presents to your clinic. The patient has a history of diabetes and a previous stroke but does not have hypertension or congestive heart failure. The patient is not currently prescribed warfarin. Based on the patient's risk factors, what is the estimated stroke rate per 100 patient-years without antithrombotic therapy?",
        "choices": {
            "A": "1.9",
            "B": "2.8",
            "C": "4.0",
            "D": "5.9",
            "E": "8.5"
        },
        "answer": "D",
        "pmid": "11401607"
    },
    {
        "question": "An 80-year-old patient with a history of nonrheumatic atrial fibrillation presents to the clinic for a routine check-up. The patient has a history of congestive heart failure and a previous stroke but does not have hypertension or diabetes. The patient is not currently prescribed warfarin. Based on these factors, what is the estimated stroke rate per 100 patient-years without antithrombotic therapy for this patient?",
        "choices": {
            "A": "Stroke rate is 1.9 per 100 patient-years",
            "B": "Stroke rate is 2.8 per 100 patient-years",
            "C": "Stroke rate is 4.0 per 100 patient-years",
            "D": "Stroke rate is 8.5 per 100 patient-years",
            "E": "Stroke rate is 12.5 per 100 patient-years"
        },
        "answer": "D",
        "pmid": "11401607"
    },
    {
        "question": "A 65-year-old patient with a history of hypertension and diabetes presents to your clinic. The patient has no history of stroke or congestive heart failure. The patient is not currently prescribed warfarin. Based on the patient's risk factors, what is the estimated stroke rate per 100 patient-years without antithrombotic therapy?",
        "choices": {
            "A": "1.9",
            "B": "2.8",
            "C": "4.0",
            "D": "5.9",
            "E": "8.5"
        },
        "answer": "C",
        "pmid": "11401607"
    },
    {
        "question": "A 50-year-old patient with HIV/HCV coinfection presents to your clinic. The patient's laboratory results show an AST level of 40 U/L, a platelet count of 150 x 10(9)/L, and an ALT level of 30 U/L. Based on these results, which of the following is the most appropriate next step in the management of this patient's liver health?",
        "choices": {
            "A": "No further testing is required as the patient is unlikely to have advanced fibrosis",
            "B": "The patient should be considered for further testing as they are at intermediate risk for significant liver fibrosis",
            "C": "Immediate treatment for advanced liver fibrosis should be initiated as the patient is likely to have advanced fibrosis",
            "D": "The patient should be referred for a liver biopsy",
            "E": "The patient should be started on antiviral therapy for HCV"
        },
        "answer": "B",
        "pmid": "16729309"
    },
    {
        "question": "A 60-year-old patient with HIV/HCV coinfection presents to your clinic. The patient's laboratory results show an AST level of 70 U/L, a platelet count of 100 x 10(9)/L, and an ALT level of 50 U/L. A calculation based on these values yields a score of 5.94. This score is used to predict the likelihood of significant liver fibrosis, potentially reducing the need for liver biopsy. What is the most likely interpretation of this score?",
        "choices": {
            "A": "The score excludes the possibility of advanced fibrosis with a high degree of certainty.",
            "B": "The score suggests an intermediate risk of advanced fibrosis, and further testing should be considered.",
            "C": "The score suggests a high likelihood of advanced fibrosis, and further diagnostic procedures are recommended.",
            "D": "The score is inconclusive and cannot be used to predict the presence of liver fibrosis.",
            "E": "The score suggests a low likelihood of advanced fibrosis, and no further action is required."
        },
        "answer": "C",
        "pmid": "16729309"
    },
    {
        "question": "A 45-year-old patient with HIV/HCV coinfection presents to your clinic. The patient's laboratory results show an AST level of 30 U/L, a platelet count of 200 x 10(9)/L, and an ALT level of 20 U/L. Based on these results, which of the following is the most appropriate next step in the management of this patient's liver health?",
        "choices": {
            "A": "No further testing is required as the patient is unlikely to have advanced fibrosis",
            "B": "Further testing is required as the patient is at intermediate risk of significant liver fibrosis",
            "C": "Immediate treatment for advanced fibrosis is required as the patient is likely to have advanced fibrosis",
            "D": "The patient is not at risk of liver fibrosis and can continue with current management",
            "E": "The patient should be referred for a liver biopsy as the results are inconclusive"
        },
        "answer": "B",
        "pmid": "16729309"
    },
    {
        "question": "A 55-year-old patient with HIV/HCV coinfection presents to your clinic. The patient's AST level is 50 U/L, platelet count is 130 x 10(9)/L, and ALT level is 40 U/L. Based on these values, which of the following is the most likely interpretation of the patient's liver fibrosis status?",
        "choices": {
            "A": "The patient is unlikely to have advanced fibrosis",
            "B": "The patient is at intermediate risk for advanced fibrosis and further testing is recommended",
            "C": "The patient has a high likelihood of having advanced fibrosis",
            "D": "The patient's results are inconclusive and should be retested",
            "E": "The patient's results are normal and no further action is needed"
        },
        "answer": "C",
        "pmid": "16729309"
    },
    {
        "question": "A 65-year-old patient with HIV/HCV coinfection presents to your clinic. The patient's laboratory results show an AST level of 80 U/L, a platelet count of 90 x 10(9)/L, and an ALT level of 60 U/L. Based on these results, which of the following is the most likely interpretation regarding the patient's liver condition?",
        "choices": {
            "A": "The patient is unlikely to have advanced fibrosis",
            "B": "The patient is at intermediate risk for advanced fibrosis and further testing is needed",
            "C": "The patient has a high likelihood of significant liver fibrosis",
            "D": "The patient's results are inconclusive and should be retested",
            "E": "The patient's liver condition cannot be determined from these results"
        },
        "answer": "C",
        "pmid": "16729309"
    },
    {
        "question": "A 70-year-old patient presents to the emergency department with chest pain. The patient has a history of hypertension, hyperlipidemia, diabetes, and smoking, indicating 4 risk factors for coronary artery disease. They also have a history of coronary stenosis of 60%. The patient's ECG at presentation showed ST-segment deviation. They reported experiencing 3 episodes of chest pain in the last 24 hours. The patient has been taking aspirin regularly for the past week. Lab results indicate elevated serum cardiac markers. Based on this information, what is the most likely prognosis for this patient over the next 14 days?",
        "choices": {
            "A": "4.7% likelihood of experiencing an event related to unstable angina or non-ST-segment elevation myocardial infarction",
            "B": "8.3% likelihood of experiencing an event related to unstable angina or non-ST-segment elevation myocardial infarction",
            "C": "19.9% likelihood of experiencing an event related to unstable angina or non-ST-segment elevation myocardial infarction",
            "D": "26.2% likelihood of experiencing an event related to unstable angina or non-ST-segment elevation myocardial infarction",
            "E": "40.9% likelihood of experiencing an event related to unstable angina or non-ST-segment elevation myocardial infarction"
        },
        "answer": "E",
        "pmid": "10938172"
    },
    {
        "question": "A 60-year-old patient presents with chest discomfort. They have a history of hypertension and hyperlipidemia, but no prior history of coronary artery disease or stenosis. The patient's ECG at presentation showed no ST-segment deviation. They reported experiencing chest pain once in the past 24 hours. The patient denies any use of aspirin or other antiplatelet agents in the past week. Laboratory tests, including troponin and CK-MB, were within normal limits. Based on these findings, what is the most likely risk of this patient experiencing a cardiac event?",
        "choices": {
            "A": "Less than 5% risk",
            "B": "Approximately 8% risk",
            "C": "Approximately 13% risk",
            "D": "Approximately 20% risk",
            "E": "More than 25% risk"
        },
        "answer": "A",
        "pmid": "10938172"
    },
    {
        "question": "A 65-year-old patient presents to the emergency department with chest discomfort. The patient has a history of hypertension, but no other risk factors for coronary artery disease. They have a history of coronary stenosis of 50% as per previous angiography. The patient's ECG at presentation showed no ST-segment deviation. They reported no anginal events in the prior 24 hours but have been using aspirin in the past 7 days. Lab results indicate no elevated serum cardiac markers. The patient's blood pressure is 140/90 mmHg, heart rate is 80 beats per minute, and respiratory rate is 16 breaths per minute. Based on the patient's clinical presentation and history, what is the most likely risk of experiencing a cardiac event?",
        "choices": {
            "A": "Low risk (4.7% event rate)",
            "B": "Moderate risk (8.3% event rate)",
            "C": "High risk (13.2% event rate)",
            "D": "Very high risk (19.9% event rate)",
            "E": "Extremely high risk (26.2% event rate)"
        },
        "answer": "C",
        "pmid": "10938172"
    },
    {
        "question": "A 60-year-old patient presents with chest pain. They have a history of hypertension, hyperlipidemia, and diabetes, making up 3 risk factors for coronary artery disease. They also have a history of coronary stenosis of 50%. The patient's ECG at presentation showed ST-segment deviation. They reported experiencing 2 episodes of angina in the last 24 hours. They have not been using aspirin in the past 7 days. Lab results indicate elevated serum cardiac markers. Based on these findings, what is the most likely risk of this patient experiencing a cardiac event?",
        "choices": {
            "A": "4.7% event rate",
            "B": "8.3% event rate",
            "C": "13.2% event rate",
            "D": "19.9% event rate",
            "E": "26.2% event rate"
        },
        "answer": "E",
        "pmid": "10938172"
    },
    {
        "question": "A 70-year-old patient presents to the emergency department. The patient has no known risk factors for coronary artery disease such as hypertension, diabetes, or hyperlipidemia. They have no history of coronary stenosis or any cardiac procedures. The electrocardiogram performed at presentation showed no ST-segment deviation. The patient denies experiencing any chest pain or discomfort in the past 24 hours. They have not been using aspirin or any other medications in the past week. Laboratory tests, including troponin levels, were within normal limits. Based on this information, what is the most likely risk of this patient experiencing a cardiac event in the near future?",
        "choices": {
            "A": "Less than 5% risk",
            "B": "Between 5% and 10% risk",
            "C": "Between 10% and 15% risk",
            "D": "Between 15% and 20% risk",
            "E": "More than 20% risk"
        },
        "answer": "A",
        "pmid": "10938172"
    },
    {
        "question": "A 70-year-old patient is admitted to the hospital with symptoms of community acquired pneumonia. The patient presents with confusion and a respiratory rate of 32 breaths per minute. Laboratory tests reveal a blood urea level of 8 mmol/l. The patient's blood pressure reading is 85/60 mm Hg. Based on these findings, what is the most likely risk of mortality for this patient?",
        "choices": {
            "A": "0.7% risk of mortality",
            "B": "3.2% risk of mortality",
            "C": "13% risk of mortality",
            "D": "41.5% risk of mortality",
            "E": "57% risk of mortality"
        },
        "answer": "E",
        "pmid": "12728155"
    },
    {
        "question": "A 60-year-old patient is admitted to the hospital with symptoms of pneumonia. The patient is alert and oriented, with no signs of confusion. The respiratory rate is recorded at 28 breaths per minute, and the blood urea level is 5 mmol/l. The blood pressure reading is 110/70 mm Hg. Based on these findings, what is the most likely risk of mortality for this patient?",
        "choices": {
            "A": "0.7% risk of mortality",
            "B": "3.2% risk of mortality",
            "C": "13% risk of mortality",
            "D": "41.5% risk of mortality",
            "E": "57% risk of mortality"
        },
        "answer": "A",
        "pmid": "12728155"
    },
    {
        "question": "A 75-year-old patient is admitted to the hospital with symptoms of confusion. The patient's respiratory rate is recorded at 35 breaths per minute, and their blood urea level is 10 mmol/l. The blood pressure reading is 80/55 mm Hg. The patient has a history of hypertension and diabetes, and is currently on medication for both. The patient lives alone and has been feeling unwell for the past few days. Based on the patient's symptoms and vital signs, what is the most likely risk of mortality and recommended management for this patient?",
        "choices": {
            "A": "0.7% risk of mortality, outpatient care",
            "B": "3.2% risk of mortality, short inpatient hospitalization or closely supervised outpatient treatment",
            "C": "13% risk of mortality, hospitalization",
            "D": "41.5% risk of mortality, hospitalization and possible ICU admission",
            "E": "57% risk of mortality, immediate and intensive medical care"
        },
        "answer": "E",
        "pmid": "12728155"
    },
    {
        "question": "A 50-year-old individual presents to the emergency department with symptoms of pneumonia. The patient is alert and oriented, with no signs of confusion. The patient's respiratory rate is recorded at 25 breaths per minute, and their blood urea level is 6 mmol/l. The blood pressure reading is 120/80 mm Hg. The patient has no history of chronic diseases and is not on any regular medication. Based on these findings, what is the most likely risk of mortality for this patient?",
        "choices": {
            "A": "0.7% risk of mortality",
            "B": "3.2% risk of mortality",
            "C": "13% risk of mortality",
            "D": "17% risk of mortality",
            "E": "41.5% risk of mortality"
        },
        "answer": "A",
        "pmid": "12728155"
    },
    {
        "question": "A 68-year-old patient is admitted to the hospital with symptoms of community acquired pneumonia. The patient presents with confusion, a respiratory rate of 30 breaths per minute, and a blood urea level of 9 mmol/l. The blood pressure reading is 90/60 mm Hg. The patient has no known allergies and is not currently on any medication. Based on these findings, what is the estimated risk of mortality for this patient?",
        "choices": {
            "A": "0.7% risk of mortality",
            "B": "3.2% risk of mortality",
            "C": "13% risk of mortality",
            "D": "41.5% risk of mortality",
            "E": "57% risk of mortality"
        },
        "answer": "E",
        "pmid": "12728155"
    },
    {
        "question": "A 70-year-old patient presents to the emergency department following a minor head injury. The patient has a Glasgow Coma Scale score of 14, has vomited 3 times since the injury, and there is a suspicion of an open skull fracture. There are no signs of a basal skull fracture, amnesia before impact, or a dangerous mechanism of injury. The patient's medical history is unremarkable, and they are not on any medication. Based on the patient's clinical presentation, which of the following is the most appropriate next step in management?",
        "choices": {
            "A": "Discharge the patient with close outpatient follow-up",
            "B": "Admit the patient for observation without further imaging",
            "C": "Perform a CT scan of the head",
            "D": "Perform an MRI of the head",
            "E": "Start the patient on prophylactic antibiotics"
        },
        "answer": "C",
        "pmid": "11356436"
    },
    {
        "question": "A 30-year-old patient presents to the emergency department following a head injury. The patient has a Glasgow Coma Scale score of 15 and has vomited once since the injury. There are no signs of an open or basal skull fracture. However, the patient experienced amnesia for over 30 minutes before the impact and the injury was caused by a dangerous mechanism. The patient is otherwise healthy with no significant past medical history. Based on these findings, what is the most appropriate next step in management?",
        "choices": {
            "A": "Discharge the patient without further imaging",
            "B": "Observe the patient in the hospital without further imaging",
            "C": "Perform a CT scan of the head",
            "D": "Perform an MRI of the head",
            "E": "Refer the patient to a neurologist without further imaging"
        },
        "answer": "C",
        "pmid": "11356436"
    },
    {
        "question": "A 50-year-old patient presents to the emergency department following a minor head injury. The patient's Glasgow Coma Scale score is 13. There is no evidence of vomiting, open skull fracture, or basal skull fracture. The patient did not experience amnesia before the impact and the injury was not caused by a dangerous mechanism. Based on the patient's clinical presentation, which of the following is the most appropriate next step in management?",
        "choices": {
            "A": "Discharge the patient without further imaging",
            "B": "Observe the patient in the hospital without immediate imaging",
            "C": "Perform a CT scan of the head",
            "D": "Perform an MRI of the head",
            "E": "Refer the patient for immediate neurosurgical intervention"
        },
        "answer": "C",
        "pmid": "11356436"
    },
    {
        "question": "A 40-year-old patient presents to the emergency department after a minor head injury. The patient is alert and oriented with a Glasgow Coma Scale score of 15. There is no history of vomiting episodes post-injury and no signs of an open skull fracture are observed. However, physical examination reveals signs suggestive of a basal skull fracture. The patient denies any amnesia before the impact and the injury was not caused by a dangerous mechanism such as a high-speed motor vehicle collision or a fall from a height of more than 3 feet or 5 stairs. Based on the patient's clinical presentation, which of the following is the most appropriate next step in management?",
        "choices": {
            "A": "Discharge the patient without further imaging",
            "B": "Observe the patient in the hospital without immediate imaging",
            "C": "Perform a CT scan of the head",
            "D": "Perform an MRI of the head",
            "E": "Refer the patient for immediate neurosurgical intervention"
        },
        "answer": "C",
        "pmid": "11356436"
    },
    {
        "question": "A 66-year-old patient presents to the emergency department after a fall. The patient has a Glasgow Coma Scale score of 14, has vomited twice, and reports experiencing amnesia for over 30 minutes before the impact. The injury was caused by a dangerous mechanism. On examination, there are no signs of an open or basal skull fracture. Based on these findings, what is the most appropriate next step in management?",
        "choices": {
            "A": "Discharge the patient without further imaging",
            "B": "Observe the patient in the hospital without further imaging",
            "C": "Perform a CT scan of the head",
            "D": "Perform an MRI of the head",
            "E": "Refer the patient for immediate neurosurgical intervention"
        },
        "answer": "C",
        "pmid": "11356436"
    },
    {
        "question": "A 78-year-old patient presents with a history of stroke and uncontrolled hypertension. The patient has had a prior bleed but does not have hepatic or renal disease, does not abuse ethanol, and has no malignancy. The patient's platelet count and function are normal, they do not have anemia, no genetic factors that increase bleeding risk, and no excessive risk of falling. The patient's risk score for major bleeding, calculated based on these factors, is 5. What does this score indicate about the patient's risk of bleeding events per 100 patient-years?",
        "choices": {
            "A": "1.9 bleeding events",
            "B": "2.5 bleeding events",
            "C": "5.3 bleeding events",
            "D": "10.4 bleeding events",
            "E": "12.3 bleeding events"
        },
        "answer": "E",
        "pmid": "16504638"
    },
    {
        "question": "An 80-year-old patient presents with a history of hepatic disease, ethanol abuse, malignancy, reduced platelet count or function, anemia, genetic factors that increase bleeding risk, and an excessive risk of falling. The patient has not had a prior bleed or stroke, and does not have uncontrolled hypertension. Given this patient's risk factors, what is the estimated risk of major bleeding events per 100 patient-years?",
        "choices": {
            "A": "1.9 bleeding events per 100 patient-years",
            "B": "5.3 bleeding events per 100 patient-years",
            "C": "8.4 bleeding events per 100 patient-years",
            "D": "10.4 bleeding events per 100 patient-years",
            "E": "12.3 bleeding events per 100 patient-years"
        },
        "answer": "E",
        "pmid": "16504638"
    },
    {
        "question": "A 76-year-old patient presents with a history of prior bleed, hepatic or renal disease, uncontrolled hypertension, anemia, and stroke. The patient does not abuse ethanol, has no malignancy, normal platelet count and function, no genetic factors that increase bleeding risk, and no excessive risk of falling. The patient's liver function tests are within normal limits, and renal function tests show mild impairment. The patient's blood pressure is 160/90 mmHg despite medication, and the hemoglobin level is 11 g/dL. The patient had a stroke 2 years ago but has since recovered with minimal residual deficits. Based on these factors, what is the estimated risk of major bleeding events per 100 patient-years for this patient?",
        "choices": {
            "A": "1.9 bleeding events per 100 patient-years",
            "B": "2.5 bleeding events per 100 patient-years",
            "C": "5.3 bleeding events per 100 patient-years",
            "D": "8.4 bleeding events per 100 patient-years",
            "E": "12.3 bleeding events per 100 patient-years"
        },
        "answer": "E",
        "pmid": "16504638"
    },
    {
        "question": "A 79-year-old patient presents with a history of ethanol abuse, malignancy, reduced platelet count or function, genetic factors that increase bleeding risk, and an excessive risk of falling. The patient has not had a prior bleed or stroke, does not have hepatic or renal disease, and does not have uncontrolled hypertension or anemia. Based on these factors, what is the estimated risk of major bleeding events per 100 patient-years for this patient?",
        "choices": {
            "A": "1.9 bleeding events per 100 patient-years",
            "B": "2.5 bleeding events per 100 patient-years",
            "C": "5.3 bleeding events per 100 patient-years",
            "D": "8.4 bleeding events per 100 patient-years",
            "E": "12.3 bleeding events per 100 patient-years"
        },
        "answer": "E",
        "pmid": "16504638"
    },
    {
        "question": "A 77-year-old patient presents with a history of prior bleed, malignancy, anemia, and an excessive risk of falling. The patient does not have hepatic or renal disease, does not abuse ethanol, has normal platelet count and function, no uncontrolled hypertension, no genetic factors that increase bleeding risk, and has not had a stroke. The patient's risk score for major bleeding is calculated to be 6. Based on this score, how many bleeding events per 100 patient-years can be expected for this patient?",
        "choices": {
            "A": "1.9 bleeding events per 100 patient-years",
            "B": "2.5 bleeding events per 100 patient-years",
            "C": "5.3 bleeding events per 100 patient-years",
            "D": "10.4 bleeding events per 100 patient-years",
            "E": "12.3 bleeding events per 100 patient-years"
        },
        "answer": "E",
        "pmid": "16504638"
    },
    {
        "question": "A 78-year-old patient with atrial fibrillation presents to your clinic. The patient has a history of anemia and severe renal disease, both of which are currently being managed with medication. They also have a history of a prior bleeding event. The patient does not have hypertension. The patient's age, anemia, renal disease, and prior bleeding event contribute to a risk score of 9. Based on this information, what is the patient's annual risk of major hemorrhage while on warfarin therapy?",
        "choices": {
            "A": "0.8% per year",
            "B": "2.6% per year",
            "C": "5.8% per year",
            "D": "7.5% per year",
            "E": "10% per year"
        },
        "answer": "C",
        "pmid": "21757117"
    },
    {
        "question": "A 65-year-old patient with atrial fibrillation presents to your clinic. The patient has a history of hypertension but no history of anemia, severe renal disease, or prior bleeding events. The patient's blood pressure is well-controlled with medication. The patient is currently on warfarin therapy. Based on these factors, what is the patient's risk of warfarin-associated hemorrhage?",
        "choices": {
            "A": "Low risk, with a major hemorrhage rate of 0.8% per year",
            "B": "Intermediate risk, with a major hemorrhage rate of 2.6% per year",
            "C": "High risk, with a major hemorrhage rate of 5.8% per year",
            "D": "The patient is not at risk of warfarin-associated hemorrhage",
            "E": "The patient's risk cannot be determined without further information"
        },
        "answer": "A",
        "pmid": "21757117"
    },
    {
        "question": "An 80-year-old patient with atrial fibrillation presents to your clinic. The patient has a history of anemia and a prior bleeding event. They do not have severe renal disease but do have hypertension. The patient is currently on warfarin therapy. Based on these factors, what is the patient's risk of major hemorrhage per year?",
        "choices": {
            "A": "0.8%",
            "B": "2.6%",
            "C": "5.8%",
            "D": "7.0%",
            "E": "10.0%"
        },
        "answer": "C",
        "pmid": "21757117"
    },
    {
        "question": "A 50-year-old patient with atrial fibrillation presents to your clinic. The patient has severe renal disease with a glomerular filtration rate of 25 ml/min. They do not have a history of anemia, prior bleeding events, or hypertension. The patient is currently on warfarin therapy. Based on these factors, what is the patient's risk of major hemorrhage per year?",
        "choices": {
            "A": "0.8%",
            "B": "2.6%",
            "C": "5.8%",
            "D": "10%",
            "E": "15%"
        },
        "answer": "A",
        "pmid": "21757117"
    },
    {
        "question": "An 85-year-old patient with atrial fibrillation presents to your clinic. The patient has a history of anemia, severe renal disease, a prior bleeding event, and hypertension. The patient's glomerular filtration rate is less than 30 ml/min, indicating dialysis-dependency. The patient is currently on warfarin therapy. Based on these factors, what is the patient's risk of major hemorrhage per year?",
        "choices": {
            "A": "0.8%",
            "B": "2.6%",
            "C": "5.8%",
            "D": "10%",
            "E": "15%"
        },
        "answer": "C",
        "pmid": "21757117"
    },
    {
        "question": "A 45-year-old male patient presents with a history of obesity. His Body Mass Index (BMI) is 30 kg/m^2. His liver function tests reveal an Aspartate Aminotransferase (AST) level of 90 U/L and an Alanine Aminotransferase (ALT) level of 100 U/L, yielding an AST/ALT ratio of 0.9. The patient does not have a history of Diabetes Mellitus (DM). Based on these findings, what is the patient's risk of developing advanced fibrosis in the context of non-alcoholic fatty liver disease (NAFLD)?",
        "choices": {
            "A": "Low risk of advanced fibrosis",
            "B": "Moderate risk of advanced fibrosis",
            "C": "High risk of advanced fibrosis",
            "D": "The patient does not have NAFLD",
            "E": "Unable to determine the risk without further testing"
        },
        "answer": "C",
        "pmid": "18390575"
    },
    {
        "question": "A 55-year-old male patient presents with a history of non-alcoholic fatty liver disease (NAFLD). He has a Body Mass Index (BMI) of 25 kg/m^2, which is within the normal range. His laboratory results show an Aspartate Aminotransferase (AST) level of 35 U/L and an Alanine Aminotransferase (ALT) level of 50 U/L, giving an AST/ALT ratio of 0.7. The patient has a known history of Diabetes Mellitus (DM). Based on these findings, what is the patient's risk of developing advanced fibrosis?",
        "choices": {
            "A": "The patient is at a high risk of advanced fibrosis",
            "B": "The patient is at a moderate risk of advanced fibrosis",
            "C": "The patient is at a low risk of advanced fibrosis",
            "D": "The patient is at no risk of advanced fibrosis",
            "E": "The patient's risk of advanced fibrosis cannot be determined from the given information"
        },
        "answer": "C",
        "pmid": "18390575"
    },
    {
        "question": "A 55-year-old male patient presents with a history of non-alcoholic fatty liver disease (NAFLD). He has a Body Mass Index (BMI) of 29 kg/m^2, indicating overweight. His laboratory results show an Aspartate Aminotransferase (AST) level of 85 U/L and an Alanine Aminotransferase (ALT) level of 100 U/L, yielding an AST/ALT ratio of 0.85. The patient also has a known diagnosis of Diabetes Mellitus (DM). Based on these findings, what is the patient's risk of developing advanced fibrosis?",
        "choices": {
            "A": "Low risk of advanced fibrosis",
            "B": "Moderate risk of advanced fibrosis",
            "C": "High risk of advanced fibrosis",
            "D": "The patient is already in the stage of advanced fibrosis",
            "E": "Unable to determine the risk without further testing"
        },
        "answer": "C",
        "pmid": "18390575"
    },
    {
        "question": "A 45-year-old male patient presents with a history of non-alcoholic fatty liver disease (NAFLD). He has a Body Mass Index (BMI) of 27 kg/m^2, indicating overweight. His laboratory results show an Aspartate Aminotransferase (AST) level of 30 U/L and an Alanine Aminotransferase (ALT) level of 40 U/L, yielding an AST/ALT ratio of 0.75. The patient does not have Diabetes Mellitus (DM). Based on these findings, what is the patient's risk of advanced fibrosis in the context of NAFLD?",
        "choices": {
            "A": "High risk of advanced fibrosis",
            "B": "Low risk of advanced fibrosis",
            "C": "Moderate risk of advanced fibrosis",
            "D": "Risk cannot be determined",
            "E": "Risk is negligible"
        },
        "answer": "B",
        "pmid": "18390575"
    },
    {
        "question": "A 55-year-old male patient presents with a history of obesity and diabetes mellitus. His body mass index (BMI) is 32 kg/m^2. His liver function tests reveal an Aspartate Aminotransferase (AST) level of 90 U/L and an Alanine Aminotransferase (ALT) level of 100 U/L, yielding an AST/ALT ratio of 0.9. The patient has been diagnosed with non-alcoholic fatty liver disease (NAFLD). Based on these findings, what is the patient's risk of developing advanced fibrosis?",
        "choices": {
            "A": "Low risk",
            "B": "Moderate risk",
            "C": "High risk",
            "D": "The patient is already in the stage of advanced fibrosis",
            "E": "Unable to determine without further testing"
        },
        "answer": "C",
        "pmid": "18390575"
    },
    {
        "question": "A 75-year-old male patient is admitted to the hospital. He is 170 cm tall and weighs 65 kg. His albumin level is 35 g/L. Based on these parameters, his risk of morbidity and mortality related to nutritional status is calculated. What is the most likely risk category for this patient?",
        "choices": {
            "A": "Major nutrition-related risk",
            "B": "Moderate nutrition-related risk",
            "C": "Low nutrition-related risk",
            "D": "No nutrition-related risk",
            "E": "Unable to determine without further information"
        },
        "answer": "C",
        "pmid": "16210706"
    },
    {
        "question": "An 80-year-old female patient has been admitted to the hospital. She is 160 cm tall and weighs 50 kg. Her albumin level is 30 g/L. She has a history of hypertension and type 2 diabetes. She has been experiencing loss of appetite and weight loss over the past few months. Based on her nutritional status, which of the following best describes her risk of morbidity and mortality?",
        "choices": {
            "A": "No nutrition-related risk",
            "B": "Low nutrition-related risk",
            "C": "Moderate nutrition-related risk",
            "D": "Major nutrition-related risk",
            "E": "Unable to determine the risk without further information"
        },
        "answer": "D",
        "pmid": "16210706"
    },
    {
        "question": "A 70-year-old male patient is admitted to the hospital. He is 180 cm tall and weighs 80 kg. His albumin level is 40 g/L. The patient's nutritional risk index was calculated and found to be 101.26. What does this score indicate about the patient's nutritional status and associated risk of morbidity and mortality?",
        "choices": {
            "A": "The patient is at major nutrition-related risk, with an odds ratio for mortality of 29 (95% CI: 5.2, 161.4) and for complications of 4.4 (95% CI: 1.3, 14.9).",
            "B": "The patient is at moderate nutrition-related risk, with an odds ratio for mortality of 6.6 (95% CI: 1.3, 33.0) and for complications of 4.9 (95% CI: 1.9, 12.5).",
            "C": "The patient is at low nutrition-related risk, with an odds ratio for mortality of 5.6 (95% CI: 1.2, 26.6) and for complications of 3.3 (95% CI: 1.4, 8.0).",
            "D": "The patient is at no nutrition-related risk.",
            "E": "The patient's nutritional status cannot be determined from the given information."
        },
        "answer": "D",
        "pmid": "16210706"
    },
    {
        "question": "An 85-year-old female patient has been admitted to the hospital. She is 150 cm tall and weighs 55 kg. Her albumin level is 25 g/L. She has no known allergies and her medical history is unremarkable. She has been experiencing loss of appetite and weight loss over the past few months. Based on her nutritional status, which of the following best describes her risk of morbidity and mortality?",
        "choices": {
            "A": "No nutrition-related risk",
            "B": "Low nutrition-related risk",
            "C": "Moderate nutrition-related risk",
            "D": "Major nutrition-related risk",
            "E": "Unable to determine without further information"
        },
        "answer": "D",
        "pmid": "16210706"
    },
    {
        "question": "A 78-year-old male patient is admitted to the hospital. He is 165 cm tall and weighs 70 kg. His albumin level is 33 g/L. Based on these parameters, a nutritional risk index was calculated to be 90.837. This score indicates a certain level of nutrition-related risk. What is the most likely risk level and associated odds ratio for mortality and complications for this patient?",
        "choices": {
            "A": "Major nutrition-related risk. Odds ratio for mortality is 29 (95% CI: 5.2, 161.4) and for complications is 4.4 (95% CI: 1.3, 14.9).",
            "B": "Moderate nutrition-related risk. Odds ratio for mortality is 6.6 (95% CI: 1.3, 33.0) and for complications is 4.9 (95% CI: 1.9, 12.5).",
            "C": "Low nutrition-related risk. Odds ratio for mortality is 5.6 (95% CI: 1.2, 26.6) and for complications is 3.3 (95% CI: 1.4, 8.0).",
            "D": "No nutrition-related risk.",
            "E": "The patient's nutritional risk cannot be determined from the given information."
        },
        "answer": "B",
        "pmid": "16210706"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal-cell carcinoma. He is currently being treated with first-line VEGF-targeted treatment. His laboratory results show anaemia and thrombocytosis. His Karnofsky performance status is 75, indicating that he requires assistance but is able to walk and carry out work of a light or sedentary nature. The time from his diagnosis to the initiation of treatment is 10 months. He does not exhibit neutrophilia or hypercalcaemia. Based on these factors, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Favourable risk group, median overall survival is 43.2 months",
            "B": "Intermediate risk group, median overall survival is 22.5 months",
            "C": "Poor risk group, median overall survival is 7.8 months",
            "D": "Intermediate risk group, median overall survival is 15 months",
            "E": "Poor risk group, median overall survival is 5 months"
        },
        "answer": "C",
        "pmid": "23312463"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal-cell carcinoma. He is currently being treated with first-line VEGF-targeted treatment. His laboratory results show neutrophilia and hypercalcaemia. His Karnofsky performance status is 85, indicating that he is able to carry on normal activity and work with no special care needed. The time from his diagnosis to the start of treatment is 15 months. He does not have anaemia or thrombocytosis. Based on these factors, what is the patient's prognostic risk group and expected median overall survival?",
        "choices": {
            "A": "Favourable risk group, median overall survival is 43.2 months",
            "B": "Intermediate risk group, median overall survival is 22.5 months",
            "C": "Poor risk group, median overall survival is 7.8 months",
            "D": "Intermediate risk group, median overall survival is 43.2 months",
            "E": "Poor risk group, median overall survival is 22.5 months"
        },
        "answer": "B",
        "pmid": "23312463"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal-cell carcinoma. He was diagnosed 8 months ago and is about to start first-line VEGF-targeted treatment. His laboratory results show anaemia but no signs of thrombocytosis, neutrophilia, or hypercalcaemia. His Karnofsky performance status is 90, indicating he is able to carry on normal activity and work with no special care needed. Based on these factors, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favourable risk group with a median overall survival of 43.2 months.",
            "B": "The patient is in the intermediate risk group with a median overall survival of 22.5 months.",
            "C": "The patient is in the poor risk group with a median overall survival of 7.8 months.",
            "D": "The patient's prognosis cannot be determined without further testing.",
            "E": "The patient's prognosis is highly variable and cannot be accurately predicted."
        },
        "answer": "B",
        "pmid": "23312463"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal-cell carcinoma. He has been treated with first-line VEGF-targeted treatment. His laboratory results show thrombocytosis, neutrophilia, and hypercalcaemia. His Karnofsky performance status is 70, indicating that he requires assistance but is able to care for most of his personal needs. The time from his diagnosis to the initiation of treatment is 11 months. He does not have anaemia. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favourable risk group with a median overall survival of 43.2 months.",
            "B": "The patient is in the intermediate risk group with a median overall survival of 22.5 months.",
            "C": "The patient is in the poor risk group with a median overall survival of 7.8 months.",
            "D": "The patient is in the high risk group with a median overall survival of less than 6 months.",
            "E": "The patient's prognosis cannot be determined based on the given information."
        },
        "answer": "C",
        "pmid": "23312463"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal-cell carcinoma. He has been treated with first-line VEGF-targeted treatment. His laboratory results show no signs of anaemia, thrombocytosis, neutrophilia, or hypercalcaemia. His Karnofsky performance status is 85, indicating that he is able to carry on normal activity and work with no special care needed. The time from his diagnosis to the start of treatment was 13 months. Based on these factors, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median overall survival is less than 8 months",
            "B": "Median overall survival is approximately 22.5 months",
            "C": "Median overall survival is approximately 43.2 months",
            "D": "Median overall survival is more than 50 months",
            "E": "Unable to determine median overall survival"
        },
        "answer": "C",
        "pmid": "23312463"
    },
    {
        "question": "A 70-year-old patient presents with a myocardial infarction. The patient has a history of prior myocardial infarction and is a current smoker. The patient does not have diabetes, and the stent placed during percutaneous coronary intervention (PCI) is not less than 3 mm in diameter. The patient does not have a paclitaxel-eluting stent, and there is no history of congestive heart failure or low ejection fraction. The patient has not undergone a vein graft intervention. The patient has not sustained major bleeding or ischemic events 1 year after PCI. Based on these factors, which of the following is the most appropriate management strategy for this patient?",
        "choices": {
            "A": "Discontinue thienopyridine due to high risk of bleeding",
            "B": "Continue thienopyridine due to high risk of ischemic events",
            "C": "Discontinue thienopyridine due to low risk of ischemic events",
            "D": "Continue thienopyridine due to low risk of bleeding",
            "E": "The decision to continue or discontinue thienopyridine should be based on patient preference"
        },
        "answer": "B",
        "pmid": "27022822"
    },
    {
        "question": "An 80-year-old patient presents with a myocardial infarction. They have a history of prior myocardial infarction and percutaneous coronary intervention. The patient is a smoker and has been diagnosed with diabetes. The stent diameter is less than 3 mm, and they have a paclitaxel-eluting stent. The patient has a history of congestive heart failure and low ejection fraction. They have also undergone a vein graft intervention. The patient has not sustained major bleeding or ischemic events 1 year after the percutaneous coronary intervention. Based on these factors, what is the most appropriate management plan for this patient?",
        "choices": {
            "A": "Discontinue thienopyridine as it is associated with smaller increases in bleeding.",
            "B": "Continue thienopyridine as it is associated with reduced ischemic events.",
            "C": "Increase the dosage of thienopyridine to reduce the risk of ischemic events.",
            "D": "Switch to a different antiplatelet therapy due to the high risk of bleeding.",
            "E": "Monitor the patient without any changes in the current medication regimen."
        },
        "answer": "B",
        "pmid": "27022822"
    },
    {
        "question": "A 65-year-old patient presents for a follow-up visit one year after Percutaneous Coronary Intervention (PCI). The patient has a history of diabetes but does not smoke. They did not present with a myocardial infarction at the time of PCI and have no history of prior myocardial infarction or PCI. Their stent diameter is not less than 3 mm, and they do not have a paclitaxel-eluting stent. They have no history of congestive heart failure or low ejection fraction and have not had a vein graft intervention. The patient has not sustained any major bleeding or ischemic events since the PCI. Based on these factors, which of the following is the most appropriate management strategy for this patient's antiplatelet therapy?",
        "choices": {
            "A": "Discontinue thienopyridine due to high risk of bleeding",
            "B": "Continue thienopyridine due to high risk of ischemic events",
            "C": "Continue thienopyridine due to low risk of bleeding",
            "D": "Discontinue thienopyridine due to low risk of ischemic events",
            "E": "Switch to a different antiplatelet therapy"
        },
        "answer": "C",
        "pmid": "27022822"
    },
    {
        "question": "A 55-year-old patient presents for a follow-up visit after a percutaneous coronary intervention (PCI). The patient did not present with a myocardial infarction and they do not have a history of prior myocardial infarction or PCI. They do not have diabetes, but their stent diameter is less than 3 mm. They are not a smoker, but they have a paclitaxel-eluting stent. They have a history of congestive heart failure or low ejection fraction and they have had a vein graft intervention. The patient has not sustained major bleeding or ischemic events 1 year after PCI. The patient's score based on these factors is 6. What is the best course of action for this patient?",
        "choices": {
            "A": "Discontinue thienopyridine as the patient is at low risk for ischemic events.",
            "B": "Continue thienopyridine as the patient is at high risk for ischemic events.",
            "C": "Increase the dosage of thienopyridine as the patient is at high risk for ischemic events.",
            "D": "Switch to a different antiplatelet therapy as the patient is at high risk for ischemic events.",
            "E": "The patient's risk for ischemic events cannot be determined based on the given information."
        },
        "answer": "B",
        "pmid": "27022822"
    },
    {
        "question": "A 76-year-old patient presents with a myocardial infarction. The patient has a history of smoking but does not have a history of prior myocardial infarction or percutaneous coronary intervention (PCI). The patient does not have diabetes and the stent diameter used in the intervention is not less than 3 mm. The patient does not have a paclitaxel-eluting stent, nor a history of congestive heart failure or low ejection fraction. The patient has not had a vein graft intervention. The patient's score, calculated based on these factors, is 0. What is the most appropriate management strategy for this patient regarding the continuation of thienopyridine therapy?",
        "choices": {
            "A": "Continue thienopyridine therapy as it is associated with reduced ischemic events",
            "B": "Discontinue thienopyridine therapy as it is associated with increased bleeding risk",
            "C": "Continue thienopyridine therapy as it is associated with smaller increases in bleeding",
            "D": "Discontinue thienopyridine therapy as it is not associated with reduced ischemic events",
            "E": "The decision to continue or discontinue thienopyridine therapy should be based on other factors not included in the score"
        },
        "answer": "C",
        "pmid": "27022822"
    },
    {
        "question": "A 55-year-old male patient with end-stage liver disease is being evaluated for liver transplantation. His Model for End-Stage Liver Disease (MELD) score is 15, and his serum sodium concentration is 130 mEq/L. Based on these parameters, what is the estimated risk of mortality within 6 months of listing for liver transplantation?",
        "choices": {
            "A": "Less than 6%",
            "B": "Between 6% and 16%",
            "C": "Between 16% and 37%",
            "D": "More than 37%",
            "E": "Cannot be determined from the given information"
        },
        "answer": "B",
        "pmid": "16697729"
    },
    {
        "question": "A 55-year-old male patient with end-stage liver disease is currently on the waiting list for liver transplantation. His recent laboratory results show a MELD score of 25 and a serum sodium concentration of 125 mEq/L. Based on these results, what is the estimated risk of death for this patient within 6 months of listing for liver transplantation?",
        "choices": {
            "A": "6%",
            "B": "16%",
            "C": "37%",
            "D": "Above 37%",
            "E": "Cannot be determined from the given information"
        },
        "answer": "D",
        "pmid": "16697729"
    },
    {
        "question": "A 55-year-old male patient with end-stage liver disease is currently on the waiting list for liver transplantation. His recent laboratory results show a Model for End-Stage Liver Disease (MELD) score of 35 and a serum sodium concentration of 120 mEq/L. Based on these results, what is the estimated risk of mortality for this patient within 6 months of listing for liver transplantation?",
        "choices": {
            "A": "Less than 6% risk of death",
            "B": "Approximately 16% risk of death",
            "C": "Approximately 37% risk of death",
            "D": "Greater than 37% risk of death",
            "E": "Unable to estimate the risk of death"
        },
        "answer": "D",
        "pmid": "16697729"
    },
    {
        "question": "A 55-year-old male patient with end-stage liver disease is currently on the waiting list for liver transplantation. His recent laboratory results show a Model for End-Stage Liver Disease (MELD) score of 40 and a serum sodium concentration of 135 mEq/L. Based on these results, what is the estimated risk of death for this patient within 6 months of listing for liver transplantation?",
        "choices": {
            "A": "6% risk of death",
            "B": "16% risk of death",
            "C": "37% risk of death",
            "D": "50% risk of death",
            "E": "75% risk of death"
        },
        "answer": "C",
        "pmid": "16697729"
    },
    {
        "question": "A 55-year-old male patient with end-stage liver disease is currently on the waiting list for liver transplantation. His recent laboratory results show a Model for End-Stage Liver Disease (MELD) score of 30 and a serum sodium concentration of 132 mEq/L. Based on these results, what is the estimated risk of death for this patient within 6 months of listing for liver transplantation?",
        "choices": {
            "A": "Less than 6%",
            "B": "Between 6% and 16%",
            "C": "Between 16% and 37%",
            "D": "More than 37%",
            "E": "Cannot be determined from the given information"
        },
        "answer": "C",
        "pmid": "16697729"
    },
    {
        "question": "A 65-year-old male patient has been admitted to the ICU for 10 days following a complicated abdominal surgery. He is nonneutropenic and has been on total parenteral nutrition since his admission. The patient's cultures have shown multifocal Candida colonization. However, he does not exhibit signs of severe sepsis. Given these factors, what is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "No need for antifungal treatment as the risk of proven candidal infection is low",
            "B": "Start early antifungal treatment due to high risk of proven candidal infection",
            "C": "Monitor the patient closely without starting antifungal treatment",
            "D": "Start prophylactic antibiotics due to high risk of bacterial infection",
            "E": "Perform a surgical debridement to remove potential sources of infection"
        },
        "answer": "B",
        "pmid": "16505659"
    },
    {
        "question": "A 65-year-old male patient has been admitted to the ICU for 10 days. He is critically ill but nonneutropenic. He has not undergone any surgical procedure recently and there is no evidence of multifocal Candida colonization. However, he is currently on total parenteral nutrition due to his inability to eat and has been diagnosed with severe sepsis. His score based on certain risk factors is 2.946. What is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "No need for antifungal treatment as the risk of candidal infection is low",
            "B": "Start early antifungal treatment due to high risk of candidal infection",
            "C": "Monitor the patient closely but withhold antifungal treatment until further signs of candidal infection",
            "D": "Start prophylactic antibiotics due to high risk of bacterial infection",
            "E": "Perform a surgical procedure to remove potential source of infection"
        },
        "answer": "B",
        "pmid": "16505659"
    },
    {
        "question": "A 55-year-old male patient has been admitted to the ICU for 10 days following a complicated abdominal surgery. He is nonneutropenic and critically ill. He has developed severe sepsis but does not show signs of multifocal Candida colonization. He is not on total parenteral nutrition. His computed score based on these factors is approximately 3.035. What is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "No need for antifungal treatment as the risk of candidal infection is low",
            "B": "Start antifungal treatment immediately due to high risk of candidal infection",
            "C": "Monitor the patient closely but withhold antifungal treatment until signs of multifocal Candida colonization appear",
            "D": "Start the patient on total parenteral nutrition to reduce the risk of candidal infection",
            "E": "Perform a surgery to remove potential sources of Candida infection"
        },
        "answer": "B",
        "pmid": "16505659"
    },
    {
        "question": "A 55-year-old male patient has been admitted to the ICU for 10 days. He is critically ill but nonneutropenic. He has not undergone any surgical procedure during this admission. He is not on total parenteral nutrition. However, he has been diagnosed with multifocal Candida colonization. He does not have severe sepsis. His score based on certain clinical factors is 1.112. What does this score suggest about his risk of proven candidal infection and the need for early antifungal treatment?",
        "choices": {
            "A": "The patient has a high risk of proven candidal infection and should receive early antifungal treatment.",
            "B": "The patient has a moderate risk of proven candidal infection and may benefit from early antifungal treatment.",
            "C": "The patient has a low risk of proven candidal infection and may not require early antifungal treatment.",
            "D": "The patient's risk of proven candidal infection cannot be determined from the score.",
            "E": "The patient's score is not relevant to the risk of proven candidal infection."
        },
        "answer": "C",
        "pmid": "16505659"
    },
    {
        "question": "A 65-year-old male patient has been admitted to the ICU for 10 days following a complicated abdominal surgery. He is nonneutropenic and critically ill. His postoperative course has been complicated by severe sepsis. The patient's cultures have shown multifocal Candida colonization. However, he is not receiving total parenteral nutrition. Based on these findings, which of the following is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "Observe and continue current management without antifungal treatment",
            "B": "Start prophylactic antifungal treatment",
            "C": "Perform a biopsy to confirm candidal infection before starting treatment",
            "D": "Start antifungal treatment only if the patient develops symptoms of candidal infection",
            "E": "Discontinue all antibiotics to reduce the risk of further fungal colonization"
        },
        "answer": "B",
        "pmid": "16505659"
    },
    {
        "question": "A 65-year-old patient presents to your clinic for a routine follow-up. The patient has a known diagnosis of Essential Thrombocythemia (ET) as defined by the World Health Organization (WHO). The patient's medical history is significant for a previous thrombotic event. The patient does not have any known cardiovascular risk factors such as hypertension, diabetes, or hyperlipidemia. Genetic testing has revealed the presence of the JAK2V617F mutation. Based on this information, what is the patient's annual risk of thrombosis?",
        "choices": {
            "A": "1.03% per year",
            "B": "2.35% per year",
            "C": "3.56% per year",
            "D": "4.75% per year",
            "E": "5.95% per year"
        },
        "answer": "C",
        "pmid": "23033268"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic for a routine check-up. He has been previously diagnosed with Essential Thrombocythemia (ET) as per the World Health Organization (WHO) criteria. He has a history of hypertension and hyperlipidemia, but no history of thrombosis or any genetic mutations such as JAK2V617F. Based on his age, history of cardiovascular risk factors, and absence of thrombosis history and JAK2V617F mutation, what is the patient's annual risk of developing thrombosis?",
        "choices": {
            "A": "Less than 1% per year",
            "B": "1.03% per year",
            "C": "2.35% per year",
            "D": "3.56% per year",
            "E": "More than 4% per year"
        },
        "answer": "B",
        "pmid": "23033268"
    },
    {
        "question": "A 65-year-old patient with a diagnosis of Essential Thrombocythemia (ET) as per World Health Organization (WHO) criteria presents for a routine follow-up. The patient has a history of hypertension and hyperlipidemia but has never experienced a thrombotic event. Genetic testing reveals the absence of the JAK2V617F mutation. Based on these factors, what is the patient's annual risk of thrombosis?",
        "choices": {
            "A": "1.03% per year",
            "B": "2.35% per year",
            "C": "3.56% per year",
            "D": "Less than 1% per year",
            "E": "More than 4% per year"
        },
        "answer": "B",
        "pmid": "23033268"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic. He has been previously diagnosed with Essential Thrombocythemia (ET) as per the World Health Organization (WHO) criteria. His medical history is significant for a thrombotic event. He does not have any known cardiovascular risk factors such as hypertension, diabetes, or hyperlipidemia. Genetic testing reveals the presence of the JAK2V617F mutation. Based on these factors, what is the patient's risk of developing thrombosis per year?",
        "choices": {
            "A": "1.03%",
            "B": "2.35%",
            "C": "3.56%",
            "D": "4.75%",
            "E": "5.98%"
        },
        "answer": "C",
        "pmid": "23033268"
    },
    {
        "question": "A 65-year-old patient presents to your clinic for a routine check-up. The patient has a history of thrombosis and cardiovascular risk factors including hypertension and hyperlipidemia. Laboratory tests reveal no evidence of the JAK2V617F mutation. Based on these findings, what is the patient's risk of developing thrombosis per year?",
        "choices": {
            "A": "1.03%",
            "B": "2.35%",
            "C": "3.56%",
            "D": "4.75%",
            "E": "5.95%"
        },
        "answer": "C",
        "pmid": "23033268"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal cell carcinoma. He has a history of anemia and thrombocytosis. His Karnofsky performance status is 75, indicating a relatively poor performance status. He started first-line targeted therapy 10 months after diagnosis. Laboratory tests show no signs of neutrophilia or hypercalcaemia. Based on these factors, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favorable risk group with a median overall survival of 35.3 months.",
            "B": "The patient is in the intermediate risk group with a median overall survival of 16.6 months.",
            "C": "The patient is in the poor risk group with a median overall survival of 5.4 months.",
            "D": "The patient is in the high risk group with a median overall survival of less than 3 months.",
            "E": "The patient's prognosis cannot be determined based on the given information."
        },
        "answer": "C",
        "pmid": "25681967"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal cell carcinoma. He has been receiving second-line targeted therapy after progression on first-line targeted therapy. His laboratory results show neutrophilia and hypercalcaemia. His Karnofsky performance status is 85, indicating a relatively good performance status. He started first-line targeted therapy 8 months after diagnosis. He does not have anaemia or thrombocytosis. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favorable risk group with a median overall survival of 35.3 months.",
            "B": "The patient is in the intermediate risk group with a median overall survival of 16.6 months.",
            "C": "The patient is in the poor risk group with a median overall survival of 5.4 months.",
            "D": "The patient is in the high risk group with a median overall survival of less than 5 months.",
            "E": "The patient's prognosis cannot be determined based on the given information."
        },
        "answer": "B",
        "pmid": "25681967"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal cell carcinoma. He has been receiving second-line targeted therapy after progression on first-line targeted therapy. The patient has a history of anaemia. His Karnofsky performance status is 90, indicating a good performance status. He started first-line targeted therapy 12 months after diagnosis. Laboratory tests show no signs of thrombocytosis, neutrophilia or hypercalcaemia. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favorable risk group with a median overall survival of 35.3 months.",
            "B": "The patient is in the intermediate risk group with a median overall survival of 16.6 months.",
            "C": "The patient is in the poor risk group with a median overall survival of 5.4 months.",
            "D": "The patient's prognosis cannot be determined without further testing.",
            "E": "The patient's prognosis is highly variable and cannot be accurately predicted."
        },
        "answer": "B",
        "pmid": "25681967"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal cell carcinoma. He has been receiving second-line targeted therapy after progression on first-line targeted therapy. His laboratory results show thrombocytosis and neutrophilia. He also has hypercalcemia. His Karnofsky performance status is 70, indicating a poor performance status. He started first-line targeted therapy 6 months after diagnosis. He does not have anaemia. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favorable risk group with a median overall survival of 35.3 months.",
            "B": "The patient is in the intermediate risk group with a median overall survival of 16.6 months.",
            "C": "The patient is in the poor risk group with a median overall survival of 5.4 months.",
            "D": "The patient is in the high risk group with a median overall survival of less than 3 months.",
            "E": "The patient's prognosis cannot be determined based on the given information."
        },
        "answer": "C",
        "pmid": "25681967"
    },
    {
        "question": "A 58-year-old male patient presents with metastatic renal cell carcinoma. He has been receiving second-line targeted therapy after progression on first-line targeted therapy. His laboratory results show anaemia, thrombocytosis, and neutrophilia. He also has hypercalcaemia. His Karnofsky performance status is 80, indicating a relatively good performance status. He started first-line targeted therapy 11 months after diagnosis. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is in the favorable risk group with an estimated median overall survival of 35.3 months.",
            "B": "The patient is in the intermediate risk group with an estimated median overall survival of 16.6 months.",
            "C": "The patient is in the poor risk group with an estimated median overall survival of 5.4 months.",
            "D": "The patient is in the high risk group with an estimated median overall survival of less than 3 months.",
            "E": "The patient's prognosis cannot be determined based on the given information."
        },
        "answer": "C",
        "pmid": "25681967"
    },
    {
        "question": "A 45-year-old male patient was admitted to the hospital with severe abdominal pain. He was diagnosed with acute pancreatitis and underwent debridement. His serum creatinine level at admission was 1.2 mg/dL and the serum albumin level was 3.5 g/dL. His other laboratory test values were within normal limits and he had no significant past medical history. Based on his Creatinine-Albumin (Cr/Alb) ratio, which of the following is the most likely prognosis for this patient?",
        "choices": {
            "A": "High risk of re-operation and mortality",
            "B": "Low risk of re-operation and mortality",
            "C": "Impaired laboratory test values",
            "D": "High APACHE II scores",
            "E": "High rates of post-operative complications"
        },
        "answer": "B",
        "pmid": "33298030"
    },
    {
        "question": "A 55-year-old male patient was admitted to the hospital with severe abdominal pain. He was diagnosed with acute pancreatitis and underwent debridement. His laboratory results at admission showed a serum creatinine level of 4.5 mg/dL and a serum albumin level of 1.0 g/dL. Based on these laboratory results, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Lower risk of re-operation and mortality",
            "B": "Higher risk of re-operation and mortality",
            "C": "Normal risk of re-operation and mortality",
            "D": "The laboratory results are not indicative of the prognosis",
            "E": "The patient is likely to recover without any complications"
        },
        "answer": "B",
        "pmid": "33298030"
    },
    {
        "question": "A 55-year-old male patient was admitted to the hospital with severe abdominal pain. He was diagnosed with acute pancreatitis and underwent debridement. His serum creatinine level at admission was 2.5 mg/dL and the serum albumin level was 0.7 g/dL. Based on these laboratory values, what is the patient's risk of re-operation and mortality?",
        "choices": {
            "A": "The patient is at a lower risk of re-operation and mortality",
            "B": "The patient is at a moderate risk of re-operation and mortality",
            "C": "The patient is at a higher risk of re-operation and mortality",
            "D": "The patient's risk of re-operation and mortality cannot be determined from these values",
            "E": "The patient's risk of re-operation and mortality is average"
        },
        "answer": "C",
        "pmid": "33298030"
    },
    {
        "question": "A 55-year-old male patient was admitted to the hospital with severe abdominal pain. He was diagnosed with acute pancreatitis and underwent debridement. His serum creatinine level at admission was 1.8 mg/dL and the serum albumin level was 2.5 g/dL. He has no history of chronic diseases. Based on his Creatinine-Albumin ratio of 0.72, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is at a high risk of re-operation and mortality",
            "B": "The patient is at a moderate risk of re-operation and mortality",
            "C": "The patient is at a low risk of re-operation and mortality",
            "D": "The patient's risk of re-operation and mortality cannot be determined",
            "E": "The patient's risk of re-operation and mortality is average"
        },
        "answer": "C",
        "pmid": "33298030"
    },
    {
        "question": "A 55-year-old male patient was admitted to the hospital with severe abdominal pain. He was diagnosed with acute pancreatitis and underwent debridement. His laboratory test results at admission showed a serum creatinine level of 3.0 mg/dL and a serum albumin level of 1.0 g/dL. Based on these values, what is the patient's risk of re-operation and mortality?",
        "choices": {
            "A": "Very high risk of re-operation and mortality",
            "B": "High risk of re-operation and mortality",
            "C": "Moderate risk of re-operation and mortality",
            "D": "Low risk of re-operation and mortality",
            "E": "Very low risk of re-operation and mortality"
        },
        "answer": "D",
        "pmid": "33298030"
    },
    {
        "question": "A 45-year-old male patient presents to the emergency department with severe abdominal pain, nausea, and vomiting. He has a history of heavy alcohol use. His physical examination reveals epigastric tenderness but no rebound abdominal tenderness. Laboratory tests show a serum creatinine level of 1.8 mg/dL. His hematocrit level is 42. This is his first episode of acute pancreatitis. Based on these findings, which of the following is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is likely to have a severe course of acute pancreatitis",
            "B": "The patient is likely to have a non-severe course of acute pancreatitis",
            "C": "The patient is likely to require surgical intervention",
            "D": "The patient is likely to develop chronic pancreatitis",
            "E": "The patient is at risk of developing pancreatic cancer"
        },
        "answer": "B",
        "pmid": "24671724"
    },
    {
        "question": "A 50-year-old woman presents to the emergency department with severe abdominal pain. She has a history of alcohol abuse and this is her first episode of acute pancreatitis. On physical examination, she has rebound abdominal tenderness. Laboratory tests reveal a serum creatinine level of 2.1 mg/dL and a hematocrit level of 40. Based on these findings, which of the following is the most likely prognosis for this patient?",
        "choices": {
            "A": "The patient is likely to have a non-severe course of acute pancreatitis",
            "B": "The patient is at risk of a severe course of acute pancreatitis",
            "C": "The patient will require immediate surgical intervention",
            "D": "The patient will recover without any complications",
            "E": "The patient's condition is not related to her alcohol abuse"
        },
        "answer": "B",
        "pmid": "24671724"
    },
    {
        "question": "A 35-year-old male patient presents to the emergency department with severe abdominal pain, nausea, and vomiting. He has a history of heavy alcohol use. His physical examination reveals epigastric tenderness but no rebound abdominal tenderness. Laboratory tests show a serum creatinine level of 1.5 mg/dL. His hematocrit level is 45. This is his first episode of acute pancreatitis. Based on these findings, which of the following best describes the likely course of his acute pancreatitis?",
        "choices": {
            "A": "The patient is likely to have a non-severe course of acute pancreatitis",
            "B": "The patient is at risk of a severe course of acute pancreatitis",
            "C": "The patient's course of acute pancreatitis cannot be determined",
            "D": "The patient is likely to have a moderate course of acute pancreatitis",
            "E": "The patient is likely to have a mild course of acute pancreatitis"
        },
        "answer": "B",
        "pmid": "24671724"
    },
    {
        "question": "A 60-year-old woman presents to the emergency department with severe abdominal pain, nausea, and vomiting. She has a history of gallstones and heavy alcohol use. She denies any recent changes in her bowel habits, weight loss, or jaundice. On physical examination, she appears uncomfortable but is not in distress. Her abdomen is soft, with mild epigastric tenderness but no rebound or guarding. Laboratory studies reveal a serum creatinine level of 1.9 mg/dL and a hematocrit level of 38. Based on these findings, which of the following is the most likely prognosis for this patient's acute pancreatitis?",
        "choices": {
            "A": "The patient is likely to have a severe course of acute pancreatitis",
            "B": "The patient is likely to have a non-severe course of acute pancreatitis",
            "C": "The patient is at risk of developing chronic pancreatitis",
            "D": "The patient is at risk of developing pancreatic cancer",
            "E": "The patient is at risk of developing diabetes mellitus"
        },
        "answer": "B",
        "pmid": "24671724"
    },
    {
        "question": "A 55-year-old male patient presents to the emergency department with severe abdominal pain. He has a documented first episode of acute pancreatitis. On examination, he has rebound abdominal tenderness. His laboratory results show a serum creatinine level of 2.2 mg/dL and a hematocrit level of 44. Based on these findings, what is the most likely prognosis for this patient's course of acute pancreatitis?",
        "choices": {
            "A": "The patient is likely to have a non-severe course of acute pancreatitis",
            "B": "The patient is at risk of a severe course of acute pancreatitis",
            "C": "The patient's condition is likely to remain stable",
            "D": "The patient's condition is likely to deteriorate rapidly",
            "E": "The patient's condition cannot be determined at this time"
        },
        "answer": "B",
        "pmid": "24671724"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic for a routine check-up. He is overweight with a BMI of 30 kg/m^2. His liver function tests reveal an ALT level of 2.5. His lipid profile shows a triglycerides level of 1.8 mmol/L. He has no history of overt liver disease, alcohol abuse, viral hepatitis, autoimmune disorders, drug-induced liver injury, or genetic liver disease. Based on these findings, what is the most likely risk of septal fibrosis in this patient?",
        "choices": {
            "A": "The patient has a very low risk of septal fibrosis",
            "B": "The patient has a moderate risk of septal fibrosis",
            "C": "The patient has a high risk of septal fibrosis",
            "D": "The patient has a very high risk of septal fibrosis",
            "E": "The patient's risk of septal fibrosis cannot be determined"
        },
        "answer": "C",
        "pmid": "10833486"
    },
    {
        "question": "A 45-year-old patient presents to the clinic for a routine check-up. The patient has a history of being overweight with a current BMI of 27 kg/m^2. The patient's recent blood work shows a triglycerides level of 1.5 mmol/L and an ALT level of 1.8. The patient does not have any known liver disease, and there is no history of alcohol abuse, viral infections, autoimmune disorders, drug-induced liver damage, or genetic liver disease. Based on the patient's age, BMI, triglycerides level, and ALT level, what is the risk of this patient developing septal fibrosis?",
        "choices": {
            "A": "The patient has a very high risk of developing septal fibrosis",
            "B": "The patient has a high risk of developing septal fibrosis",
            "C": "The patient has a moderate risk of developing septal fibrosis",
            "D": "The patient has a low risk of developing septal fibrosis",
            "E": "The patient has a very low risk of developing septal fibrosis"
        },
        "answer": "E",
        "pmid": "10833486"
    },
    {
        "question": "A 52-year-old patient presents to the clinic for a routine check-up. The patient has a history of being overweight with a current BMI of 26 kg/m^2. The patient's recent blood work shows a triglycerides level of 1.6 mmol/L and an ALT level of 2.2. The patient has no history of overt liver disease, alcoholic, viral, autoimmune, drug-induced, or genetic liver disease. Based on the patient's age, BMI, triglycerides, and ALT levels, what is the most likely risk of septal fibrosis in this patient?",
        "choices": {
            "A": "The patient has a very low risk of septal fibrosis",
            "B": "The patient has a moderate risk of septal fibrosis",
            "C": "The patient has a high risk of septal fibrosis",
            "D": "The patient has a very high risk of septal fibrosis",
            "E": "The patient's risk of septal fibrosis cannot be determined"
        },
        "answer": "B",
        "pmid": "10833486"
    },
    {
        "question": "A 60-year-old patient presents to the clinic for a routine check-up. The patient has a history of being overweight with a current BMI of 29 kg/m^2. The patient's recent blood work shows a triglycerides level of 1.9 mmol/L. The patient's ALT level is 1.5. The patient does not have any known liver disease, and there is no history of alcohol abuse, viral hepatitis, autoimmune disease, drug-induced liver disease, or genetic liver disease. Based on the patient's age, BMI, triglycerides level, and ALT level, what is the most likely risk level for septal fibrosis in this patient?",
        "choices": {
            "A": "The patient has a very low risk of septal fibrosis",
            "B": "The patient has a moderate risk of septal fibrosis",
            "C": "The patient has a high risk of septal fibrosis",
            "D": "The patient has a very high risk of septal fibrosis",
            "E": "The patient's risk of septal fibrosis cannot be determined"
        },
        "answer": "C",
        "pmid": "10833486"
    },
    {
        "question": "A 48-year-old patient presents with abnormal liver function tests. The patient is overweight with a BMI of 28 kg/m^2. The patient's triglycerides level is 1.4 mmol/L and ALT level is 2.5. The patient has no history of overt liver disease, alcoholic, viral, autoimmune, drug-induced, or genetic liver disease. Based on the patient's age, BMI, triglycerides, and ALT levels, what is the risk of septal fibrosis in this patient?",
        "choices": {
            "A": "The patient has a very low risk of septal fibrosis",
            "B": "The patient has a moderate risk of septal fibrosis",
            "C": "The patient has a high risk of septal fibrosis",
            "D": "The patient has a very high risk of septal fibrosis",
            "E": "The risk of septal fibrosis in this patient cannot be determined"
        },
        "answer": "B",
        "pmid": "10833486"
    },
    {
        "question": "A 60-year-old male patient presents with fatigue, weight loss, and peripheral edema. He has a history of hypertension and type 2 diabetes. Laboratory tests reveal a FLC-diff of 20 mg/dL, cTnT of 0.03 ng/mL, and NT-ProBNP of 2000 pg/mL. A bone marrow biopsy confirms the diagnosis of light chain amyloidosis. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median overall survival from diagnosis is 94.1 months (Stage I)",
            "B": "Median overall survival from diagnosis is 40.3 months (Stage II)",
            "C": "Median overall survival from diagnosis is 14 months (Stage III)",
            "D": "Median overall survival from diagnosis is 5.8 months (Stage IV)",
            "E": "The prognosis cannot be determined based on the given information"
        },
        "answer": "D",
        "pmid": "22331953"
    },
    {
        "question": "A 55-year-old female patient presents to your clinic with fatigue, weight loss, and peripheral edema. After a series of tests, she is newly diagnosed with light chain amyloidosis. Her laboratory results show a difference between involved and uninvolved light chain (FLC-diff) of 15 mg/dL, cardiac biomarker troponin-T (cTnT) of 0.02 ng/mL, and N-terminal pro-B-type natriuretic peptide (NT-ProBNP) of 1500 pg/mL. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median overall survival from diagnosis is 94.1 months",
            "B": "Median overall survival from diagnosis is 40.3 months",
            "C": "Median overall survival from diagnosis is 14 months",
            "D": "Median overall survival from diagnosis is 5.8 months",
            "E": "Unable to determine prognosis without further testing"
        },
        "answer": "A",
        "pmid": "22331953"
    },
    {
        "question": "A 65-year-old male patient presents to your clinic with fatigue, weight loss, and peripheral edema. He has a history of hypertension and type 2 diabetes. His recent lab results show an FLC-diff of 18 mg/dL, cTnT of 0.03 ng/mL, and NT-ProBNP of 1800 pg/mL. He has been newly diagnosed with light chain amyloidosis. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median overall survival from diagnosis is 94.1 months",
            "B": "Median overall survival from diagnosis is 40.3 months",
            "C": "Median overall survival from diagnosis is 14 months",
            "D": "Median overall survival from diagnosis is 5.8 months",
            "E": "Median overall survival from diagnosis is unknown"
        },
        "answer": "D",
        "pmid": "22331953"
    },
    {
        "question": "A 70-year-old female patient presents to your clinic with fatigue, weight loss, and peripheral edema. She has a history of hypertension and type 2 diabetes. Laboratory tests reveal a FLC-diff of 10 mg/dL, cTnT of 0.01 ng/mL, and NT-ProBNP of 1000 pg/mL. She has been newly diagnosed with light chain amyloidosis. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median overall survival from diagnosis is 94.1 months",
            "B": "Median overall survival from diagnosis is 40.3 months",
            "C": "Median overall survival from diagnosis is 14 months",
            "D": "Median overall survival from diagnosis is 5.8 months",
            "E": "Unable to determine prognosis without further testing"
        },
        "answer": "A",
        "pmid": "22331953"
    },
    {
        "question": "A 75-year-old male patient presents with fatigue, weight loss, and peripheral edema. He has a history of hypertension and type 2 diabetes. His recent lab results show an FLC-diff of 22 mg/dL, cTnT of 0.04 ng/mL, and NT-ProBNP of 2500 pg/mL. He has been newly diagnosed with light chain amyloidosis. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median overall survival from diagnosis is 94.1 months",
            "B": "Median overall survival from diagnosis is 40.3 months",
            "C": "Median overall survival from diagnosis is 14 months",
            "D": "Median overall survival from diagnosis is 5.8 months",
            "E": "Median overall survival from diagnosis is unknown"
        },
        "answer": "D",
        "pmid": "22331953"
    },
    {
        "question": "A 50-year-old patient has been diagnosed with a cerebral low-grade glioma. The histology subtype of the tumor is not astrocytoma. The largest diameter of the tumor is 7.5 cm and it has been observed to cross the midline. The patient did not present with a neurologic deficit prior to surgery. Based on these factors, which of the following best describes the patient's prognosis?",
        "choices": {
            "A": "The patient is in the low-risk group, indicating a lower risk of poor prognosis.",
            "B": "The patient is in the high-risk group, indicating a higher risk of poor prognosis.",
            "C": "The patient's risk cannot be determined without further information.",
            "D": "The patient's risk is average, indicating a moderate risk of poor prognosis.",
            "E": "The patient's risk is dependent on the specific type of non-astrocytoma subtype."
        },
        "answer": "B",
        "pmid": "11956268"
    },
    {
        "question": "A 35-year-old patient has been diagnosed with a cerebral low-grade glioma, specifically an astrocytoma subtype. The largest diameter of the tumor is 5.5 cm and it does not cross the midline. The patient had a neurologic deficit before surgery. The patient's risk score, based on age, histology subtype, tumor diameter, whether the tumor crosses the midline, and presence of neurologic deficit before surgery, is 2. What does this risk score indicate about the patient's prognosis?",
        "choices": {
            "A": "The patient is in the high-risk group, indicating a less favorable prognosis.",
            "B": "The patient is in the low-risk group, indicating a more favorable prognosis.",
            "C": "The patient's risk score is inconclusive and further tests are needed.",
            "D": "The patient's risk score indicates an immediate need for aggressive treatment.",
            "E": "The patient's risk score suggests a high likelihood of tumor recurrence."
        },
        "answer": "B",
        "pmid": "11956268"
    },
    {
        "question": "A 42-year-old patient has been diagnosed with a cerebral low-grade glioma. The histology subtype of the tumor is not astrocytoma. The largest diameter of the tumor is 4.2 cm and it does not cross the midline. The patient did not have a neurologic deficit before surgery. Based on these factors, which of the following best describes the patient's survival prognosis?",
        "choices": {
            "A": "The patient is in the high-risk group for survival prognosis.",
            "B": "The patient is in the low-risk group for survival prognosis.",
            "C": "The patient's survival prognosis cannot be determined without further information.",
            "D": "The patient's survival prognosis is average.",
            "E": "The patient's survival prognosis is excellent."
        },
        "answer": "B",
        "pmid": "11956268"
    },
    {
        "question": "A 55-year-old patient has been diagnosed with a cerebral low-grade glioma, specifically an astrocytoma subtype. The largest diameter of the tumor is 6.5 cm and it has been observed to cross the midline. Prior to surgery, the patient had a neurologic deficit. Based on these factors, which of the following best describes the patient's prognosis?",
        "choices": {
            "A": "The patient is in the low-risk group, suggesting a more favorable prognosis",
            "B": "The patient is in the high-risk group, suggesting a less favorable prognosis",
            "C": "The patient's risk cannot be determined based on the provided information",
            "D": "The patient's risk is average, suggesting a moderate prognosis",
            "E": "The patient's risk is undetermined due to the presence of a neurologic deficit prior to surgery"
        },
        "answer": "B",
        "pmid": "11956268"
    },
    {
        "question": "A 30-year-old patient has been diagnosed with a cerebral low-grade glioma. The histology subtype of the tumor is not astrocytoma. The largest diameter of the tumor is 5.0 cm and it does not cross the midline. The patient did not have a neurologic deficit before surgery. Based on these factors, which of the following best describes the patient's prognosis?",
        "choices": {
            "A": "The patient is in a high-risk group for survival",
            "B": "The patient is in a low-risk group for survival",
            "C": "The patient's prognosis cannot be determined without further information",
            "D": "The patient's prognosis is average",
            "E": "The patient's prognosis is excellent"
        },
        "answer": "B",
        "pmid": "11956268"
    },
    {
        "question": "A 55-year-old male patient presents to the clinic for a routine check-up. He has a history of hypertension and depression. He does not take warfarin and has no history of skin ulcers or cellulitis. His Charlson comorbidity index score is 1. Based on these conditions, what is the predicted annual cost for managing this patient's chronic diseases?",
        "choices": {
            "A": "$4,317",
            "B": "$5,986",
            "C": "$7,654",
            "D": "$10,990",
            "E": "$13,326"
        },
        "answer": "B",
        "pmid": "18619805"
    },
    {
        "question": "A 55-year-old male patient presents to the clinic for a routine check-up. He has a history of depression, uses warfarin, and has skin ulcers or cellulitis. He does not have hypertension. His Charlson comorbidity index score is 3. Based on these conditions, what is the predicted annual cost of his chronic disease management?",
        "choices": {
            "A": "Less than $4,317",
            "B": "Between $4,317 and $5,986",
            "C": "Between $5,986 and $13,326",
            "D": "More than $13,326",
            "E": "Cannot be determined from the given information"
        },
        "answer": "C",
        "pmid": "18619805"
    },
    {
        "question": "A 65-year-old male patient presents to your clinic for a routine check-up. He has a history of hypertension and is currently on warfarin therapy. On examination, you notice skin ulcers and signs of cellulitis. The patient denies any feelings of sadness, loss of interest, or other symptoms suggestive of depression. His Charlson comorbidity index score is 4, indicating a moderate risk of one-year mortality. Based on this information, what is the estimated annual cost for the management of this patient's chronic diseases?",
        "choices": {
            "A": "$4,317",
            "B": "$5,986",
            "C": "$13,326",
            "D": "Cost cannot be determined",
            "E": "Cost is dependent on the patient's income"
        },
        "answer": "C",
        "pmid": "18619805"
    },
    {
        "question": "A 65-year-old patient with a history of skin ulcers or cellulitis presents to the clinic for a routine check-up. The patient does not have a history of hypertension or depression and does not take warfarin. The patient's Charlson comorbidity index score is 5. Based on the patient's comorbidity score, which of the following is the most likely predicted annual cost of managing the patient's chronic disease?",
        "choices": {
            "A": "Less than $4,317",
            "B": "Between $4,317 and $5,986",
            "C": "Between $5,986 and $13,326",
            "D": "More than $13,326",
            "E": "The cost cannot be determined from the given information"
        },
        "answer": "C",
        "pmid": "18619805"
    },
    {
        "question": "A 65-year-old male patient with a history of hypertension and depression is currently under primary care. He is on warfarin therapy but does not have any skin ulcers or cellulitis. His Charlson comorbidity index score is 6. Based on these conditions, what is the predicted annual cost for managing this patient's chronic diseases in primary care?",
        "choices": {
            "A": "$4,317",
            "B": "$5,986",
            "C": "$13,326",
            "D": "Cost cannot be determined",
            "E": "Cost is less than $4,000"
        },
        "answer": "C",
        "pmid": "18619805"
    },
    {
        "question": "A 58-year-old male patient is being evaluated as a candidate for left ventricular assist device (LVAD) surgery. He has a history of chronic heart failure and has been requiring vasopressor support. His recent laboratory results show an aspartate aminotransferase (AST) level of 85 IU/l, a bilirubin level of 2.1 mg/dl, and a creatinine level of 2.4 mg/dl. Based on these findings, what is the patient's estimated risk of right ventricular (RV) failure and 180-day survival rate following LVAD surgery?",
        "choices": {
            "A": "Low risk of RV failure (odds ratio 0.49), 180-day survival rate of 90%",
            "B": "Moderate risk of RV failure (odds ratio 2.8), 180-day survival rate of 80%",
            "C": "High risk of RV failure (odds ratio 7.6), 180-day survival rate of 66%",
            "D": "Low risk of RV failure (odds ratio 0.49), 180-day survival rate of 80%",
            "E": "Moderate risk of RV failure (odds ratio 2.8), 180-day survival rate of 90%"
        },
        "answer": "C",
        "pmid": "18510965"
    },
    {
        "question": "A 65-year-old male patient is being evaluated as a candidate for left ventricular assist device (LVAD) surgery. He has a history of chronic heart failure and his condition has been deteriorating despite optimal medical management. His current medications include beta-blockers, ACE inhibitors, and diuretics. He does not require vasopressor support. His recent laboratory results show an aspartate aminotransferase (AST) level of 75 IU/l, a bilirubin level of 1.8 mg/dl, and a creatinine level of 2.0 mg/dl. Based on these findings, what is the estimated risk of right ventricular (RV) failure post-operation and the associated 180-day survival rate?",
        "choices": {
            "A": "Low risk of RV failure, 180-day survival rate of 90%",
            "B": "Moderate risk of RV failure, 180-day survival rate of 80%",
            "C": "High risk of RV failure, 180-day survival rate of 66%",
            "D": "Low risk of RV failure, 180-day survival rate of 80%",
            "E": "High risk of RV failure, 180-day survival rate of 90%"
        },
        "answer": "A",
        "pmid": "18510965"
    },
    {
        "question": "A 65-year-old male patient is being evaluated as a candidate for left ventricular assist device (LVAD) surgery. He has a history of chronic heart failure and has been requiring vasopressor support. His recent laboratory results show an aspartate aminotransferase (AST) level of 90 IU/l, a bilirubin level of 2.5 mg/dl, and a creatinine level of 1.8 mg/dl. Based on these findings, what is the most likely post-operative risk of right ventricular (RV) failure for this patient?",
        "choices": {
            "A": "Low risk of RV failure (odds ratio 0.49, 180-day survival 90%)",
            "B": "Moderate risk of RV failure (odds ratio 2.8, 180-day survival 80%)",
            "C": "High risk of RV failure (odds ratio 7.6, 180-day survival 66%)",
            "D": "The patient is not a suitable candidate for LVAD surgery",
            "E": "The patient's risk cannot be determined without further testing"
        },
        "answer": "C",
        "pmid": "18510965"
    },
    {
        "question": "A 65-year-old male patient is being evaluated as a candidate for left ventricular assist device (LVAD) surgery. He has a history of chronic kidney disease and his current creatinine level is 2.5 mg/dl. His liver function tests show an aspartate aminotransferase (AST) level of 60 IU/l and a bilirubin level of 1.5 mg/dl. He is hemodynamically stable and does not require vasopressor support. Based on these pre-operative clinical factors, what is the estimated risk of right ventricular (RV) failure and the expected 180-day survival rate post-LVAD surgery?",
        "choices": {
            "A": "High risk of RV failure, 180-day survival rate 66%",
            "B": "Moderate risk of RV failure, 180-day survival rate 80%",
            "C": "Low risk of RV failure, 180-day survival rate 90%",
            "D": "High risk of RV failure, 180-day survival rate 90%",
            "E": "Moderate risk of RV failure, 180-day survival rate 66%"
        },
        "answer": "C",
        "pmid": "18510965"
    },
    {
        "question": "A 65-year-old male patient is being evaluated as a candidate for left ventricular assist device (LVAD) surgery. He has a history of chronic heart failure and has been requiring vasopressor support. His recent laboratory results show an aspartate aminotransferase (AST) level of 100 IU/l, a bilirubin level of 3.0 mg/dl, and a creatinine level of 3.0 mg/dl. Based on these findings, what is the patient's estimated risk of right ventricular (RV) failure post-LVAD surgery and the predicted 180-day survival rate?",
        "choices": {
            "A": "Low risk of RV failure, 90% survival rate",
            "B": "Moderate risk of RV failure, 80% survival rate",
            "C": "High risk of RV failure, 66% survival rate",
            "D": "Low risk of RV failure, 80% survival rate",
            "E": "Moderate risk of RV failure, 66% survival rate"
        },
        "answer": "C",
        "pmid": "18510965"
    },
    {
        "question": "A 75-year-old male patient was recently discharged from a general medical service at a hospital. He is dependent on 3 Activities of Daily Living (ADLs), including bathing, dressing, and transferring. He has a history of congestive heart failure and solitary cancer. His creatinine level at discharge was 3.5 mg/dL, and his albumin level was 2.9 g/dL. He has been experiencing fatigue and shortness of breath. His family is concerned about his prognosis. Based on the given parameters, what is the most likely 1-year mortality rate for this patient post-hospitalization?",
        "choices": {
            "A": "13% 1-year mortality",
            "B": "20% 1-year mortality",
            "C": "37% 1-year mortality",
            "D": "68% 1-year mortality",
            "E": "Unable to determine without further information"
        },
        "answer": "D",
        "pmid": "11410097"
    },
    {
        "question": "A 72-year-old female patient was recently discharged from the hospital. She has a history of hypertension and type 2 diabetes mellitus, both of which are well-controlled with medication. She lives alone and is dependent on assistance for bathing, one of the Activities of Daily Living (ADL). She has no history of congestive heart failure or cancer. Her creatinine level at discharge was 2.5 mg/dL, and her albumin level was 3.5 g/dL. She is not on any renal replacement therapy. Based on these parameters, what is the estimated 1-year mortality risk for this patient after hospital discharge?",
        "choices": {
            "A": "13%",
            "B": "20%",
            "C": "37%",
            "D": "68%",
            "E": "Unable to determine from the given information"
        },
        "answer": "B",
        "pmid": "11410097"
    },
    {
        "question": "A 78-year-old male patient was recently discharged from a general medical service at a hospital. He is dependent on all 5 Activities of Daily Living (ADLs), including bathing, dressing, toileting, transferring, and feeding. He has a history of congestive heart failure and metastatic cancer. His creatinine level at discharge was 4.0 mg/dL, and his albumin level was 2.8 g/dL. He has been experiencing fatigue and loss of appetite. Based on these factors, what is the most likely 1-year mortality risk for this patient?",
        "choices": {
            "A": "13% 1-year mortality",
            "B": "20% 1-year mortality",
            "C": "37% 1-year mortality",
            "D": "68% 1-year mortality",
            "E": "Higher than 68% 1-year mortality"
        },
        "answer": "E",
        "pmid": "11410097"
    },
    {
        "question": "A 70-year-old female patient was recently discharged from the hospital. She is independent in all Activities of Daily Living (ADLs), and has no history of congestive heart failure or cancer. Her creatinine level at discharge was 2.0 mg/dL, and her albumin level was 3.5 g/dL. She has no other significant medical history. Based on these factors, what is the estimated 1-year mortality risk for this patient after hospital discharge?",
        "choices": {
            "A": "13%",
            "B": "20%",
            "C": "37%",
            "D": "68%",
            "E": "Unable to determine based on the given information"
        },
        "answer": "A",
        "pmid": "11410097"
    },
    {
        "question": "A 73-year-old male patient was recently discharged from a general medical service at a hospital. He is dependent on 2 Activities of Daily Living (ADLs), including bathing and dressing. He has a history of congestive heart failure and solitary cancer. His creatinine level at discharge was 3.2 mg/dL, and his albumin level was 3.1 g/dL. He has no other significant medical history. Based on these factors, what is the most likely 1-year mortality rate for this patient post-hospitalization?",
        "choices": {
            "A": "13%",
            "B": "20%",
            "C": "37%",
            "D": "68%",
            "E": "Unable to determine"
        },
        "answer": "D",
        "pmid": "11410097"
    },
    {
        "question": "A 50-year-old male patient presents with a recent diagnosis of adult acute lymphocytic leukemia (ALL). He is planned to undergo Hyper-CVAD chemotherapy. His leukocyte count is 55 x 10(9)/L, and he has an Eastern Cooperative Oncology Group score of 2, indicating he is ambulatory and capable of all self-care but unable to carry out any work activities. He is up and about more than 50% of waking hours. His disease is Philadelphia chromosome-positive, and the French-American-British morphology is L1. He achieved complete response (CR) after 1 course of chemotherapy. On Day 14, his bone marrow blasts were 4%. Based on these factors, what is the most likely 5-year complete response (CR) duration rate for this patient?",
        "choices": {
            "A": "10%",
            "B": "37%",
            "C": "52%",
            "D": "75%",
            "E": "90%"
        },
        "answer": "B",
        "pmid": "15481055"
    },
    {
        "question": "A 60-year-old male patient presents with a recent diagnosis of adult acute lymphocytic leukemia (ALL). He is scheduled to undergo Hyper-CVAD chemotherapy. His leukocyte count is 60 x 10(9)/L, and he has an Eastern Cooperative Oncology Group score of 3, indicating severe disease with limited self-care capabilities. The patient's disease is Philadelphia chromosome-positive and exhibits French-American-British L2 morphology. He achieved complete response (CR) after 2 courses of chemotherapy, and his Day 14 bone marrow biopsy showed 6% blasts. Based on these factors, what is the patient's estimated 5-year complete response (CR) duration rate?",
        "choices": {
            "A": "52%",
            "B": "37%",
            "C": "10%",
            "D": "25%",
            "E": "45%"
        },
        "answer": "C",
        "pmid": "15481055"
    },
    {
        "question": "A 40-year-old male patient presents with a recent diagnosis of adult acute lymphocytic leukemia (ALL). He has a leukocyte count of 45 x 10(9)/L and an Eastern Cooperative Oncology Group score of 1, indicating that he is fully active and able to carry on all pre-disease performance without restriction. His disease is Philadelphia chromosome-negative and exhibits French-American-British L1 morphology. He achieved complete response (CR) after 1 course of chemotherapy, and his Day 14 bone marrow examination showed 4% blasts. Based on these parameters, what is the most likely 5-year complete response (CR) duration rate for this patient?",
        "choices": {
            "A": "10%",
            "B": "37%",
            "C": "52%",
            "D": "70%",
            "E": "85%"
        },
        "answer": "C",
        "pmid": "15481055"
    },
    {
        "question": "A 55-year-old male patient presents with a recent diagnosis of adult acute lymphocytic leukemia (ALL). He has a leukocyte count of 70 x 10(9)/L and an Eastern Cooperative Oncology Group score of 4, indicating a poor performance status. The patient's disease is Philadelphia chromosome-positive and exhibits French-American-British L2 morphology. He achieved complete response (CR) after 3 courses of chemotherapy. On Day 14, his bone marrow blasts were found to be 7%. Based on these factors, what is the patient's 5-year complete response (CR) duration rate?",
        "choices": {
            "A": "52%",
            "B": "37%",
            "C": "10%",
            "D": "25%",
            "E": "15%"
        },
        "answer": "C",
        "pmid": "15481055"
    },
    {
        "question": "A 30-year-old male patient presents with a recent diagnosis of adult acute lymphocytic leukemia (ALL). He has a leukocyte count of 40 x 10(9)/L and an Eastern Cooperative Oncology Group score of 2, indicating that he is ambulatory and capable of all self-care but unable to carry out any work activities. He is Philadelphia chromosome-negative and his disease morphology is classified as French-American-British L1. He achieved a complete response after just one course of chemotherapy. On Day 14, his bone marrow blasts were found to be 3%. Based on these factors, what is the patient's 5-year complete response (CR) duration rate?",
        "choices": {
            "A": "10%",
            "B": "37%",
            "C": "52%",
            "D": "Unable to determine without further information",
            "E": "The patient is not eligible for a 5-year CR duration rate prediction"
        },
        "answer": "C",
        "pmid": "15481055"
    },
    {
        "question": "A 65-year-old male patient presents with moderate to severe chronic heart failure. He has a serum uric acid level of 600 micromol/L, a left ventricular ejection fraction of 20%, and a peak oxygen consumption of 15 mL/kg per min. He has been experiencing increasing shortness of breath and fatigue. Based on these parameters, which of the following is the most likely prognosis for this patient over the next 12 months?",
        "choices": {
            "A": "98% survival rate",
            "B": "77% survival rate",
            "C": "64% survival rate",
            "D": "31% survival rate",
            "E": "The patient does not meet the criteria for prognosis estimation"
        },
        "answer": "C",
        "pmid": "12707250"
    },
    {
        "question": "A 65-year-old male patient presents with moderate to severe chronic heart failure. He has a serum uric acid level of 500 micromol/L, a left ventricular ejection fraction of 30%, and a peak oxygen consumption of 16 mL/kg per min. He has no other significant medical history. Based on these parameters, which of the following is the most likely prognosis for this patient over the next 12 months?",
        "choices": {
            "A": "He has a 31% chance of survival and is likely to need a heart transplant.",
            "B": "He has a 64% chance of survival and may need a heart transplant.",
            "C": "He has a 77% chance of survival and may need a heart transplant.",
            "D": "He has a 98% chance of survival and is unlikely to need a heart transplant.",
            "E": "His survival rate cannot be determined from these parameters."
        },
        "answer": "D",
        "pmid": "12707250"
    },
    {
        "question": "A 65-year-old male patient with a history of moderate to severe chronic heart failure presents to the clinic for a routine check-up. His recent laboratory results show a serum uric acid level of 600 micromol/L. His echocardiogram reveals a left ventricular ejection fraction of 28%. During a treadmill stress test, his peak oxygen consumption was measured to be 13 mL/kg per min. Based on these findings, which of the following is the most likely prognosis for this patient over the next 12 months?",
        "choices": {
            "A": "98% survival rate",
            "B": "77% survival rate",
            "C": "64% survival rate",
            "D": "51% chance of being listed for heart transplantation",
            "E": "31% survival rate"
        },
        "answer": "C",
        "pmid": "12707250"
    },
    {
        "question": "A 65-year-old male patient presents with moderate to severe chronic heart failure. He has a serum uric acid level of 570 micromol/L, a left ventricular ejection fraction of 24%, and a peak oxygen consumption of 15 mL/kg per min. He has been experiencing increasing fatigue and shortness of breath. Based on these parameters, what is the most likely prognosis for this patient over the next 12 months?",
        "choices": {
            "A": "The patient has a 98% chance of survival and is unlikely to need a heart transplant.",
            "B": "The patient has a 77% chance of survival and may need to be considered for a heart transplant.",
            "C": "The patient has a 64% chance of survival and may need to be considered for a heart transplant.",
            "D": "The patient has a 31% chance of survival and is likely to need a heart transplant.",
            "E": "The patient's condition is too severe to predict a prognosis."
        },
        "answer": "C",
        "pmid": "12707250"
    },
    {
        "question": "A 65-year-old male patient presents with moderate to severe chronic heart failure. He has a serum uric acid level of 580 micromol/L, a left ventricular ejection fraction of 22%, and a peak oxygen consumption of 12 mL/kg per min. He has been experiencing increasing shortness of breath and fatigue. Based on these parameters, which of the following is the most likely prognosis for this patient over the next 12 months?",
        "choices": {
            "A": "The patient has a 98% chance of survival and is unlikely to require heart transplantation.",
            "B": "The patient has a 77% chance of survival and may require heart transplantation.",
            "C": "The patient has a 64% chance of survival and is likely to require heart transplantation.",
            "D": "The patient has a 31% chance of survival and is very likely to require heart transplantation.",
            "E": "The patient has a 50% chance of survival and the need for heart transplantation cannot be determined."
        },
        "answer": "D",
        "pmid": "12707250"
    },
    {
        "question": "A 70-year-old patient presents with a Killip class of 2. The patient's baseline left ventricular ejection fraction is 35%. The patient has a history of anemia, renal insufficiency, and triple-vessel disease. The patient's post-procedural Thrombolysis In Myocardial Infarction flow grade is positive. The patient has recently undergone primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Based on these parameters, what is the patient's risk category for mortality after primary PCI for AMI?",
        "choices": {
            "A": "Low risk",
            "B": "Intermediate risk",
            "C": "High risk",
            "D": "The patient is not at risk",
            "E": "The risk cannot be determined"
        },
        "answer": "C",
        "pmid": "15862409"
    },
    {
        "question": "A 60-year-old patient presents with an acute myocardial infarction and undergoes primary percutaneous coronary intervention. The patient's Killip class is 1, indicating no clinical signs of heart failure. The baseline left ventricular ejection fraction is 45%, which is within the normal range. The patient does not have anemia, renal insufficiency, or triple-vessel disease. The post-procedural Thrombolysis In Myocardial Infarction flow grade is negative, indicating no reperfusion. Based on these parameters, what is the patient's risk of mortality after the intervention?",
        "choices": {
            "A": "High risk",
            "B": "Intermediate risk",
            "C": "Low risk",
            "D": "The risk cannot be determined based on these parameters",
            "E": "The patient is not at risk"
        },
        "answer": "C",
        "pmid": "15862409"
    },
    {
        "question": "A 68-year-old patient presents with acute myocardial infarction (AMI) and has undergone primary percutaneous coronary intervention (PCI). The patient's Killip class is 3, indicating signs of moderate to severe heart failure. The baseline left ventricular ejection fraction is 38%, suggesting a decreased pumping ability of the heart. The patient also has anemia, renal insufficiency, and triple-vessel disease, further complicating the clinical picture. However, the post-procedural Thrombolysis In Myocardial Infarction (TIMI) flow grade is negative, indicating no significant residual stenosis or clot. Based on these clinical parameters, what is the patient's risk category for mortality after primary PCI for AMI?",
        "choices": {
            "A": "Low risk",
            "B": "Intermediate risk",
            "C": "High risk",
            "D": "The risk cannot be determined",
            "E": "The patient is not eligible for risk assessment"
        },
        "answer": "C",
        "pmid": "15862409"
    },
    {
        "question": "A 55-year-old patient presents with an acute myocardial infarction and has undergone primary percutaneous coronary intervention. The patient's Killip class is 2, indicating some heart failure. The baseline left ventricular ejection fraction is 50%, which is within the normal range. The patient does not have anemia, renal insufficiency, or triple-vessel disease. The post-procedural Thrombolysis In Myocardial Infarction flow grade is positive, indicating successful reperfusion. Based on these parameters, what is the patient's risk of mortality after the intervention?",
        "choices": {
            "A": "Low risk",
            "B": "Intermediate risk",
            "C": "High risk",
            "D": "The risk cannot be determined based on the given parameters",
            "E": "The patient is not at risk"
        },
        "answer": "B",
        "pmid": "15862409"
    },
    {
        "question": "A 72-year-old patient presents with acute myocardial infarction (AMI) and has undergone primary percutaneous coronary intervention (PCI). The patient's baseline left ventricular ejection fraction is 42%, indicating a relatively preserved systolic function. The patient has a history of anemia and triple-vessel disease but does not have renal insufficiency. The patient's Killip class is 1, suggesting no clinical signs of heart failure. Post-procedural Thrombolysis In Myocardial Infarction (TIMI) flow grade is positive, indicating successful reperfusion. Based on these clinical parameters, what is the patient's risk category for mortality after primary PCI for AMI?",
        "choices": {
            "A": "Low risk",
            "B": "Intermediate risk",
            "C": "High risk",
            "D": "The risk cannot be determined based on the given parameters",
            "E": "The patient is not eligible for risk assessment"
        },
        "answer": "C",
        "pmid": "15862409"
    },
    {
        "question": "A 55-year-old male patient presents with a history of Chagas' heart disease. He is currently classified as New York Heart Association class III, indicating marked limitation of physical activity. He is comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea. Radiographic imaging reveals evidence of cardiomegaly. An echocardiogram shows left ventricular systolic dysfunction. A 24-hour Holter monitor indicates the presence of nonsustained ventricular tachycardia. However, his electrocardiogram shows normal QRS voltage. Based on these findings, what is the most likely 10-year mortality risk for this patient?",
        "choices": {
            "A": "Low risk with a 10-year mortality rate of 10%",
            "B": "Intermediate risk with a 10-year mortality rate of 44%",
            "C": "High risk with a 10-year mortality rate of 84%",
            "D": "Very high risk with a 10-year mortality rate of 100%",
            "E": "Cannot be determined without further testing"
        },
        "answer": "C",
        "pmid": "16928995"
    },
    {
        "question": "A 45-year-old female patient presents with a confirmed diagnosis of Chagas' heart disease. She is not classified under New York Heart Association class III or IV, indicating that her heart disease is not severely limiting her physical activity. Radiographic imaging does not show any evidence of cardiomegaly. However, an echocardiogram reveals the presence of left ventricular systolic dysfunction. A 24-hour Holter monitoring does not indicate any nonsustained ventricular tachycardia. Electrocardiography shows low QRS voltage. Based on these findings, what is the estimated 10-year mortality risk for this patient?",
        "choices": {
            "A": "Low risk with a 10-year mortality rate of 10%",
            "B": "Intermediate risk with a 10-year mortality rate of 44%",
            "C": "High risk with a 10-year mortality rate of 84%",
            "D": "Very high risk with a 10-year mortality rate of 100%",
            "E": "Cannot be determined based on the given information"
        },
        "answer": "A",
        "pmid": "16928995"
    },
    {
        "question": "A 55-year-old male patient presents with a history of Chagas' heart disease. He is currently classified as New York Heart Association class III. His recent chest radiography shows evidence of cardiomegaly. However, an echocardiography reveals no left ventricular systolic dysfunction. A 24-hour Holter monitoring was performed, which indicated no nonsustained ventricular tachycardia. His electrocardiography shows normal QRS voltage. Based on these findings, what is the estimated 10-year mortality risk for this patient?",
        "choices": {
            "A": "Low risk with a 10-year mortality rate of 10%",
            "B": "Intermediate risk with a 10-year mortality rate of 44%",
            "C": "High risk with a 10-year mortality rate of 84%",
            "D": "Cannot be determined without further testing",
            "E": "Risk is negligible due to absence of left ventricular systolic dysfunction and nonsustained ventricular tachycardia"
        },
        "answer": "C",
        "pmid": "16928995"
    },
    {
        "question": "A 45-year-old female patient presents with a confirmed diagnosis of Chagas' heart disease. She is not classified under New York Heart Association class III or IV, indicating that her heart disease is not severely limiting her physical activity. Radiographic imaging does not show any evidence of cardiomegaly, and echocardiographic findings do not reveal any left ventricular systolic dysfunction. However, a 24-hour Holter monitoring indicates the presence of nonsustained ventricular tachycardia. Electrocardiography also shows low QRS voltage. Based on these findings, what is the estimated 10-year mortality risk for this patient?",
        "choices": {
            "A": "10%",
            "B": "20%",
            "C": "44%",
            "D": "60%",
            "E": "84%"
        },
        "answer": "A",
        "pmid": "16928995"
    },
    {
        "question": "A 55-year-old male patient presents with a confirmed diagnosis of Chagas' heart disease. He is currently classified as New York Heart Association class III, indicating marked limitation of physical activity. He is comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea. Radiographic imaging does not show any evidence of cardiomegaly. However, an echocardiogram reveals left ventricular systolic dysfunction. A 24-hour Holter monitoring indicates the presence of nonsustained ventricular tachycardia. Electrocardiography shows normal QRS voltage. Based on these findings, what is the estimated 10-year mortality risk for this patient?",
        "choices": {
            "A": "10%",
            "B": "44%",
            "C": "84%",
            "D": "Less than 10%",
            "E": "More than 90%"
        },
        "answer": "C",
        "pmid": "16928995"
    },
    {
        "question": "A 65-year-old male patient presents with a recent diagnosis of metastatic colorectal cancer. He is scheduled to start 5-fluorouracil-based therapy. His Eastern Cooperative Oncology Group (ECOG) performance status is 1, indicating he is fully active and able to carry on all pre-disease activities without restriction. Laboratory results show a white blood cell count of 9 x 10^9/l, which is within the normal range. His alkaline phosphatase level is 280 U/l, slightly elevated but still below the threshold of 300 U/l. Imaging studies reveal two distinct tumor sites. Based on these parameters, what is the most likely median survival time for this patient?",
        "choices": {
            "A": "6.1 months",
            "B": "10.7 months",
            "C": "15 months",
            "D": "20 months",
            "E": "24 months"
        },
        "answer": "B",
        "pmid": "11886010"
    },
    {
        "question": "A 65-year-old male patient presents with a recent diagnosis of metastatic colorectal cancer. He is currently undergoing 5-fluorouracil-based therapy. The patient is ambulatory and capable of all self-care but unable to carry out any work activities, indicating an ECOG performance status of 2. Laboratory results show a white blood cell count of 12 x 10^9/l and an alkaline phosphatase level of 350 U/l. Imaging studies reveal three distinct tumor sites. Based on these clinical parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median survival of 15 months",
            "B": "Median survival of 10.7 months",
            "C": "Median survival of 6.1 months",
            "D": "Median survival of 5 months",
            "E": "Median survival of 12 months"
        },
        "answer": "C",
        "pmid": "11886010"
    },
    {
        "question": "A 55-year-old male patient presents with a diagnosis of metastatic colorectal cancer. He is currently undergoing 5-fluorouracil-based therapy. The patient is fully active and able to carry on all pre-disease activities without restriction, indicating an ECOG performance status of 0. Laboratory results show a white blood cell count of 8 x 10^9/l and an alkaline phosphatase level of 250 U/l, both within the normal range. The patient has one identified tumor site. Based on these clinical parameters, what is the most likely median survival time for this patient?",
        "choices": {
            "A": "6.1 months",
            "B": "10.7 months",
            "C": "15 months",
            "D": "20 months",
            "E": "25 months"
        },
        "answer": "C",
        "pmid": "11886010"
    },
    {
        "question": "A 65-year-old male patient presents with a recent diagnosis of metastatic colorectal cancer. He is currently undergoing 5-fluorouracil-based therapy. His ECOG performance status is 3, indicating he is capable of only limited self-care and is confined to bed or chair more than 50% of waking hours. Laboratory results show a white blood cell count of 15 x 10^9/l and an alkaline phosphatase level of 400 U/l, both significantly above the normal range. Imaging studies reveal the presence of four tumor sites. Based on these clinical parameters, what is the most likely median survival time for this patient?",
        "choices": {
            "A": "15 months",
            "B": "10.7 months",
            "C": "6.1 months",
            "D": "3 months",
            "E": "1 month"
        },
        "answer": "C",
        "pmid": "11886010"
    },
    {
        "question": "A 65-year-old male patient presents with a recent diagnosis of metastatic colorectal cancer. He is scheduled to undergo 5-fluorouracil-based therapy. His Eastern Cooperative Oncology Group (ECOG) performance status is 1, indicating he is fully active and able to carry on all pre-disease activities without restriction. Laboratory results show a white blood cell (WBC) count of 7 x 10^9/l, which is within the normal range. His alkaline phosphatase level is 290 U/l, slightly elevated but still below the threshold of 300 U/l. Imaging studies reveal the presence of a single tumor site. Based on these parameters, what is the most likely median survival time for this patient?",
        "choices": {
            "A": "6.1 months",
            "B": "10.7 months",
            "C": "15 months",
            "D": "20 months",
            "E": "25 months"
        },
        "answer": "C",
        "pmid": "11886010"
    },
    {
        "question": "A 5-month-old infant presents with a fever, rash, and conjunctivitis. The infant was diagnosed with Kawasaki disease 3 days ago. Laboratory findings reveal a platelet count of 28 x 10(10)/L, C-reactive protein (CRP) level of 9 mg/dL, and alanine aminotransferase (ALT) level of 85 IU/L. The infant has been receiving initial high-dose intravenous immunoglobulin (IVIG) treatment. Based on these findings, how is the infant likely to respond to IVIG treatment?",
        "choices": {
            "A": "The infant is very likely to respond to IVIG treatment",
            "B": "The infant is likely to respond to IVIG treatment",
            "C": "The infant may or may not respond to IVIG treatment",
            "D": "The infant is likely to be resistant to IVIG treatment",
            "E": "The infant is very likely to be resistant to IVIG treatment"
        },
        "answer": "E",
        "pmid": "16887442"
    },
    {
        "question": "A 10-month-old patient presents with a diagnosis of Kawasaki disease. The illness onset was 5 days ago. Laboratory findings reveal a platelet count of 35 x 10(10)/L, C-reactive protein (CRP) level of 7 mg/dL, and alanine aminotransferase (ALT) level of 75 IU/L. The patient is receiving initial high-dose intravenous immunoglobulin (IVIG) treatment. Based on these findings, how would you predict the patient's response to IVIG treatment?",
        "choices": {
            "A": "The patient is likely to be resistant to IVIG treatment",
            "B": "The patient is likely to respond to IVIG treatment",
            "C": "The patient's response to IVIG treatment cannot be determined",
            "D": "The patient will have a moderate response to IVIG treatment",
            "E": "The patient will have no response to IVIG treatment"
        },
        "answer": "B",
        "pmid": "16887442"
    },
    {
        "question": "A 7-month-old infant presents to the clinic with a 2-day history of fever, rash, and conjunctivitis. The infant was diagnosed with Kawasaki disease and is scheduled to receive initial high-dose intravenous immunoglobulin (IVIG) treatment. Laboratory findings reveal a platelet count of 29 x 10(10)/L, C-reactive protein (CRP) level of 8.5 mg/dL, and alanine aminotransferase (ALT) level of 90 IU/L. Based on these findings, how is the infant likely to respond to IVIG treatment?",
        "choices": {
            "A": "The infant is likely to respond well to IVIG treatment",
            "B": "The infant is likely to be resistant to IVIG treatment",
            "C": "The infant's response to IVIG treatment cannot be determined",
            "D": "The infant should not receive IVIG treatment",
            "E": "The infant requires a higher dose of IVIG treatment"
        },
        "answer": "B",
        "pmid": "16887442"
    },
    {
        "question": "A 12-month-old patient presents with a diagnosis of Kawasaki disease. The illness onset was 6 days ago. The patient's laboratory results show a platelet count of 40 x 10(10)/L, C-reactive protein (CRP) level of 6 mg/dL, and alanine aminotransferase (ALT) level of 70 IU/L. The patient has no other significant medical history and is not currently on any medication. Based on these findings, how is the patient likely to respond to initial high-dose intravenous immunoglobulin (IVIG) treatment?",
        "choices": {
            "A": "The patient is likely to be resistant to IVIG treatment",
            "B": "The patient is likely to respond to IVIG treatment",
            "C": "The patient's response to IVIG treatment cannot be determined",
            "D": "The patient is likely to have an adverse reaction to IVIG treatment",
            "E": "The patient is likely to require a higher dose of IVIG treatment"
        },
        "answer": "B",
        "pmid": "16887442"
    },
    {
        "question": "A 4-month-old infant presents to the clinic with a diagnosis of Kawasaki disease. The illness onset was 3 days ago. Laboratory findings reveal a platelet count of 25 x 10(10)/L, C-reactive protein (CRP) level of 10 mg/dL, and alanine aminotransferase (ALT) level of 100 IU/L. The infant is currently receiving initial high-dose intravenous immunoglobulin (IVIG) treatment. Based on these findings, how would you predict the infant's response to IVIG treatment?",
        "choices": {
            "A": "The infant is very likely to respond to IVIG treatment",
            "B": "The infant is somewhat likely to respond to IVIG treatment",
            "C": "The infant's response to IVIG treatment is uncertain",
            "D": "The infant is somewhat likely to be resistant to IVIG treatment",
            "E": "The infant is very likely to be resistant to IVIG treatment"
        },
        "answer": "E",
        "pmid": "16887442"
    },
    {
        "question": "A 15-year-old patient has been diagnosed with primary disseminated multifocal Ewing sarcomas (PDMES). The primary tumor volume is 250 mL. The patient has two bone metastatic sites and bone marrow metastases. There are no additional lung metastases. Based on these factors, what is the estimated event-free survival (EFS) rate for this patient?",
        "choices": {
            "A": "EFS rate of 50%",
            "B": "EFS rate of 25%",
            "C": "EFS rate of 10%",
            "D": "EFS rate of 75%",
            "E": "EFS rate of 5%"
        },
        "answer": "C",
        "pmid": "20547982"
    },
    {
        "question": "A 12-year-old patient has been diagnosed with primary disseminated multifocal Ewing sarcomas (PDMES). The primary tumor volume is 150 mL. The patient has one bone metastatic site and additional lung metastases. There are no bone marrow metastases. The patient's risk score, based on these factors, is 1.5. What is the estimated event-free survival (EFS) rate for this patient?",
        "choices": {
            "A": "10%",
            "B": "25%",
            "C": "50%",
            "D": "75%",
            "E": "90%"
        },
        "answer": "C",
        "pmid": "20547982"
    },
    {
        "question": "A 16-year-old patient has been recently diagnosed with primary disseminated multifocal Ewing sarcomas (PDMES). The primary tumor volume is 300 mL. The patient has three bone metastatic sites, bone marrow metastases, and additional lung metastases. The patient's risk score, calculated based on these factors, is 8.5. What is the estimated event-free survival (EFS) rate for this patient?",
        "choices": {
            "A": "EFS rate of 50%",
            "B": "EFS rate of 25%",
            "C": "EFS rate of 10%",
            "D": "EFS rate of 75%",
            "E": "EFS rate of 5%"
        },
        "answer": "C",
        "pmid": "20547982"
    },
    {
        "question": "A 10-year-old patient has been diagnosed with primary disseminated multifocal Ewing sarcomas (PDMES). The primary tumor volume is 180 mL. The patient has one bone metastatic site. There are no bone marrow metastases or additional lung metastases. The patient is otherwise healthy with no significant past medical history. Based on these factors, what is the estimated event-free survival (EFS) rate for this patient?",
        "choices": {
            "A": "10%",
            "B": "25%",
            "C": "50%",
            "D": "75%",
            "E": "90%"
        },
        "answer": "C",
        "pmid": "20547982"
    },
    {
        "question": "An 18-year-old patient has been diagnosed with primary disseminated multifocal Ewing sarcomas (PDMES). The primary tumor volume is 220 mL. The patient has two bone metastatic sites and bone marrow metastases. There are no additional lung metastases. The patient's risk score, based on these factors, is 7.0. What is the estimated event-free survival (EFS) rate for this patient?",
        "choices": {
            "A": "EFS rate of 50%",
            "B": "EFS rate of 25%",
            "C": "EFS rate of 10%",
            "D": "EFS rate of 75%",
            "E": "EFS rate of 5%"
        },
        "answer": "C",
        "pmid": "20547982"
    },
    {
        "question": "A 65-year-old patient is scheduled for cardiac surgery. The patient has a history of stroke and currently has abnormal albumin levels. The patient's Mini Mental State Examination score is 22, indicating some cognitive impairment. The Geriatric Depression Scale score is 5, suggesting the presence of depressive symptoms. Based on these parameters, what is the estimated risk of this patient developing delirium post-surgery?",
        "choices": {
            "A": "19% risk of delirium",
            "B": "47% risk of delirium",
            "C": "63% risk of delirium",
            "D": "86% risk of delirium",
            "E": "The risk cannot be determined with the given information"
        },
        "answer": "D",
        "pmid": "19118253"
    },
    {
        "question": "A 70-year-old patient is scheduled for cardiac surgery. The patient has no history of stroke or transient ischemic attack. Laboratory tests reveal normal albumin levels. The patient's Mini Mental State Examination score is 28, indicating normal cognitive function, and the Geriatric Depression Scale score is 3, suggesting no significant depressive symptoms. The patient has no other significant medical history and takes no regular medications. Based on these findings, what is the most likely risk of postoperative delirium for this patient?",
        "choices": {
            "A": "19% risk of delirium",
            "B": "47% risk of delirium",
            "C": "63% risk of delirium",
            "D": "86% risk of delirium",
            "E": "The risk cannot be determined"
        },
        "answer": "A",
        "pmid": "19118253"
    },
    {
        "question": "A 75-year-old patient is scheduled for cardiac surgery. The patient has a history of stroke but currently has normal albumin levels. The patient's Mini Mental State Examination score is 24, indicating mild cognitive impairment. The Geriatric Depression Scale score is 2, suggesting no significant depressive symptoms. Based on these parameters, what is the risk of this patient developing delirium after the surgery?",
        "choices": {
            "A": "19% risk of delirium",
            "B": "47% risk of delirium",
            "C": "63% risk of delirium",
            "D": "86% risk of delirium",
            "E": "The patient is not at risk of delirium"
        },
        "answer": "C",
        "pmid": "19118253"
    },
    {
        "question": "A 62-year-old patient is scheduled for cardiac surgery. The patient has no history of stroke or transient ischemic attack but currently has abnormal albumin levels. The patient's Mini Mental State Examination score is 26, indicating mild cognitive impairment. The Geriatric Depression Scale score is 6, suggesting the presence of depressive symptoms. Based on these parameters, what is the patient's risk of developing delirium post-surgery?",
        "choices": {
            "A": "19% risk of delirium",
            "B": "47% risk of delirium",
            "C": "63% risk of delirium",
            "D": "86% risk of delirium",
            "E": "The risk cannot be determined"
        },
        "answer": "D",
        "pmid": "19118253"
    },
    {
        "question": "A 68-year-old patient is scheduled for cardiac surgery. The patient has a history of stroke and currently has abnormal albumin levels. The patient's Mini Mental State Examination score is 30, indicating normal cognitive function. The Geriatric Depression Scale score is 1, suggesting no significant depressive symptoms. The patient is otherwise healthy and takes no medications. Based on these parameters, what is the estimated risk of this patient developing delirium after cardiac surgery?",
        "choices": {
            "A": "19% risk of delirium",
            "B": "47% risk of delirium",
            "C": "63% risk of delirium",
            "D": "86% risk of delirium",
            "E": "The patient is not at risk of delirium"
        },
        "answer": "C",
        "pmid": "19118253"
    },
    {
        "question": "A 70-year-old patient is scheduled for elective cardiac surgery. The patient's preoperative assessments show a Katz score of 4, indicating dependence in performing some activities of daily living. The patient took 16 seconds to complete the Timed Up and Go test, suggesting potential mobility issues. The Charlson Comorbidity Index is 3, indicating the presence of several comorbidities. The patient's anemia level is 30%, which is below the normal range. The Mini-Cog score is 3, suggesting potential cognitive impairment. The patient's albumin level is 3.3 g/dL, which is below the normal range, indicating potential malnutrition or liver disease. The patient has experienced 2 falls within the past 6 months, suggesting potential balance or strength issues. Based on these preoperative assessments, what is the patient's risk of postoperative complications?",
        "choices": {
            "A": "Low risk of postoperative complications",
            "B": "Moderate risk of postoperative complications",
            "C": "High risk of postoperative complications",
            "D": "The patient is not at risk for postoperative complications",
            "E": "The patient's risk for postoperative complications cannot be determined"
        },
        "answer": "C",
        "pmid": "23880071"
    },
    {
        "question": "A 75-year-old patient is scheduled for elective colorectal surgery. The patient's preoperative assessments show a Katz score of 6, a Timed Up and Go test result of 10 seconds, and a Charlson Index of 2. The patient has an anemia level of 40%, a Mini-Cog score of 5, an albumin level of 3.5 g/dL, and has experienced no falls within the past 6 months. The patient has no history of chronic diseases and is generally in good health. Based on these preoperative traits, what is the patient's risk of postoperative complications?",
        "choices": {
            "A": "High risk",
            "B": "Moderate risk",
            "C": "Low risk",
            "D": "Risk cannot be determined",
            "E": "Risk is negligible"
        },
        "answer": "C",
        "pmid": "23880071"
    },
    {
        "question": "A 68-year-old patient is scheduled for elective cardiac surgery. The patient's preoperative assessments show a Katz score of 5, a Timed Up and Go test result of 14 seconds, and a Charlson Index of 3. The patient has an anemia level of 36%, a Mini-Cog score of 4, an albumin level of 3.4 g/dL, and has experienced 1 fall within the past 6 months. The patient has no history of smoking or alcohol consumption and follows a balanced diet. The patient's frailty score, calculated using the given parameters, is 3. What does this score indicate about the patient's risk of postoperative complications?",
        "choices": {
            "A": "The patient is nonfrail and has a lower risk of postoperative complications",
            "B": "The patient is prefrail and has a moderate risk of postoperative complications",
            "C": "The patient is frail and has a high risk of postoperative complications",
            "D": "The patient's risk of postoperative complications cannot be determined",
            "E": "The patient's risk of postoperative complications is extremely high"
        },
        "answer": "B",
        "pmid": "23880071"
    },
    {
        "question": "A 72-year-old patient is scheduled for elective colorectal surgery. The patient's preoperative assessments show a Katz score of 7, a Timed Up and Go test result of 12 seconds, and a Charlson Index of 1. The patient has an anemia level of 38%, a Mini-Cog score of 5, an albumin level of 3.6 g/dL, and has experienced no falls within the past 6 months. The patient's medical history is unremarkable, and they have no known allergies. The patient's frailty score, calculated using the given parameters, is 0. What is the risk of postoperative complications for this patient?",
        "choices": {
            "A": "High risk",
            "B": "Moderate risk",
            "C": "Low risk",
            "D": "The patient is not eligible for surgery",
            "E": "The risk cannot be determined"
        },
        "answer": "C",
        "pmid": "23880071"
    },
    {
        "question": "A 77-year-old patient is scheduled for elective cardiac surgery. The patient's preoperative assessments show a Katz score of 5, a Timed Up and Go test result of 15 seconds, and a Charlson Index of 4. The patient has an anemia level of 33%, a Mini-Cog score of 2, an albumin level of 3.2 g/dL, and has experienced 3 falls within the past 6 months. The patient's medical history includes hypertension, diabetes, and a previous myocardial infarction. The patient lives alone and has been experiencing increasing difficulty with daily activities. Based on these preoperative traits, how would you categorize the patient's risk of postoperative complications?",
        "choices": {
            "A": "Nonfrail, indicating a lower risk of postoperative complications",
            "B": "Prefrail, indicating a moderate risk of postoperative complications",
            "C": "Frail, indicating a high risk of postoperative complications",
            "D": "Unable to determine without further testing",
            "E": "Risk is not influenced by these preoperative traits"
        },
        "answer": "C",
        "pmid": "23880071"
    },
    {
        "question": "A 65-year-old patient presents with a history of non-breast primary tumor, specifically melanoma. The patient had a disease-free interval of 10 months before the detection of extrahepatic metastases. The patient underwent an R2 resection and a major hepatectomy. Based on these factors, what is the estimated 5-year survival rate for this patient?",
        "choices": {
            "A": "Greater than 46%",
            "B": "Between 33% and 46%",
            "C": "Between 10% and 33%",
            "D": "Less than 10%",
            "E": "Cannot be determined from the given information"
        },
        "answer": "D",
        "pmid": "16998361"
    },
    {
        "question": "A 55-year-old patient with a non-breast primary tumor underwent a major hepatectomy. The histology of the tumor is not melanoma or squamous. The patient had a disease-free interval of more than 12 months and does not have extrahepatic metastases. The patient underwent a resection that was not R2. Based on these factors, what is the most likely 5-year survival rate for this patient?",
        "choices": {
            "A": "<10%",
            "B": "33%",
            "C": "46%",
            "D": "55%",
            "E": "60%"
        },
        "answer": "C",
        "pmid": "16998361"
    },
    {
        "question": "A 65-year-old patient with a history of breast cancer presents for follow-up after undergoing hepatic resection for liver metastases. The histology of the tumor is not melanoma or squamous. The patient had a disease-free interval of less than 12 months before the detection of liver metastases. There is no evidence of extrahepatic metastases. The patient underwent an R2 resection but did not have a major hepatectomy. Based on these factors, what is the most likely 5-year survival rate for this patient?",
        "choices": {
            "A": "<10%",
            "B": "33%",
            "C": "46%",
            "D": "60%",
            "E": "75%"
        },
        "answer": "C",
        "pmid": "16998361"
    },
    {
        "question": "A 55-year-old patient with a history of breast cancer presents to your clinic. The histology of the tumor is melanoma. The patient had a disease-free interval of more than 12 months. The patient has extrahepatic metastases. The patient underwent a resection that was not R2 and did not have a major hepatectomy. Based on these factors, what is the most likely 5-year survival rate for this patient after hepatic resection for noncolorectal nonendocrine liver metastases?",
        "choices": {
            "A": "<10%",
            "B": "33%",
            "C": "46%",
            "D": "60%",
            "E": "75%"
        },
        "answer": "C",
        "pmid": "16998361"
    },
    {
        "question": "A 65-year-old patient presents with a history of non-breast primary tumor, specifically melanoma. The patient had a disease-free interval of more than 12 months but has been diagnosed with extrahepatic metastases. The patient recently underwent an R2 resection and a major hepatectomy. Based on these factors, what is the patient's predicted 5-year survival rate following hepatic resection for noncolorectal nonendocrine liver metastases?",
        "choices": {
            "A": "Less than 10%",
            "B": "33%",
            "C": "46%",
            "D": "More than 50%",
            "E": "The survival rate cannot be determined"
        },
        "answer": "B",
        "pmid": "16998361"
    },
    {
        "question": "A 70-year-old patient presents with mild cognitive impairment. Recent MRI data estimates the patient's brain age to be 75 years, suggesting a potential risk of accelerated brain atrophy. Given this information, what is the most likely risk of this patient developing Alzheimer's disease?",
        "choices": {
            "A": "There is no increased risk of developing Alzheimer's disease",
            "B": "10% increased risk of developing Alzheimer's disease",
            "C": "50% increased risk of developing Alzheimer's disease",
            "D": "100% increased risk of developing Alzheimer's disease",
            "E": "The patient already has Alzheimer's disease"
        },
        "answer": "C",
        "pmid": "23826273"
    },
    {
        "question": "A 70-year-old patient presents with mild cognitive impairment (MCI). The patient's MRI data suggests an estimated brain age of 65 years, indicating a slower rate of brain atrophy compared to their chronological age. Given this information, which of the following best describes the patient's risk of developing Alzheimer's disease (AD)?",
        "choices": {
            "A": "The patient has a significantly increased risk of developing AD",
            "B": "The patient has a moderately increased risk of developing AD",
            "C": "The patient has an average risk of developing AD",
            "D": "The patient has a moderately decreased risk of developing AD",
            "E": "The patient has a significantly decreased risk of developing AD"
        },
        "answer": "E",
        "pmid": "23826273"
    },
    {
        "question": "A 75-year-old patient presents with mild cognitive impairment. Recent MRI data estimates the patient's brain age to be 80 years. This suggests a potential risk of accelerated brain atrophy. Based on this information, what is the most likely risk of this patient developing Alzheimer's disease?",
        "choices": {
            "A": "There is no increased risk of developing Alzheimer's disease",
            "B": "10% increased risk of developing Alzheimer's disease",
            "C": "50% increased risk of developing Alzheimer's disease",
            "D": "100% increased risk of developing Alzheimer's disease",
            "E": "The patient has already developed Alzheimer's disease"
        },
        "answer": "C",
        "pmid": "23826273"
    },
    {
        "question": "A 72-year-old patient presents with mild cognitive impairment (MCI). An MRI of the brain was performed, and the estimated brain age was found to be 68 years. This suggests a slower rate of brain atrophy compared to the patient's chronological age. Based on these findings, which of the following best describes the patient's risk of progression from MCI to Alzheimer's disease (AD)?",
        "choices": {
            "A": "The patient has a significantly increased risk of progression to AD",
            "B": "The patient has a moderately increased risk of progression to AD",
            "C": "The patient has an average risk of progression to AD",
            "D": "The patient has a moderately decreased risk of progression to AD",
            "E": "The patient has a significantly decreased risk of progression to AD"
        },
        "answer": "D",
        "pmid": "23826273"
    },
    {
        "question": "A 80-year-old patient presents with mild cognitive impairment (MCI). Recent MRI data estimates the patient's brain age to be 85 years, suggesting a potential risk of accelerated brain atrophy. Given this information, which of the following best describes the patient's risk of developing Alzheimer's disease (AD)?",
        "choices": {
            "A": "The patient has no increased risk of developing AD.",
            "B": "The patient has a 10% increased risk of developing AD.",
            "C": "The patient has a 50% increased risk of developing AD.",
            "D": "The patient has a 100% increased risk of developing AD.",
            "E": "The patient has a 200% increased risk of developing AD."
        },
        "answer": "C",
        "pmid": "23826273"
    },
    {
        "question": "A 65-year-old male patient presents with fatigue and unexplained weight loss. He has been diagnosed with Chronic Myelomonocytic Leukemia (CMML). His laboratory results show a hemoglobin level of 115 g/L, presence of circulating immature myeloid cells, an absolute lymphocyte count of 3 x 10^9/L, and marrow blasts of 12%. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, median survival of 24 months",
            "B": "Intermediate-1 risk, median survival of 15 months",
            "C": "Intermediate-2 risk, median survival of 8 months",
            "D": "High risk, median survival of 5 months",
            "E": "Unable to determine without further testing"
        },
        "answer": "D",
        "pmid": "11806985"
    },
    {
        "question": "A 65-year-old male patient presents with fatigue and weakness. He has been diagnosed with Chronic Myelomonocytic Leukemia (CMML). His hemoglobin level is 130 g/L, there is no presence of circulating immature myeloid cells, his absolute lymphocyte count is 2 x 10^9/L, and marrow blasts are at 8%. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, median survival of 24 months",
            "B": "Intermediate-1 risk, median survival of 15 months",
            "C": "Intermediate-2 risk, median survival of 8 months",
            "D": "High risk, median survival of 5 months",
            "E": "Very high risk, median survival of less than 5 months"
        },
        "answer": "A",
        "pmid": "11806985"
    },
    {
        "question": "A 65-year-old male patient presents with fatigue and unexplained weight loss. He has been diagnosed with Chronic Myelomonocytic Leukemia (CMML). His laboratory results show a hemoglobin level of 110 g/L, presence of circulating immature myeloid cells, an absolute lymphocyte count of 1 x 10^9/L, and marrow blasts of 15%. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, median survival of 24 months",
            "B": "Intermediate-1 risk, median survival of 15 months",
            "C": "Intermediate-2 risk, median survival of 8 months",
            "D": "High risk, median survival of 5 months",
            "E": "Unable to determine without further testing"
        },
        "answer": "D",
        "pmid": "11806985"
    },
    {
        "question": "A 65-year-old male patient presents with fatigue and unexplained weight loss. He has been diagnosed with Chronic Myelomonocytic Leukemia (CMML). His hemoglobin level is 125 g/L, there is no presence of circulating immature myeloid cells, his absolute lymphocyte count is 3.5 x 10^9/L, and marrow blasts are at 9%. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, median survival of 24 months",
            "B": "Intermediate-1 risk, median survival of 15 months",
            "C": "Intermediate-2 risk, median survival of 8 months",
            "D": "High risk, median survival of 5 months",
            "E": "Unable to determine without further testing"
        },
        "answer": "B",
        "pmid": "11806985"
    },
    {
        "question": "A 65-year-old male patient presents with fatigue and unexplained weight loss. He has been diagnosed with Chronic Myelomonocytic Leukemia (CMML). His hemoglobin level is 118 g/L, there is presence of circulating immature myeloid cells, his absolute lymphocyte count is 2.6 x 10^9/L, and marrow blasts are 11%. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, median survival of 24 months",
            "B": "Intermediate-1 risk, median survival of 15 months",
            "C": "Intermediate-2 risk, median survival of 8 months",
            "D": "High risk, median survival of 5 months",
            "E": "Unable to determine without further testing"
        },
        "answer": "D",
        "pmid": "11806985"
    },
    {
        "question": "A 70-year-old patient is scheduled for a high-risk elective operation. The patient has a Charlson Comorbidity Index, is dependent in activities of daily living and instrumental activities of daily living, has dementia, is at risk of delirium, has a short midarm circumference, and is malnourished. The patient's overall score, calculated based on these factors, is 7. What does this score indicate about the patient's postoperative mortality risk?",
        "choices": {
            "A": "The patient has a low risk of postoperative mortality",
            "B": "The patient has a moderate risk of postoperative mortality",
            "C": "The patient has a high risk of postoperative mortality",
            "D": "The patient's postoperative mortality risk cannot be determined",
            "E": "The patient's score is not related to postoperative mortality risk"
        },
        "answer": "C",
        "pmid": "24804971"
    },
    {
        "question": "A 75-year-old patient is scheduled for an intermediate-risk elective operation. The patient is independent in activities of daily living, does not have dementia, and is not malnourished. However, the patient is dependent in instrumental activities of daily living and is at risk of delirium. The patient does not have any comorbidities as per the Charlson Comorbidity Index and has a normal midarm circumference. Based on these factors, what is the patient's risk of 1-year all-cause mortality post-operation?",
        "choices": {
            "A": "High risk",
            "B": "Low risk",
            "C": "Moderate risk",
            "D": "Risk cannot be determined",
            "E": "Risk is negligible"
        },
        "answer": "B",
        "pmid": "24804971"
    },
    {
        "question": "A 68-year-old patient is scheduled for a high-risk elective operation. The patient has a Charlson Comorbidity Index, indicating the presence of at least one comorbidity. The patient also has a short midarm circumference and is malnourished. However, the patient is independent in activities of daily living and instrumental activities of daily living, does not have dementia, and is not at risk of delirium. Based on these factors, what is the patient's risk of postoperative mortality within 1 year after undergoing the operation?",
        "choices": {
            "A": "Very high risk",
            "B": "High risk",
            "C": "Moderate risk",
            "D": "Low risk",
            "E": "Very low risk"
        },
        "answer": "D",
        "pmid": "24804971"
    },
    {
        "question": "A 72-year-old patient is scheduled for an intermediate-risk elective operation. The patient has a history of dementia and is dependent on others for activities of daily living such as bathing, dressing, and feeding. However, the patient is independent in instrumental activities of daily living such as managing medications, handling finances, and using a telephone. The patient does not have any comorbidities as per the Charlson Comorbidity Index, is not at risk of delirium, has a normal midarm circumference, and is not malnourished. Based on this information, what is the patient's risk of postoperative mortality within 1 year?",
        "choices": {
            "A": "Very high risk",
            "B": "High risk",
            "C": "Moderate risk",
            "D": "Low risk",
            "E": "Very low risk"
        },
        "answer": "D",
        "pmid": "24804971"
    },
    {
        "question": "A 77-year-old patient is scheduled for a high-risk elective operation. The patient has a Charlson Comorbidity Index and is dependent in activities of daily living and instrumental activities of daily living. The patient does not have dementia, is not at risk of delirium, does not have a short midarm circumference, and is not malnourished. The patient's score, calculated based on these factors, is 3. What does this score indicate about the patient's risk of postoperative mortality?",
        "choices": {
            "A": "The patient is at a high risk of postoperative mortality",
            "B": "The patient is at a moderate risk of postoperative mortality",
            "C": "The patient is at a low risk of postoperative mortality",
            "D": "The patient's risk of postoperative mortality cannot be determined",
            "E": "The patient's risk of postoperative mortality is average"
        },
        "answer": "C",
        "pmid": "24804971"
    },
    {
        "question": "A 55-year-old patient presents with a new onset of morning stiffness in the shoulders. The patient also reports sudden visual loss. Laboratory tests reveal an erythrocyte sedimentation rate of 55 mm/hour. A temporal artery biopsy was performed and the results were positive. Based on these findings, how would you classify this patient's condition?",
        "choices": {
            "A": "The patient is unlikely to have Giant Cell Arteritis",
            "B": "The patient could be classified as having Giant Cell Arteritis",
            "C": "The patient's condition cannot be determined",
            "D": "The patient has a low risk of developing Giant Cell Arteritis",
            "E": "The patient has a high risk of developing Giant Cell Arteritis"
        },
        "answer": "B",
        "pmid": "36350123"
    },
    {
        "question": "A 60-year-old patient presents with complaints of morning stiffness in the shoulders and neck, and a new temporal headache. The patient has no history of visual loss or positive temporal artery biopsy. Laboratory tests reveal an erythrocyte sedimentation rate of 60 mm/hour. No other symptoms or signs of vasculitis are present. Based on these findings, how would you classify the patient's condition?",
        "choices": {
            "A": "The patient is unlikely to have Giant Cell Arteritis (GCA)",
            "B": "The patient could be classified as having GCA",
            "C": "The patient definitely has GCA",
            "D": "The patient's condition cannot be classified without further testing",
            "E": "The patient's symptoms are not consistent with GCA"
        },
        "answer": "B",
        "pmid": "36350123"
    },
    {
        "question": "A 70-year-old patient presents to the clinic with a recent positive temporal artery biopsy. The patient denies any symptoms such as morning stiffness in shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, or temporal artery abnormality on vascular examination. There is no evidence of bilateral axillary involvement on imaging, and fluorodeoxyglucose-positron emission tomography activity throughout the aorta is normal. Laboratory tests reveal an erythrocyte sedimentation rate of 45 mm/hour and C-reactive protein of 8 mg/liter. The patient also denies any sudden visual loss. Based on the patient's presentation and test results, which of the following is the most likely diagnosis?",
        "choices": {
            "A": "The patient is likely to have Giant Cell Arteritis",
            "B": "The patient is unlikely to have Giant Cell Arteritis",
            "C": "The patient may have a different type of vasculitis",
            "D": "The patient needs further testing to confirm Giant Cell Arteritis",
            "E": "The patient's symptoms are likely due to a non-vascular cause"
        },
        "answer": "B",
        "pmid": "36350123"
    },
    {
        "question": "A 65-year-old patient presents to the clinic with complaints of sudden visual loss. The patient also reports experiencing morning stiffness in the shoulders, a new temporal headache, and scalp tenderness. The patient denies any recent trauma or injury. Laboratory tests reveal normal erythrocyte sedimentation rate and C-reactive protein levels. Temporal artery biopsy and ultrasound were performed and did not show any abnormalities. Based on the patient's symptoms and test results, which of the following is the most likely diagnosis?",
        "choices": {
            "A": "The patient is unlikely to have Giant Cell Arteritis",
            "B": "The patient could be classified as having Giant Cell Arteritis",
            "C": "The patient definitely has Giant Cell Arteritis",
            "D": "The patient has a low risk of developing Giant Cell Arteritis",
            "E": "The patient has a high risk of developing Giant Cell Arteritis"
        },
        "answer": "B",
        "pmid": "36350123"
    },
    {
        "question": "A 52-year-old patient presents to the clinic with an erythrocyte sedimentation rate of 55 mm/hour. The patient denies any symptoms such as morning stiffness in shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, or temporal artery abnormality. There is no evidence of bilateral axillary involvement on imaging, and fluorodeoxyglucose-positron emission tomography activity throughout the aorta is normal. The patient also denies any sudden visual loss. A temporal artery biopsy was performed and did not show any signs of Giant Cell Arteritis. Based on the patient's symptoms and test results, which of the following is the most likely diagnosis?",
        "choices": {
            "A": "The patient is likely to have Giant Cell Arteritis",
            "B": "The patient is unlikely to have Giant Cell Arteritis",
            "C": "The patient may have a mild form of Giant Cell Arteritis",
            "D": "The patient's symptoms are inconclusive for Giant Cell Arteritis",
            "E": "The patient needs further testing to confirm Giant Cell Arteritis"
        },
        "answer": "B",
        "pmid": "36350123"
    },
    {
        "question": "A 65-year-old male patient with a diagnosis of advanced non-small-cell lung cancer (NSCLC) is about to start first-line pembrolizumab treatment. His tumor expresses programmed death-ligand 1 at a level of \u226550%. His pretreatment laboratory results show an albumin level of 33 g/l and a neutrophil count of 8 \u00d7 10^9/l. He has no other significant medical history. Based on these findings, which of the following is the most likely prognosis for this patient?",
        "choices": {
            "A": "Progression-free survival of 17.9 months and overall survival of 28.7 months",
            "B": "Progression-free survival of 8.7 months and overall survival of 12.4 months",
            "C": "Progression-free survival of 2.5 months and overall survival of 5.1 months",
            "D": "Progression-free survival of 5.1 months and overall survival of 2.5 months",
            "E": "Progression-free survival of 12.4 months and overall survival of 8.7 months"
        },
        "answer": "C",
        "pmid": "35398717"
    },
    {
        "question": "A 70-year-old female patient with advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 \u226550% is about to start first-line pembrolizumab treatment. She has no significant past medical history. Her pretreatment albumin level is 36 g/l and neutrophil count is 7 \u00d7 10^9/l. She is a non-smoker and has a good performance status. Based on her albumin and neutrophil count, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Progression-free survival (PFS) of 2.5 months and overall survival (OS) of 5.1 months",
            "B": "PFS of 8.7 months and OS of 12.4 months",
            "C": "PFS of 17.9 months and OS of 28.7 months",
            "D": "PFS of 24 months and OS of 36 months",
            "E": "PFS of 30 months and OS of 48 months"
        },
        "answer": "C",
        "pmid": "35398717"
    },
    {
        "question": "A 60-year-old male patient with advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 \u226550% is about to start first-line pembrolizumab treatment. His pretreatment albumin level is 34 g/l and neutrophil count is 6 \u00d7 10^9/l. He has no other significant medical history. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Progression-free survival (PFS) of 17.9 months and overall survival (OS) of 28.7 months",
            "B": "PFS of 8.7 months and OS of 12.4 months",
            "C": "PFS of 2.5 months and OS of 5.1 months",
            "D": "PFS of 6 months and OS of 10 months",
            "E": "PFS of 12 months and OS of 24 months"
        },
        "answer": "B",
        "pmid": "35398717"
    },
    {
        "question": "A 55-year-old female patient with advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 \u226550% is about to start first-line pembrolizumab treatment. Her pretreatment albumin level is 37 g/l and neutrophil count is 8.5 \u00d7 10^9/l. She has no other significant medical history. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Progression-free survival (PFS) of 17.9 months and overall survival (OS) of 28.7 months",
            "B": "PFS of 8.7 months and OS of 12.4 months",
            "C": "PFS of 2.5 months and OS of 5.1 months",
            "D": "PFS of 12 months and OS of 24 months",
            "E": "PFS of 6 months and OS of 12 months"
        },
        "answer": "B",
        "pmid": "35398717"
    },
    {
        "question": "A 68-year-old male patient with advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 \u226550% is about to start first-line pembrolizumab treatment. His pretreatment albumin level is 35 g/l and neutrophil count is 7.5 \u00d7 10^9/l. He has no other significant medical history. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Progression-free survival (PFS) of 2.5 months and overall survival (OS) of 5.1 months",
            "B": "PFS of 8.7 months and OS of 12.4 months",
            "C": "PFS of 17.9 months and OS of 28.7 months",
            "D": "PFS of 24 months and OS of 36 months",
            "E": "PFS of 12 months and OS of 18 months"
        },
        "answer": "C",
        "pmid": "35398717"
    },
    {
        "question": "A 78-year-old female patient is scheduled for surgery. She has an American Society of Anesthesiologists score of 3 and a Body Mass Index of 22. Her preoperative Braden score is 14. She has been diagnosed with anaemia, respiratory disease, and hypertension. Based on these preoperative data, what is the patient's risk of developing hospital-acquired pressure ulcers (HAPU)?",
        "choices": {
            "A": "Low risk of developing HAPU",
            "B": "Moderate risk of developing HAPU",
            "C": "High risk of developing HAPU",
            "D": "The patient is not at risk of developing HAPU",
            "E": "Unable to determine the risk without further information"
        },
        "answer": "C",
        "pmid": "30289624"
    },
    {
        "question": "A 65-year-old male is scheduled for a surgical procedure. He has an American Society of Anesthesiologists score of 2 and a Body Mass Index of 25. His preoperative Braden score is 16. He does not have any history of anaemia, respiratory disease, or hypertension. His laboratory results including complete blood count, liver function tests, and renal function tests are within normal limits. Based on his preoperative data, what is the risk of this patient developing hospital-acquired pressure ulcers (HAPU)?",
        "choices": {
            "A": "High risk, with a positive predictive value of 73.2%",
            "B": "High risk, with a negative predictive value of 80.7%",
            "C": "Low risk, with a positive predictive value of 73.2%",
            "D": "Low risk, with a negative predictive value of 80.7%",
            "E": "Cannot be determined from the given data"
        },
        "answer": "D",
        "pmid": "30289624"
    },
    {
        "question": "An 80-year-old male patient is scheduled for surgery. He has an American Society of Anesthesiologists score of 4 and a Body Mass Index of 20. His preoperative Braden score is 13. He has been diagnosed with anaemia, respiratory disease, and hypertension. He does not have any history of smoking or alcohol consumption. His family history is non-contributory. His vital signs are within normal limits. Based on his preoperative data, what is the risk of this patient developing hospital-acquired pressure ulcers (HAPU)?",
        "choices": {
            "A": "Low risk of developing HAPU",
            "B": "Moderate risk of developing HAPU",
            "C": "High risk of developing HAPU, with a positive predictive value of 73.2%",
            "D": "High risk of developing HAPU, with a negative predictive value of 80.7%",
            "E": "Cannot be determined based on the given data"
        },
        "answer": "C",
        "pmid": "30289624"
    },
    {
        "question": "A 70-year-old female patient is scheduled for surgery. She has an American Society of Anesthesiologists score of 2 and a Body Mass Index of 24. Her preoperative Braden score is 15. She does not have anaemia or respiratory disease, but she has been diagnosed with hypertension. She has no history of diabetes or cardiovascular disease. She is a non-smoker and does not consume alcohol. Based on her preoperative data, what is her risk of developing hospital-acquired pressure ulcers (HAPU)?",
        "choices": {
            "A": "High risk, with a positive predictive value of 73.2%",
            "B": "High risk, with a negative predictive value of 80.7%",
            "C": "Low risk, with a positive predictive value of 73.2%",
            "D": "Low risk, with a negative predictive value of 80.7%",
            "E": "Cannot be determined from the given data"
        },
        "answer": "D",
        "pmid": "30289624"
    },
    {
        "question": "A 76-year-old male is scheduled for surgery. He has an American Society of Anesthesiologists score of 3 and a Body Mass Index of 28. His preoperative Braden score is 12. He has been diagnosed with anaemia, but does not have respiratory disease or hypertension. Based on these preoperative data, what is the patient's risk of developing hospital-acquired pressure ulcers (HAPU)?",
        "choices": {
            "A": "High risk, with a positive predictive value of 73.2%",
            "B": "High risk, with a negative predictive value of 80.7%",
            "C": "Low risk, with a positive predictive value of 73.2%",
            "D": "Low risk, with a negative predictive value of 80.7%",
            "E": "Cannot be determined from the given data"
        },
        "answer": "D",
        "pmid": "30289624"
    },
    {
        "question": "A 65-year-old male patient with a history of lung cancer has recently undergone surgery for spinal metastasis. He was admitted emergently due to severe back pain. His medical history is significant for anemia and chronic lung disease. Laboratory findings confirm the presence of anemia but show no signs of coagulopathy, electrolyte abnormalities, or renal failure. The patient's nutritional status is within normal limits. The surgical approach was posterior. Based on these findings, how would you classify the patient's risk for inpatient complications and mortality?",
        "choices": {
            "A": "Not frail, lowest risk",
            "B": "Mildly frail",
            "C": "Moderately frail",
            "D": "Severely frail, highest risk",
            "E": "Cannot be determined"
        },
        "answer": "D",
        "pmid": "27544340"
    },
    {
        "question": "A 55-year-old woman with a history of breast cancer presents with back pain. Imaging reveals spinal metastasis and she undergoes surgery. She has a history of coagulopathy, electrolyte abnormalities, pulmonary circulation disorders, and renal failure. She has been diagnosed with malnutrition and underwent an anterior or combined surgical approach. She was not admitted emergently and does not have anemia or chronic lung disease. Her laboratory results show no signs of anemia and her pulmonary function tests are normal. Based on these findings, what is the most likely prediction for this patient's inpatient morbidity, mortality, and length of stay?",
        "choices": {
            "A": "Not frail, lowest risk",
            "B": "Mildly frail",
            "C": "Moderately frail",
            "D": "Severely frail, highest risk",
            "E": "Cannot be determined without further information"
        },
        "answer": "D",
        "pmid": "27544340"
    },
    {
        "question": "A 68-year-old male with a history of prostate cancer presents with back pain. Imaging reveals spinal metastasis. He underwent an anterior surgical approach for spinal decompression. His medical history is significant for anemia, coagulopathy, and pulmonary circulation disorders. He was admitted emergently due to severe pain. His nutritional status is poor, indicating malnutrition. However, he does not have chronic lung disease, electrolyte abnormalities, or renal failure. Based on these factors, what is the most likely prediction for this patient's inpatient outcome?",
        "choices": {
            "A": "Low risk of inpatient morbidity and mortality, short length of stay",
            "B": "Mild risk of inpatient morbidity and mortality, moderate length of stay",
            "C": "Moderate risk of inpatient morbidity and mortality, moderate length of stay",
            "D": "High risk of inpatient morbidity and mortality, potentially longer length of stay",
            "E": "Unable to determine without further information"
        },
        "answer": "D",
        "pmid": "27544340"
    },
    {
        "question": "A 65-year-old male patient with a history of thyroid cancer has recently undergone surgery for spinal metastasis. He has a known history of chronic lung disease and renal failure. His recent blood tests showed electrolyte abnormalities. The surgical approach was anterior. He was not admitted emergently and does not have anemia, coagulopathy, pulmonary circulation disorders, or malnutrition. Based on these factors, how would you classify the patient's risk for inpatient complications and mortality?",
        "choices": {
            "A": "Not frail, lowest risk",
            "B": "Mildly frail",
            "C": "Moderately frail",
            "D": "Severely frail, highest risk",
            "E": "Cannot be determined"
        },
        "answer": "D",
        "pmid": "27544340"
    },
    {
        "question": "A 65-year-old male patient with a history of renal cancer has recently undergone surgery for spinal metastasis. The patient was admitted emergently and the surgical approach was anterior. He has a history of anemia, chronic lung disease, coagulopathy, electrolyte abnormalities, pulmonary circulation disorders, and renal failure. He also shows signs of malnutrition. Based on these factors, how would you classify the patient's risk of inpatient morbidity, mortality, and length of stay?",
        "choices": {
            "A": "Not frail, lowest risk",
            "B": "Mildly frail",
            "C": "Moderately frail",
            "D": "Severely frail, highest risk",
            "E": "Cannot be determined"
        },
        "answer": "D",
        "pmid": "27544340"
    },
    {
        "question": "A 35-year-old male patient in the intensive care unit has a severe brain injury. He displays visual pursuit and attempts to swallow. His Glasgow coma score is 11. Based on these parameters, what is the most likely probability of successful extubation for this patient?",
        "choices": {
            "A": "Less than 90%",
            "B": "90%",
            "C": "Greater than 90%",
            "D": "The probability cannot be determined",
            "E": "The patient is not eligible for extubation"
        },
        "answer": "C",
        "pmid": "28640020"
    },
    {
        "question": "A 45-year-old patient with a severe brain injury is being considered for extubation in the intensive care unit. The patient does not display visual pursuit and does not attempt to swallow. The Glasgow coma score of the patient is 9. Based on these parameters, what is the most likely probability of successful extubation for this patient?",
        "choices": {
            "A": "Greater than 90%",
            "B": "Less than 90%",
            "C": "Exactly 90%",
            "D": "The probability cannot be determined from the given parameters",
            "E": "The patient is not eligible for extubation"
        },
        "answer": "B",
        "pmid": "28640020"
    },
    {
        "question": "A 50-year-old patient in the intensive care unit has suffered a severe brain injury. The patient displays visual pursuit and attempts to swallow. The Glasgow coma score of the patient is 8. Based on these parameters, what is the most likely probability of successful extubation for this patient?",
        "choices": {
            "A": "Greater than 90%",
            "B": "Less than 90%",
            "C": "Exactly 90%",
            "D": "The probability cannot be determined",
            "E": "The patient is not eligible for extubation"
        },
        "answer": "B",
        "pmid": "28640020"
    },
    {
        "question": "A 30-year-old patient with a severe brain injury is being considered for extubation in the intensive care unit. The patient does not display visual pursuit but attempts to swallow. The Glasgow coma score of the patient is 12. Based on these parameters, what is the most likely outcome of extubation for this patient?",
        "choices": {
            "A": "The probability of successful extubation is less than 90%",
            "B": "The probability of successful extubation is 90%",
            "C": "The patient is not eligible for extubation",
            "D": "The patient needs further evaluation before extubation",
            "E": "The patient should not be extubated"
        },
        "answer": "B",
        "pmid": "28640020"
    },
    {
        "question": "A 42-year-old patient in the intensive care unit has a severe brain injury. The patient displays visual pursuit but does not attempt to swallow. The Glasgow coma score of the patient is 11. Based on these parameters, what is the most likely probability of successful extubation for this patient?",
        "choices": {
            "A": "Greater than 90%",
            "B": "Less than 90%",
            "C": "Exactly 90%",
            "D": "The probability cannot be determined",
            "E": "The patient is not eligible for extubation"
        },
        "answer": "B",
        "pmid": "28640020"
    },
    {
        "question": "A 65-year-old male patient has been recently diagnosed with Refractory Anemia with Ring Sideroblasts and Thrombocytosis (RARS-T). The patient's hemoglobin level is 9.5 gm/dl, which is below the normal range. Genetic testing has revealed an abnormal karyotype and the presence of an ASXL1 mutation. The patient does not have a SETBP1 mutation. The patient has no other significant medical history. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, with a median survival of 80 months",
            "B": "Intermediate risk, with a median survival of 42 months",
            "C": "High risk, with a median survival of 11 months",
            "D": "Very high risk, with a median survival of less than 6 months",
            "E": "The prognosis cannot be determined based on the given information"
        },
        "answer": "C",
        "pmid": "26874914"
    },
    {
        "question": "A 55-year-old male patient has been recently diagnosed with Refractory Anemia with Ring Sideroblasts and Thrombocytosis (RARS-T). The patient's hemoglobin level is 11.0 gm/dl, which is within the normal range. Genetic testing has revealed a normal karyotype and the absence of ASXL1 and SETBP1 mutations. The patient has no other significant medical history. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "High risk, with a median survival of 11 months",
            "B": "Intermediate risk, with a median survival of 42 months",
            "C": "Low risk, with a median survival of 80 months",
            "D": "High risk, with a median survival of less than 6 months",
            "E": "Intermediate risk, with a median survival of 60 months"
        },
        "answer": "C",
        "pmid": "26874914"
    },
    {
        "question": "A 65-year-old male patient has been recently diagnosed with Refractory Anemia with Ring Sideroblasts and Thrombocytosis (RARS-T). The patient's hemoglobin level is 10.5 gm/dl, which is within the normal range. Genetic testing has revealed an abnormal karyotype and the presence of a SETBP1 mutation. The patient does not have an ASXL1 mutation. The patient has no other significant medical history and is currently not on any medication. Based on these clinical and genetic factors, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, with a median survival of 80 months",
            "B": "Intermediate risk, with a median survival of 42 months",
            "C": "High risk, with a median survival of 11 months",
            "D": "Low risk, with a median survival of 42 months",
            "E": "Intermediate risk, with a median survival of 11 months"
        },
        "answer": "C",
        "pmid": "26874914"
    },
    {
        "question": "A 65-year-old male patient has been recently diagnosed with Refractory Anemia with Ring Sideroblasts and Thrombocytosis (RARS-T). His complete blood count shows a hemoglobin level of 9.0 gm/dl, which is below the normal range. Genetic testing has been performed, revealing a normal karyotype but the presence of both ASXL1 and SETBP1 mutations. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, with a median survival of 80 months",
            "B": "Intermediate risk, with a median survival of 42 months",
            "C": "High risk, with a median survival of 11 months",
            "D": "Very high risk, with a median survival of less than 6 months",
            "E": "The prognosis cannot be determined based on the given information"
        },
        "answer": "C",
        "pmid": "26874914"
    },
    {
        "question": "A 65-year-old male patient has been recently diagnosed with Refractory Anemia with Ring Sideroblasts and Thrombocytosis (RARS-T). His complete blood count shows a hemoglobin level of 10.0 gm/dl. Genetic testing has revealed an abnormal karyotype. However, the patient does not have ASXL1 or SETBP1 mutations. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low risk, with a median survival of 80 months",
            "B": "Intermediate risk, with a median survival of 42 months",
            "C": "High risk, with a median survival of 11 months",
            "D": "Intermediate risk, with a median survival of 11 months",
            "E": "High risk, with a median survival of 42 months"
        },
        "answer": "C",
        "pmid": "26874914"
    },
    {
        "question": "A 45-year-old patient is scheduled for an unplanned surgery. The patient has a history of difficult peripheral intravenous cannulation. On examination, the target vein for intravenous cannulation is not palpable or visible, and the vein diameter is less than 2 millimeters. Based on these findings, what is the risk of failed first attempt of peripheral intravenous cannulation in this patient?",
        "choices": {
            "A": "Low risk (5% failure rate)",
            "B": "Medium risk (37% failure rate)",
            "C": "High risk (93% failure rate)",
            "D": "The risk cannot be determined",
            "E": "There is no risk of failure"
        },
        "answer": "B",
        "pmid": "27100437"
    },
    {
        "question": "A 50-year-old patient is scheduled for a planned surgery. The target vein for intravenous cannulation is both palpable and visible. The patient has no history of difficult peripheral intravenous cannulation and the vein diameter is more than 2 millimeters. Based on these clinical variables, what is the risk of a failed first attempt at peripheral intravenous cannulation?",
        "choices": {
            "A": "Low risk (5% failure rate)",
            "B": "Medium risk (37% failure rate)",
            "C": "High risk (93% failure rate)",
            "D": "The patient is not eligible for this risk assessment",
            "E": "Insufficient information to determine the risk"
        },
        "answer": "B",
        "pmid": "27100437"
    },
    {
        "question": "A 60-year-old patient is scheduled for a planned surgical procedure. The target vein for intravenous cannulation is visible but not palpable. The patient has a history of difficult peripheral intravenous cannulation. The diameter of the target vein is less than 2 millimeters. Based on these clinical variables, what is the risk of a failed first attempt at peripheral intravenous cannulation?",
        "choices": {
            "A": "Low risk (5% failure rate)",
            "B": "Medium risk (37% failure rate)",
            "C": "High risk (93% failure rate)",
            "D": "The risk cannot be determined based on the given information",
            "E": "The risk is negligible"
        },
        "answer": "B",
        "pmid": "27100437"
    },
    {
        "question": "A 70-year-old patient is scheduled for an unplanned surgery. The target vein for intravenous cannulation is palpable but not visible. The patient has no history of difficult peripheral intravenous cannulation and the vein diameter is more than 2 millimeters. Based on these factors, what is the risk of a failed first attempt at peripheral intravenous cannulation?",
        "choices": {
            "A": "Low risk (5% failure rate)",
            "B": "Medium risk (37% failure rate)",
            "C": "High risk (93% failure rate)",
            "D": "The risk cannot be determined based on the given information",
            "E": "The patient is not eligible for peripheral intravenous cannulation"
        },
        "answer": "B",
        "pmid": "27100437"
    },
    {
        "question": "A 55-year-old patient is scheduled for an unplanned surgery. The target vein for intravenous cannulation is both palpable and visible. The patient has a history of difficult peripheral intravenous cannulation. The vein diameter is more than 2 millimeters. Based on these clinical variables, what is the predicted difficulty of peripheral intravenous cannulation for this patient?",
        "choices": {
            "A": "Low risk of failed first attempt of peripheral intravenous cannulation (5% failure rate)",
            "B": "Medium risk of failed first attempt of peripheral intravenous cannulation (37% failure rate)",
            "C": "High risk of failed first attempt of peripheral intravenous cannulation (93% failure rate)",
            "D": "The patient is not eligible for peripheral intravenous cannulation",
            "E": "The patient's clinical variables do not affect the difficulty of peripheral intravenous cannulation"
        },
        "answer": "C",
        "pmid": "27100437"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic for a follow-up visit after successful treatment for hepatitis C virus. He achieved sustained virological responses at 24 weeks after treatment. His recent laboratory results show a Gamma-glutamyl transferase (GGT) level of 25 IU/L, an Alpha-fetoprotein (AFP) level of 3.5 ng/mL, and a Fibrosis-4 Index (F4I) of 4.0. He has a history of advanced fibrosis. Based on these findings, how would you classify the patient's risk for hepatocellular carcinoma (HCC) development and what would be the expected HCC development rate per 100 person-years?",
        "choices": {
            "A": "Low risk, 0.5-1.1 per 100 person-years",
            "B": "Low risk, 1.2-2.0 per 100 person-years",
            "C": "High risk, 0.5-1.1 per 100 person-years",
            "D": "High risk, 1.2-2.0 per 100 person-years",
            "E": "High risk, 2.1-3.0 per 100 person-years"
        },
        "answer": "A",
        "pmid": "34676692"
    },
    {
        "question": "A 55-year-old male patient with a history of advanced fibrosis due to hepatitis C virus infection, which was successfully treated 24 weeks ago, presents for a routine follow-up. His laboratory results show a Gamma-glutamyl transferase (GGT) level of 30 IU/L, an Alpha-fetoprotein (AFP) level of 5.0 ng/mL, and a Fibrosis-4 Index (F4I) of 4.5. Based on these values, which of the following is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "Discontinue hepatocellular carcinoma (HCC) surveillance as the patient is at low risk for HCC development",
            "B": "Continue HCC surveillance as the patient is at high risk for HCC development",
            "C": "Initiate treatment for hepatitis C virus infection",
            "D": "Refer the patient for liver transplantation",
            "E": "Start the patient on antiviral therapy for hepatitis B virus infection"
        },
        "answer": "B",
        "pmid": "34676692"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic for a follow-up visit. He has a history of chronic hepatitis C infection, for which he completed treatment 6 months ago. His recent lab results show a sustained virological response. His Gamma-glutamyl transferase (GGT) level is 27 IU/L, Alpha-fetoprotein (AFP) level is 3.9 ng/mL, and Fibrosis-4 Index (F4I) is 4.3. Based on these findings, which of the following is the most appropriate next step in management?",
        "choices": {
            "A": "Discontinue hepatocellular carcinoma (HCC) surveillance",
            "B": "Continue regular HCC surveillance",
            "C": "Increase the frequency of HCC surveillance",
            "D": "Start treatment for HCC",
            "E": "Refer for liver transplantation"
        },
        "answer": "B",
        "pmid": "34676692"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic for a follow-up visit. He has a history of chronic hepatitis C infection, for which he completed treatment 6 months ago. His recent lab results show a Gamma-glutamyl transferase (GGT) level of 28 IU/L, an Alpha-fetoprotein (AFP) level of 4.0 ng/mL, and a Fibrosis-4 Index (F4I) of 4.0. He has no other significant medical history. Based on these findings, which of the following is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "Discontinue hepatocellular carcinoma (HCC) surveillance",
            "B": "Continue with HCC surveillance",
            "C": "Initiate treatment for liver cirrhosis",
            "D": "Refer for liver transplantation",
            "E": "Start antiviral therapy for hepatitis C recurrence"
        },
        "answer": "B",
        "pmid": "34676692"
    },
    {
        "question": "A 55-year-old male patient presents to your clinic for a follow-up visit. He has a history of chronic hepatitis C infection, for which he completed treatment 6 months ago. His recent lab results show a Gamma-glutamyl transferase (GGT) level of 35 IU/L, an Alpha-fetoprotein (AFP) level of 6.0 ng/mL, and a Fibrosis-4 Index (F4I) of 5.0. He has no other significant medical history. Based on these findings, which of the following is the most appropriate next step in the management of this patient?",
        "choices": {
            "A": "Discontinue hepatocellular carcinoma (HCC) surveillance",
            "B": "Continue HCC surveillance",
            "C": "Initiate treatment for liver cirrhosis",
            "D": "Refer for liver transplantation",
            "E": "Start antiviral therapy for hepatitis C recurrence"
        },
        "answer": "B",
        "pmid": "34676692"
    },
    {
        "question": "A 55-year-old male patient recently underwent a glansectomy for penile squamous cell carcinoma. The pathology report indicates the presence of perineural invasion and carcinoma in situ. However, there was no evidence of a positive margin or high-grade disease. His post-operative recovery has been uneventful. Based on these findings, what is the patient's risk of local recurrence after glansectomy for penile squamous cell carcinoma?",
        "choices": {
            "A": "Low risk of local recurrence",
            "B": "Intermediate risk of local recurrence",
            "C": "High risk of local recurrence",
            "D": "The patient has no risk of local recurrence",
            "E": "The risk cannot be determined based on the given information"
        },
        "answer": "B",
        "pmid": "28882673"
    },
    {
        "question": "A 55-year-old male patient has recently undergone glansectomy for penile squamous cell carcinoma. The pathology report indicates the presence of carcinoma in situ, positive margin on definitive pathology, and high-grade disease, but no perineural invasion. The patient's risk score is 3. Based on this information, what is the patient's risk of local recurrence after glansectomy for penile squamous cell carcinoma?",
        "choices": {
            "A": "Low risk of local recurrence",
            "B": "Intermediate risk of local recurrence",
            "C": "High risk of local recurrence",
            "D": "The patient is not at risk of local recurrence",
            "E": "The risk of local recurrence cannot be determined"
        },
        "answer": "B",
        "pmid": "28882673"
    },
    {
        "question": "A 55-year-old male patient has recently undergone glansectomy for penile squamous cell carcinoma. The pathology report indicates the presence of perineural invasion, positive margin on definitive pathology, and high-grade disease, but no carcinoma in situ. The patient has no other significant medical history. Based on these findings, what is the patient's risk of local recurrence after glansectomy for penile squamous cell carcinoma?",
        "choices": {
            "A": "Low risk",
            "B": "Intermediate risk",
            "C": "High risk",
            "D": "The patient's risk cannot be determined",
            "E": "The patient is not at risk"
        },
        "answer": "B",
        "pmid": "28882673"
    },
    {
        "question": "A 55-year-old male patient has recently undergone a glansectomy for penile squamous cell carcinoma. The pathology report indicates no presence of perineural invasion, carcinoma in situ, positive margin on definitive pathology, or high-grade disease. The patient has no significant past medical history and is currently recovering well from the surgery. Based on the pathology report, what is the risk of local recurrence for this patient?",
        "choices": {
            "A": "Low risk",
            "B": "Intermediate risk",
            "C": "High risk",
            "D": "The risk cannot be determined",
            "E": "The patient is not at risk"
        },
        "answer": "A",
        "pmid": "28882673"
    },
    {
        "question": "A 55-year-old male patient has recently undergone glansectomy for penile squamous cell carcinoma. The pathology report indicates the presence of perineural invasion, carcinoma in situ, positive margin on definitive pathology, and high-grade disease. The patient's risk score is 4. What is the risk of local recurrence for this patient after glansectomy for penile squamous cell carcinoma?",
        "choices": {
            "A": "Low risk of local recurrence",
            "B": "Intermediate risk of local recurrence",
            "C": "High risk of local recurrence",
            "D": "The risk cannot be determined",
            "E": "No risk of local recurrence"
        },
        "answer": "C",
        "pmid": "28882673"
    },
    {
        "question": "A 55-year-old male patient has recently initiated Peritoneal Dialysis (PD). Based on his clinical characteristics at the time of PD initiation, he falls into the third quartile. He has also been diagnosed with peritonitis. The computed risk score for this patient is 2.7482. What does this score indicate about the patient's risk of transitioning from Peritoneal Dialysis to Hemodialysis?",
        "choices": {
            "A": "The patient has a low risk of transitioning to Hemodialysis.",
            "B": "The patient has a moderate risk of transitioning to Hemodialysis.",
            "C": "The patient has a high risk of transitioning to Hemodialysis.",
            "D": "The patient has the highest risk of transitioning to Hemodialysis.",
            "E": "The patient's risk of transitioning to Hemodialysis cannot be determined."
        },
        "answer": "C",
        "pmid": "31301926"
    },
    {
        "question": "A 55-year-old male patient has recently initiated Peritoneal Dialysis (PD). His clinical characteristics at the time of PD initiation place him in the first quartile. He has no history of peritonitis. Based on these factors, what is the patient's risk of transitioning from Peritoneal Dialysis to Hemodialysis?",
        "choices": {
            "A": "Lowest risk of transition to Hemodialysis",
            "B": "Moderate risk of transition to Hemodialysis",
            "C": "High risk of transition to Hemodialysis",
            "D": "Highest risk of transition to Hemodialysis",
            "E": "Cannot be determined without further information"
        },
        "answer": "A",
        "pmid": "31301926"
    },
    {
        "question": "A 55-year-old male patient has recently initiated Peritoneal Dialysis (PD). Based on his clinical characteristics at PD initiation, he falls into the fourth quartile. He has also been diagnosed with peritonitis. Given these conditions, what is the most likely risk of this patient transitioning from Peritoneal Dialysis to Hemodialysis?",
        "choices": {
            "A": "Low risk of transition to Hemodialysis",
            "B": "Moderate risk of transition to Hemodialysis",
            "C": "High risk of transition to Hemodialysis",
            "D": "Very high risk of transition to Hemodialysis",
            "E": "Cannot be determined from the given information"
        },
        "answer": "D",
        "pmid": "31301926"
    },
    {
        "question": "A 55-year-old male patient has recently initiated Peritoneal Dialysis (PD). His clinical characteristics at the time of PD initiation place him in the second quartile. He has no history of peritonitis. His laboratory results, including complete blood count, renal function tests, and liver function tests, are within normal limits. Based on his clinical characteristics and absence of peritonitis, a risk score was calculated to predict his risk of transitioning from PD to Hemodialysis (HD). The computed risk score for this patient is 1.31. What does this risk score indicate about the patient's risk of transitioning to HD?",
        "choices": {
            "A": "The patient has the lowest risk of transition to HD.",
            "B": "The patient has a moderate risk of transition to HD.",
            "C": "The patient has a high risk of transition to HD.",
            "D": "The patient has the highest risk of transition to HD.",
            "E": "The patient's risk of transition to HD cannot be determined."
        },
        "answer": "B",
        "pmid": "31301926"
    },
    {
        "question": "A 55-year-old male patient has recently initiated Peritoneal Dialysis (PD) due to end-stage renal disease. His clinical characteristics at PD initiation place him in the first quartile, indicating a lower risk of transition to Hemodialysis (HD). However, he has been diagnosed with peritonitis. His risk score for transitioning from PD to HD, calculated based on his clinical characteristics and the presence of peritonitis, is 1.82. What does this risk score indicate about the patient's risk of transitioning to HD?",
        "choices": {
            "A": "The patient has the lowest risk of transitioning to HD, and the presence of peritonitis does not affect this risk.",
            "B": "The patient has a moderate risk of transitioning to HD, and the presence of peritonitis increases this risk.",
            "C": "The patient has a high risk of transitioning to HD, and the presence of peritonitis increases this risk.",
            "D": "The patient has the highest risk of transitioning to HD, and the presence of peritonitis increases this risk.",
            "E": "The patient has the lowest risk of transitioning to HD, but the presence of peritonitis increases this risk."
        },
        "answer": "E",
        "pmid": "31301926"
    },
    {
        "question": "A 78-year-old patient with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP presents to the clinic for a follow-up visit. The patient's serum albumin level is 3.5 g/dL, and the Charlson Comorbidity Index score is 4. The patient has a history of hypertension and diabetes. Based on the patient's age, serum albumin level, and Charlson Comorbidity Index score, which of the following best describes the patient's prognosis, tolerability to cytotoxic drugs, and adherence to treatment?",
        "choices": {
            "A": "Excellent prognosis, high tolerability to cytotoxic drugs, and high adherence to treatment",
            "B": "Good prognosis, moderate tolerability to cytotoxic drugs, and moderate adherence to treatment",
            "C": "Moderate prognosis, low tolerability to cytotoxic drugs, and low adherence to treatment",
            "D": "Poor prognosis, very low tolerability to cytotoxic drugs, and very low adherence to treatment",
            "E": "The patient's age, serum albumin level, and Charlson Comorbidity Index score do not provide enough information to determine prognosis, tolerability to cytotoxic drugs, and adherence to treatment"
        },
        "answer": "D",
        "pmid": "28408622"
    },
    {
        "question": "A 70-year-old patient with diffuse large B-cell lymphoma (DLBCL) is being treated with R-CHOP. The patient's serum albumin level is 4.0 g/dL, and the Charlson Comorbidity Index score is 2. The patient has no other significant medical history. Based on these parameters, which of the following best describes the patient's prognosis, tolerability to cytotoxic drugs, and adherence to treatment?",
        "choices": {
            "A": "Poor prognosis, very low tolerability to cytotoxic drugs, and very low adherence to treatment",
            "B": "Moderate prognosis, low tolerability to cytotoxic drugs, and low adherence to treatment",
            "C": "Good prognosis, moderate tolerability to cytotoxic drugs, and moderate adherence to treatment",
            "D": "Excellent prognosis, high tolerability to cytotoxic drugs, and high adherence to treatment",
            "E": "The patient's parameters do not allow for a prognosis, tolerability, or adherence assessment"
        },
        "answer": "D",
        "pmid": "28408622"
    },
    {
        "question": "A 76-year-old patient with diffuse large B-cell lymphoma (DLBCL) is being treated with R-CHOP. The patient's serum albumin level is 3.8 g/dL, and the Charlson Comorbidity Index score is 1. The patient has no other significant medical history. Based on these parameters, how would you classify the patient's prognosis, tolerability to cytotoxic drugs, and adherence to treatment?",
        "choices": {
            "A": "Excellent prognosis, high tolerability to cytotoxic drugs, and high adherence to treatment",
            "B": "Good prognosis, moderate tolerability to cytotoxic drugs, and moderate adherence to treatment",
            "C": "Moderate prognosis, low tolerability to cytotoxic drugs, and low adherence to treatment",
            "D": "Poor prognosis, very low tolerability to cytotoxic drugs, and very low adherence to treatment",
            "E": "The patient's parameters do not allow for a classification"
        },
        "answer": "B",
        "pmid": "28408622"
    },
    {
        "question": "An 80-year-old patient with diffuse large B-cell lymphoma (DLBCL) is being treated with R-CHOP. The patient's serum albumin level is 3.6 g/dL, and the Charlson Comorbidity Index score is 3. The patient has a history of hypertension and diabetes. Based on these parameters, which of the following best describes the patient's prognosis, tolerability to cytotoxic drugs, and adherence to treatment?",
        "choices": {
            "A": "Excellent prognosis, high tolerability to cytotoxic drugs, and high adherence to treatment",
            "B": "Good prognosis, moderate tolerability to cytotoxic drugs, and moderate adherence to treatment",
            "C": "Moderate prognosis, low tolerability to cytotoxic drugs, and low adherence to treatment",
            "D": "Poor prognosis, very low tolerability to cytotoxic drugs, and very low adherence to treatment",
            "E": "The patient's parameters do not allow for a prognosis, tolerability, or adherence assessment"
        },
        "answer": "D",
        "pmid": "28408622"
    },
    {
        "question": "A 68-year-old patient with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP presents for a follow-up visit. The patient's serum albumin level is 4.2 g/dL, and the Charlson Comorbidity Index score is 2. The patient has no other significant medical history. Based on these parameters, which of the following best describes the patient's prognosis, tolerability to cytotoxic drugs, and adherence to treatment?",
        "choices": {
            "A": "Poor prognosis, very low tolerability to cytotoxic drugs, and very low adherence to treatment",
            "B": "Moderate prognosis, low tolerability to cytotoxic drugs, and low adherence to treatment",
            "C": "Good prognosis, moderate tolerability to cytotoxic drugs, and moderate adherence to treatment",
            "D": "Excellent prognosis, high tolerability to cytotoxic drugs, and high adherence to treatment",
            "E": "The patient's parameters do not allow for a prognosis, tolerability to cytotoxic drugs, or adherence to treatment assessment"
        },
        "answer": "D",
        "pmid": "28408622"
    },
    {
        "question": "A 70-year-old male patient is admitted to the hospital with an acute exacerbation of his chronic obstructive pulmonary disease (COPD). He is confused, has a blood urea level of 8 mmol/L, a respiratory rate of 32/min, and low blood pressure. He has a history of hypertension and type 2 diabetes mellitus, both of which are well-controlled with medication. He is a former smoker and quit 10 years ago. Based on these findings, what is the most likely 30-day mortality risk for this patient?",
        "choices": {
            "A": "Low risk, with a 30-day mortality rate of 2.0%",
            "B": "Moderate risk, with a 30-day mortality rate of 6.7%",
            "C": "High risk, with a 30-day mortality rate of 21.3%",
            "D": "Very high risk, with a 30-day mortality rate of 30.0%",
            "E": "Extremely high risk, with a 30-day mortality rate of 50.0%"
        },
        "answer": "C",
        "pmid": "20920140"
    },
    {
        "question": "A 60-year-old male patient is admitted to the hospital with an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD). He is alert and oriented, with a blood urea level of 6 mmol/L, a respiratory rate of 28/min, and normal blood pressure. He has a history of smoking and has been diagnosed with COPD for the past 10 years. He is currently on bronchodilators and corticosteroids. Based on his clinical parameters, what is the predicted 30-day mortality risk for this patient?",
        "choices": {
            "A": "Low risk, with a 30-day mortality rate of 2.0%",
            "B": "Moderate risk, with a 30-day mortality rate of 6.7%",
            "C": "High risk, with a 30-day mortality rate of 21.3%",
            "D": "Very high risk, with a 30-day mortality rate of 30.0%",
            "E": "Extremely high risk, with a 30-day mortality rate of 50.0%"
        },
        "answer": "A",
        "pmid": "20920140"
    },
    {
        "question": "A 66-year-old female patient is admitted to the hospital with an acute exacerbation of her chronic obstructive pulmonary disease (COPD). She is confused and has a respiratory rate of 30 breaths per minute. Laboratory tests reveal a blood urea level of 7.5 mmol/L. Her blood pressure is within the normal range. Based on these findings, what is the most likely 30-day mortality risk for this patient?",
        "choices": {
            "A": "Low risk, with a 30-day mortality rate of 2.0%",
            "B": "Moderate risk, with a 30-day mortality rate of 6.7%",
            "C": "High risk, with a 30-day mortality rate of 21.3%",
            "D": "Very high risk, with a 30-day mortality rate of 30.0%",
            "E": "Extremely high risk, with a 30-day mortality rate of 40.0%"
        },
        "answer": "C",
        "pmid": "20920140"
    },
    {
        "question": "A 64-year-old female patient is admitted to the hospital with an acute exacerbation of her chronic obstructive pulmonary disease (COPD). She is alert and oriented, with a blood urea level of 5 mmol/L, a respiratory rate of 25/min, and normal blood pressure. She has no history of confusion or low blood pressure. Based on these findings, what is the most likely 30-day mortality risk for this patient?",
        "choices": {
            "A": "Low risk, with a 30-day mortality rate of 2.0%",
            "B": "Moderate risk, with a 30-day mortality rate of 6.7%",
            "C": "High risk, with a 30-day mortality rate of 21.3%",
            "D": "Very high risk, with a 30-day mortality rate of over 30%",
            "E": "Unable to determine without further information"
        },
        "answer": "A",
        "pmid": "20920140"
    },
    {
        "question": "A 68-year-old male patient is admitted to the hospital with an acute exacerbation of his chronic obstructive pulmonary disease (COPD). He is confused, has a blood urea level of 9 mmol/L, a respiratory rate of 35/min, and low blood pressure. He has a history of hypertension and type 2 diabetes mellitus. His current medications include metformin and lisinopril. Based on these findings, what is the estimated 30-day mortality risk for this patient?",
        "choices": {
            "A": "Low risk, with a 30-day mortality rate of 2.0%",
            "B": "Moderate risk, with a 30-day mortality rate of 6.7%",
            "C": "High risk, with a 30-day mortality rate of 21.3%",
            "D": "Very high risk, with a 30-day mortality rate of 30.0%",
            "E": "Extremely high risk, with a 30-day mortality rate of 50.0%"
        },
        "answer": "C",
        "pmid": "20920140"
    },
    {
        "question": "A 1-year-old patient underwent a SubAS resection. The distance from the membrane to the aortic valve was measured to be 4.5 mm. The patient also has associated left-sided heart lesions. The patient has been followed up for 3 years post-operation. Based on these preoperative factors, what is the risk of this patient requiring a reintervention for recurrent Subaortic Stenosis?",
        "choices": {
            "A": "Low risk, with 4% of patients requiring a reintervention",
            "B": "High risk, with 34% of patients requiring a reintervention",
            "C": "Moderate risk, with 20% of patients requiring a reintervention",
            "D": "Very high risk, with 50% of patients requiring a reintervention",
            "E": "The risk cannot be determined based on the given information"
        },
        "answer": "B",
        "pmid": "32712099"
    },
    {
        "question": "A 3-year-old patient underwent a SubAS resection. The distance from the membrane to the aortic valve was measured to be 6.0 mm. The patient does not have any associated left-sided heart lesions. The patient has been followed up for 3 years post-operation. Based on these preoperative factors, what is the risk of this patient requiring a reintervention for recurrent Subaortic Stenosis?",
        "choices": {
            "A": "The patient has a high risk, with a 34% chance of requiring a reintervention.",
            "B": "The patient has a moderate risk, with a 20% chance of requiring a reintervention.",
            "C": "The patient has a low risk, with a 4% chance of requiring a reintervention.",
            "D": "The patient has a very low risk, with a 1% chance of requiring a reintervention.",
            "E": "The patient has no risk of requiring a reintervention."
        },
        "answer": "C",
        "pmid": "32712099"
    },
    {
        "question": "A 2-year-old patient has undergone a SubAS resection. The distance from the membrane to the aortic valve is 4.0 mm. The patient also has associated left-sided heart lesions. Based on these preoperative factors, what is the risk of this patient requiring a reintervention for recurrent Subaortic Stenosis (SubAS)?",
        "choices": {
            "A": "Low risk, with 4% of patients requiring a reintervention",
            "B": "High risk, with 34% of patients requiring a reintervention",
            "C": "Moderate risk, with 20% of patients requiring a reintervention",
            "D": "Very high risk, with 50% of patients requiring a reintervention",
            "E": "The risk cannot be determined based on the given information"
        },
        "answer": "B",
        "pmid": "32712099"
    },
    {
        "question": "A 1-year-old patient underwent a SubAS resection. The patient has been followed up for 3 years post-operation. The distance from the membrane to the aortic valve was measured to be 5.5 mm during the index operation. The patient does not have any associated left-sided heart lesions. Based on these preoperative factors, what is the risk of this patient requiring a reintervention for recurrent SubAS?",
        "choices": {
            "A": "Low risk, with 4% of patients requiring a reintervention",
            "B": "High risk, with 34% of patients requiring a reintervention",
            "C": "Moderate risk, with 20% of patients requiring a reintervention",
            "D": "Very high risk, with 50% of patients requiring a reintervention",
            "E": "The risk cannot be determined based on the given information"
        },
        "answer": "A",
        "pmid": "32712099"
    },
    {
        "question": "A 3-year-old patient underwent SubAS resection. The patient has been followed up for 3 years post-operation. The distance from the membrane to the aortic valve was measured to be 4.5 mm during the index operation. The patient also has associated left-sided heart lesions. Based on these preoperative factors, what is the risk of the patient requiring a reintervention for recurrent Subaortic Stenosis?",
        "choices": {
            "A": "Low risk, with 4% of patients requiring a reintervention",
            "B": "High risk, with 34% of patients requiring a reintervention",
            "C": "Moderate risk, with 20% of patients requiring a reintervention",
            "D": "Very high risk, with 50% of patients requiring a reintervention",
            "E": "The risk cannot be determined based on the given information"
        },
        "answer": "B",
        "pmid": "32712099"
    },
    {
        "question": "A 65-year-old male presents to the emergency department with a fever of 39.2\u00b0C, a Charlson comorbidity index of 4, a respiratory rate of 24 breaths per minute, a leukocyte count of 13,000/mm3, and a procalcitonin concentration of 0.6 ng/mL. He has a history of hypertension, diabetes, and chronic kidney disease. He is currently on medication for his chronic conditions. He appears ill and is experiencing chills. Based on his clinical presentation and laboratory results, what is the patient's risk for bacteremia?",
        "choices": {
            "A": "Low risk (1.1% predicted probability)",
            "B": "Intermediate risk (10.5% predicted probability)",
            "C": "High risk (77% predicted probability)",
            "D": "The patient does not have bacteremia",
            "E": "The patient's risk cannot be determined"
        },
        "answer": "C",
        "pmid": "32125106"
    },
    {
        "question": "A 70-year-old female presents to the emergency department with a 2-day history of fever, chills, and malaise. She has a past medical history of hypertension and type 2 diabetes mellitus. Her vital signs are as follows: temperature 37.5\u00b0C, heart rate 90 beats per minute, respiratory rate 20 breaths per minute, and blood pressure 130/80 mmHg. Laboratory findings reveal a leukocyte count of 11,000/mm3 and a procalcitonin concentration of 0.4 ng/mL. Her Charlson comorbidity index is 2. Based on these findings, what is the most likely risk level for bacteremia in this patient?",
        "choices": {
            "A": "Low risk (1.1% predicted probability)",
            "B": "Intermediate risk (10.5% predicted probability)",
            "C": "High risk (77% predicted probability)",
            "D": "Very high risk (>90% predicted probability)",
            "E": "Unable to determine without further testing"
        },
        "answer": "A",
        "pmid": "32125106"
    },
    {
        "question": "A 55-year-old male presents to the emergency department with a fever of 38.5\u00b0C, a Charlson comorbidity index of 3, a respiratory rate of 23 breaths per minute, a leukocyte count of 12,500/mm3, and a procalcitonin concentration of 0.52 ng/mL. The patient has a history of hypertension and diabetes. He has been feeling unwell for the past few days with symptoms of fever, cough, and shortness of breath. Based on the patient's clinical parameters, what is the predicted risk of bacteremia for this patient?",
        "choices": {
            "A": "Low risk (1.1% predicted probability)",
            "B": "Intermediate risk (10.5% predicted probability)",
            "C": "High risk (77% predicted probability)",
            "D": "The patient is not at risk for bacteremia",
            "E": "The risk cannot be determined from the given parameters"
        },
        "answer": "C",
        "pmid": "32125106"
    },
    {
        "question": "A 60-year-old female presents to the emergency department with a fever of 37.8\u00b0C. She has a history of hypertension and is currently on medication for the same. Her Charlson comorbidity index is 1. She is breathing at a rate of 21 breaths per minute. Her leukocyte count is 10,000/mm3, and her procalcitonin concentration is 0.3 ng/mL. She denies any recent travel or exposure to sick contacts. She has no known drug allergies. Based on her clinical presentation and laboratory findings, what is the most likely risk level for bacteremia in this patient?",
        "choices": {
            "A": "Low risk (1.1% predicted probability)",
            "B": "Intermediate risk (10.5% predicted probability)",
            "C": "High risk (77% predicted probability)",
            "D": "Very high risk (90% predicted probability)",
            "E": "Cannot be determined from the given information"
        },
        "answer": "A",
        "pmid": "32125106"
    },
    {
        "question": "A 75-year-old male presents to the emergency department with a fever of 39.0\u00b0C, a Charlson comorbidity index of 5, a respiratory rate of 25 breaths per minute, a leukocyte count of 15,000/mm3, and a procalcitonin concentration of 0.7 ng/mL. The patient has a history of hypertension, diabetes, and chronic kidney disease. He has been feeling unwell for the past week with symptoms of fatigue, loss of appetite, and chills. He denies any recent travel or exposure to sick contacts. Based on the patient's clinical presentation and laboratory findings, what is the predicted probability of bacteremia for this patient?",
        "choices": {
            "A": "1.1%",
            "B": "10.5%",
            "C": "77%",
            "D": "50%",
            "E": "25%"
        },
        "answer": "C",
        "pmid": "32125106"
    },
    {
        "question": "A 55-year-old male patient has been recently diagnosed with Combined Hepatocellular-Cholangiocarcinoma (CHC). He has a history of chronic hepatitis B infection. His recent imaging studies show vascular invasion, a single tumor measuring 3 cm in diameter, and the presence of multiple tumors in the liver. Laboratory tests reveal elevated liver enzymes. Based on these findings, which of the following best describes the patient's risk group and the potential benefit of liver transplantation?",
        "choices": {
            "A": "Low-risk group, more likely to benefit from liver transplantation",
            "B": "Low-risk group, less likely to benefit from liver transplantation",
            "C": "High-risk group, more likely to benefit from liver transplantation",
            "D": "High-risk group, less likely to benefit from liver transplantation",
            "E": "Intermediate-risk group, unclear benefit from liver transplantation"
        },
        "answer": "D",
        "pmid": "35571416"
    },
    {
        "question": "A 55-year-old male patient has recently been diagnosed with Combined Hepatocellular-Cholangiocarcinoma (CHC). He has no history of vascular invasion and only one tumor has been identified in his liver. The size of the tumor is 1.5 cm. The patient has no other significant medical history and his liver function tests, including AST and ALT, are within normal limits. Based on these findings, which of the following best describes the patient's risk and potential benefit from liver transplantation?",
        "choices": {
            "A": "High risk, unlikely to benefit from liver transplantation",
            "B": "High risk, potential benefit from liver transplantation unclear",
            "C": "Low risk, unlikely to benefit from liver transplantation",
            "D": "Low risk, likely to benefit from liver transplantation",
            "E": "Cannot be determined without further information"
        },
        "answer": "D",
        "pmid": "35571416"
    },
    {
        "question": "A 55-year-old male patient has been recently diagnosed with Combined Hepatocellular-Cholangiocarcinoma (CHC). The patient's medical history reveals that he has vascular invasion and a single tumor measuring 2.5 cm. He does not have multiple tumors. Based on these findings, which of the following best describes the patient's risk group and the potential benefit from liver transplantation?",
        "choices": {
            "A": "The patient is in the high-risk group and is less likely to benefit from liver transplantation.",
            "B": "The patient is in the low-risk group and is more likely to benefit from liver transplantation.",
            "C": "The patient is in the high-risk group but may still benefit from liver transplantation.",
            "D": "The patient is in the low-risk group but may not benefit from liver transplantation.",
            "E": "The patient's risk group cannot be determined from the given information."
        },
        "answer": "B",
        "pmid": "35571416"
    },
    {
        "question": "A 55-year-old male patient has been recently diagnosed with Combined Hepatocellular-Cholangiocarcinoma (CHC). He has no history of vascular invasion. The largest tumor identified measures 1 cm in diameter. However, multiple tumors have been identified in his liver. Based on these findings, which of the following best describes the patient's prognosis and potential benefit from liver transplantation?",
        "choices": {
            "A": "The patient is in the high-risk group and is less likely to benefit from liver transplantation.",
            "B": "The patient is in the low-risk group and is more likely to benefit from liver transplantation.",
            "C": "The patient's risk cannot be determined without information on extrahepatic metastasis.",
            "D": "The patient's risk cannot be determined without information on the exact number of tumors.",
            "E": "The patient's risk cannot be determined without information on the exact size of all tumors."
        },
        "answer": "B",
        "pmid": "35571416"
    },
    {
        "question": "A 55-year-old male patient has been recently diagnosed with Combined Hepatocellular-Cholangiocarcinoma (CHC). The patient's medical history reveals the presence of vascular invasion. The largest tumor measures 1 cm in diameter. Additionally, the patient has multiple tumors. Based on these factors, which of the following best describes the patient's risk group and the potential benefit of liver transplantation?",
        "choices": {
            "A": "The patient is in the low-risk group and is likely to benefit from liver transplantation.",
            "B": "The patient is in the low-risk group but the benefits of liver transplantation are less clear.",
            "C": "The patient is in the high-risk group and is likely to benefit from liver transplantation.",
            "D": "The patient is in the high-risk group but the benefits of liver transplantation are less clear.",
            "E": "The patient's risk group cannot be determined based on the provided information."
        },
        "answer": "D",
        "pmid": "35571416"
    },
    {
        "question": "A 65-year-old male patient has recently undergone surgery for stage II colon cancer. His baseline carcinoembryonic antigen (CEA) level was found to be 6 ng/L. During the surgery, evidence of large vessel invasion and extramural vascular invasion was found. The pathology report also indicated that the disease is high-grade. However, there was no evidence of perineural invasion. Based on these findings, what is the risk of mortality and recurrence for this patient?",
        "choices": {
            "A": "Low risk of mortality and recurrence",
            "B": "Moderate risk of mortality and recurrence",
            "C": "High risk of mortality and recurrence",
            "D": "Very high risk of mortality and recurrence",
            "E": "Unable to determine the risk without further information"
        },
        "answer": "D",
        "pmid": "27380640"
    },
    {
        "question": "A 65-year-old male patient has recently undergone surgery for stage II colon cancer. His baseline carcinoembryonic antigen (CEA) level was measured to be 4.5 ng/L, which is below the high-risk threshold of 5 ng/L. Pathology reports from the surgery show no evidence of large vessel invasion or extramural vascular invasion. However, perineural invasion was detected. The histopathological examination of the tumor did not indicate high-grade disease. Based on these features, what is the patient's risk of mortality and recurrence?",
        "choices": {
            "A": "Low risk of mortality and recurrence",
            "B": "Moderate risk of mortality and recurrence",
            "C": "High risk of mortality and recurrence",
            "D": "Very high risk of mortality and recurrence",
            "E": "Unable to determine without further information"
        },
        "answer": "B",
        "pmid": "27380640"
    },
    {
        "question": "A 65-year-old male patient has recently undergone surgery for stage II colon cancer. His baseline carcinoembryonic antigen (CEA) level was found to be 6 ng/L. Pathology reports indicate the absence of large vessel invasion and perineural invasion. However, the presence of extramural vascular invasion was noted, and the disease was classified as high-grade. Based on these findings, how would you categorize the patient's risk of mortality and recurrence?",
        "choices": {
            "A": "Low risk",
            "B": "Moderate risk",
            "C": "High risk",
            "D": "Very high risk",
            "E": "Unable to determine without further information"
        },
        "answer": "C",
        "pmid": "27380640"
    },
    {
        "question": "A 65-year-old male patient has recently undergone surgery for stage II colon cancer. His baseline carcinoembryonic antigen (CEA) level was measured to be 4.5 ng/L. Pathology reports indicate the presence of large vessel invasion and perineural invasion. However, there is no evidence of extramural vascular invasion and the disease is not high-grade. The patient has a history of hypertension and type 2 diabetes, both of which are well-controlled with medication. He is a non-smoker and does not consume alcohol. Based on these features, what is the patient's risk of mortality and recurrence?",
        "choices": {
            "A": "Low risk of mortality and recurrence",
            "B": "Moderate risk of mortality and recurrence",
            "C": "High risk of mortality and recurrence",
            "D": "Very high risk of mortality and recurrence",
            "E": "Unable to determine the risk without further information"
        },
        "answer": "C",
        "pmid": "27380640"
    },
    {
        "question": "A 65-year-old male patient has recently undergone surgery for stage II colon cancer. His baseline carcinoembryonic antigen (CEA) level was found to be 6 ng/L. Pathological examination of the resected tumor revealed the presence of large vessel invasion and perineural invasion. However, there was no evidence of extramural vascular invasion and the disease was not classified as high-grade. Based on these findings, how would you stratify this patient's risk of mortality and recurrence?",
        "choices": {
            "A": "Low risk of mortality and recurrence",
            "B": "Moderate risk of mortality and recurrence",
            "C": "High risk of mortality and recurrence",
            "D": "Very high risk of mortality and recurrence",
            "E": "Unable to determine risk without further information"
        },
        "answer": "C",
        "pmid": "27380640"
    },
    {
        "question": "A 15-year-old child is undergoing stereotactic radiosurgery for an arteriovenous malformation (AVM) located in the basal ganglia/thalamus/brainstem region. The volume of the AVM is 3.4 cm3. Based on these parameters, what is the most likely outcome for this patient following the procedure?",
        "choices": {
            "A": "The patient will have an excellent outcome with a probability of 88%",
            "B": "The patient will have an excellent outcome with a probability of 52%",
            "C": "The patient will have a poor outcome with a probability of 48%",
            "D": "The patient will have a poor outcome with a probability of 12%",
            "E": "The outcome cannot be predicted based on the given parameters"
        },
        "answer": "B",
        "pmid": "16776373"
    },
    {
        "question": "A 10-year-old child is scheduled to undergo stereotactic radiosurgery for an arteriovenous malformation (AVM). The AVM, located in the frontal/temporal region, has a volume of 1.2 cm3. Based on the child's age, the volume of the AVM, and its location, a score was calculated to predict the outcome of the surgery. The score was found to be 0.32. Which of the following best describes the expected outcome for this patient?",
        "choices": {
            "A": "The patient is expected to have a poor outcome following surgery",
            "B": "The patient is expected to have a moderate outcome following surgery",
            "C": "The patient is expected to have a favorable outcome following surgery",
            "D": "The patient's outcome cannot be predicted based on the given information",
            "E": "The patient should not undergo surgery due to high risk"
        },
        "answer": "C",
        "pmid": "16776373"
    },
    {
        "question": "An 8-year-old child is undergoing stereotactic radiosurgery for an arteriovenous malformation (AVM) located in the parietal/occipital/corpus callosum/cerebellar region. The volume of the AVM is 2.5 cm3. Based on these parameters, what is the most likely outcome for this patient after the surgery?",
        "choices": {
            "A": "The patient is likely to experience a poor outcome after the surgery.",
            "B": "The patient is likely to experience a moderate outcome after the surgery.",
            "C": "The patient is likely to experience an excellent outcome after the surgery.",
            "D": "The patient's outcome cannot be predicted based on the given parameters.",
            "E": "The patient is not eligible for stereotactic radiosurgery."
        },
        "answer": "C",
        "pmid": "16776373"
    },
    {
        "question": "A 12-year-old child is scheduled to undergo stereotactic radiosurgery for an arteriovenous malformation (AVM). The AVM, located in the basal ganglia/thalamus/brainstem region, has a volume of 4.0 cm3. The child is otherwise healthy, with no other significant medical history. Based on these parameters, what is the most likely outcome of the radiosurgery for this patient?",
        "choices": {
            "A": "The patient will have an excellent outcome with a probability of 88%",
            "B": "The patient will have an excellent outcome with a probability of 52%",
            "C": "The patient will have a poor outcome with a probability of 88%",
            "D": "The patient will have a poor outcome with a probability of 52%",
            "E": "The outcome cannot be predicted with the given information"
        },
        "answer": "B",
        "pmid": "16776373"
    },
    {
        "question": "A 6-year-old child is scheduled to undergo stereotactic radiosurgery for an arteriovenous malformation (AVM). The AVM, located in the frontal/temporal region, has a volume of 0.8 cm3. Based on the child's age, the volume of the AVM, and its location, a score was calculated to predict the outcome of the surgery. What is the most likely outcome for this patient following the surgery?",
        "choices": {
            "A": "The patient has a high likelihood of an excellent outcome following the surgery.",
            "B": "The patient has a moderate likelihood of an excellent outcome following the surgery.",
            "C": "The patient has a low likelihood of an excellent outcome following the surgery.",
            "D": "The patient has a high likelihood of a poor outcome following the surgery.",
            "E": "The patient has a moderate likelihood of a poor outcome following the surgery."
        },
        "answer": "A",
        "pmid": "16776373"
    },
    {
        "question": "A 55-year-old patient presents to the hospital with a history of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and chronic liver disease. The patient has been previously exposed to vancomycin and currently has a nontunneled central venous catheter. The patient's risk score, computed using a specific predictor, is 10. Given that a score of 4 or more indicates a high risk of high vancomycin minimum inhibitory concentration (MIC), this patient is at a high risk. The positive predictive value for this score range is 30%. What is the most likely interpretation of this patient's risk score?",
        "choices": {
            "A": "The patient has a low risk of high vancomycin MIC.",
            "B": "The patient has a moderate risk of high vancomycin MIC.",
            "C": "The patient has a high risk of high vancomycin MIC.",
            "D": "The patient's risk of high vancomycin MIC cannot be determined.",
            "E": "The patient's risk of high vancomycin MIC is negligible."
        },
        "answer": "C",
        "pmid": "21460313"
    },
    {
        "question": "A 45-year-old patient presents to the clinic with a history of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. The patient has never been exposed to vancomycin and does not have a history of chronic liver disease. The patient currently does not have a nontunneled central venous catheter. Based on these factors, what is the risk of this patient having a high vancomycin minimum inhibitory concentration (MIC) in MRSA bacteremia?",
        "choices": {
            "A": "The patient is at high risk of high vancomycin MIC in MRSA bacteremia",
            "B": "The patient is at low risk of high vancomycin MIC in MRSA bacteremia",
            "C": "The patient's risk of high vancomycin MIC in MRSA bacteremia cannot be determined",
            "D": "The patient's risk of high vancomycin MIC in MRSA bacteremia is moderate",
            "E": "The patient's risk of high vancomycin MIC in MRSA bacteremia is negligible"
        },
        "answer": "B",
        "pmid": "21460313"
    },
    {
        "question": "A 60-year-old patient presents to the hospital with a fever and chills. The patient has a history of chronic liver disease and currently has a nontunneled central venous catheter in place. Laboratory tests confirm the presence of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. However, the patient has no prior exposure to vancomycin or history of MRSA bacteremia. Based on the patient's age, history of chronic liver disease, presence of a nontunneled central venous catheter, and lack of prior vancomycin exposure or MRSA bacteremia, what is the risk of high vancomycin minimum inhibitory concentration (MIC) in this patient?",
        "choices": {
            "A": "Low risk of high vancomycin MIC",
            "B": "Moderate risk of high vancomycin MIC",
            "C": "High risk of high vancomycin MIC",
            "D": "The risk cannot be determined",
            "E": "The patient is not at risk of high vancomycin MIC"
        },
        "answer": "C",
        "pmid": "21460313"
    },
    {
        "question": "A 40-year-old patient presents to the hospital with symptoms of bacteremia. The patient has a history of prior exposure to vancomycin and currently has a nontunneled central venous catheter in place. However, the patient has no history of MRSA bacteremia or chronic liver disease. Laboratory tests confirm the presence of methicillin-resistant Staphylococcus aureus (MRSA) in the patient's blood. Based on the patient's age, prior exposure to vancomycin, absence of MRSA bacteremia history, absence of chronic liver disease, and the presence of a nontunneled central venous catheter, the patient's risk score for high vancomycin minimum inhibitory concentration (MIC) in MRSA bacteremia is calculated to be 3. What does this risk score indicate about the patient's risk of high vancomycin MIC in MRSA bacteremia?",
        "choices": {
            "A": "The patient is at a high risk of high vancomycin MIC in MRSA bacteremia.",
            "B": "The patient is at a moderate risk of high vancomycin MIC in MRSA bacteremia.",
            "C": "The patient is at a low risk of high vancomycin MIC in MRSA bacteremia.",
            "D": "The patient's risk of high vancomycin MIC in MRSA bacteremia cannot be determined from the risk score.",
            "E": "The patient's risk of high vancomycin MIC in MRSA bacteremia is average."
        },
        "answer": "C",
        "pmid": "21460313"
    },
    {
        "question": "A 55-year-old patient presents to the hospital with symptoms of fever, chills, and fatigue. Blood cultures are drawn and the patient is found to have methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. The patient has a history of prior exposure to vancomycin but no history of MRSA bacteremia, chronic liver disease, or a nontunneled central venous catheter. Based on the patient's risk factors, what is the likelihood of high vancomycin minimum inhibitory concentration (MIC) in this patient?",
        "choices": {
            "A": "Low risk of high vancomycin MIC (negative predictive value, 91%)",
            "B": "High risk of high vancomycin MIC (positive predictive value, 30%)",
            "C": "Moderate risk of high vancomycin MIC",
            "D": "The patient's risk cannot be determined",
            "E": "The patient is not at risk for high vancomycin MIC"
        },
        "answer": "B",
        "pmid": "21460313"
    },
    {
        "question": "A 55-year-old patient with a history of diabetes and obesity is considering combined abdominal and breast surgery. The patient's ASA status is 2. Based on the patient's risk factors, what is the estimated complication rate for this patient?",
        "choices": {
            "A": "9.78%",
            "B": "16.63%",
            "C": "38.46%",
            "D": "The patient is not eligible for the surgery due to high risk",
            "E": "The patient's risk cannot be determined without further information"
        },
        "answer": "C",
        "pmid": "26163312"
    },
    {
        "question": "A 55-year-old woman presents for a preoperative evaluation. She is scheduled for a combined abdominal and breast surgery. She has a history of hypertension and is classified as ASA status 3. She is not obese and does not have a history of diabetes. Her vital signs are within normal limits. Based on her risk factors, what is the estimated complication rate for her upcoming surgery?",
        "choices": {
            "A": "9.78%",
            "B": "16.63%",
            "C": "38.46%",
            "D": "25.00%",
            "E": "50.00%"
        },
        "answer": "C",
        "pmid": "26163312"
    },
    {
        "question": "A 49-year-old female patient with a history of diabetes and obesity is considering combined abdominal and breast surgery. She has an ASA status of 3, indicating severe systemic disease. Her BMI is 32, which classifies her as obese. She has been managing her diabetes with metformin and lifestyle modifications. She does not have any other significant medical history. Based on her risk factors, what is the estimated complication rate for her upcoming surgery?",
        "choices": {
            "A": "9.78%",
            "B": "16.63%",
            "C": "38.46%",
            "D": "25.00%",
            "E": "50.00%"
        },
        "answer": "C",
        "pmid": "26163312"
    },
    {
        "question": "A 45-year-old woman presents to the clinic for a consultation. She is considering combined abdominal and breast surgery. She has a BMI of 22, does not have diabetes, and her ASA status is 2. She has no other significant medical history. Based on her risk factors, what is the estimated complication rate for her surgery?",
        "choices": {
            "A": "9.78%",
            "B": "16.63%",
            "C": "38.46%",
            "D": "25.00%",
            "E": "50.00%"
        },
        "answer": "A",
        "pmid": "26163312"
    },
    {
        "question": "A 57-year-old woman presents to your clinic for a preoperative evaluation. She has a history of type 2 diabetes and is currently managed with metformin. Her most recent HbA1c was 7.2%. She is not obese with a BMI of 24. She has been classified as ASA 3 due to her diabetes and hypertension. She is considering combined abdominal and breast surgery. Based on her risk factors, what is the estimated risk of complications for this patient?",
        "choices": {
            "A": "Low risk, with a 9.78% complication rate",
            "B": "Medium risk, with a 16.63% complication rate",
            "C": "High risk, with a 38.46% complication rate",
            "D": "Medium risk, with a 20% complication rate",
            "E": "High risk, with a 50% complication rate"
        },
        "answer": "C",
        "pmid": "26163312"
    },
    {
        "question": "A 55-year-old male patient recently underwent liver transplantation due to end-stage liver disease. His post-operative course has been complicated. His current laboratory results show an International Normalized Ratio (INR) of 2.3 and a Plasma Disappearance Rate (PDR) of indocyanine green of 9.5%/min. Based on these parameters, what is the most likely short-term outcome for this patient?",
        "choices": {
            "A": "4.4% risk of early death or retransplantation",
            "B": "6.5% risk of early death or retransplantation",
            "C": "12% risk of early death or retransplantation",
            "D": "50% risk of early death or retransplantation",
            "E": "The patient is not at risk of early death or retransplantation"
        },
        "answer": "D",
        "pmid": "26569066"
    },
    {
        "question": "A 60-year-old female patient recently underwent liver transplantation. Her post-operative course has been uneventful so far. Her most recent laboratory results show an International Normalized Ratio (INR) of 1.8 and a Plasma Disappearance Rate (PDR) of indocyanine green of 11.0%/min. Based on these parameters, what is the estimated risk of early death or need for retransplantation in this patient?",
        "choices": {
            "A": "4.4%",
            "B": "6.5%",
            "C": "12%",
            "D": "50%",
            "E": "The risk cannot be estimated with the given parameters"
        },
        "answer": "A",
        "pmid": "26569066"
    },
    {
        "question": "A 45-year-old male patient recently underwent liver transplantation. His post-operative course has been uneventful so far. His most recent laboratory results show an International Normalized Ratio (INR) of 2.5. Additionally, the Plasma Disappearance Rate (PDR) of indocyanine green was measured to be 12.0%/min. Based on these parameters, what is the estimated risk of early death or need for retransplantation in this patient?",
        "choices": {
            "A": "4.4% risk of early death or retransplantation",
            "B": "6.5% risk of early death or retransplantation",
            "C": "12% risk of early death or retransplantation",
            "D": "50% risk of early death or retransplantation",
            "E": "The risk cannot be estimated with the given parameters"
        },
        "answer": "B",
        "pmid": "26569066"
    },
    {
        "question": "A 70-year-old female patient recently underwent liver transplantation. Her post-operative lab results show an International Normalized Ratio (INR) of 2.2 and a Plasma Disappearance Rate (PDR) of indocyanine green of 9.0%/min. She has a history of hypertension and type 2 diabetes, both of which are well-controlled with medication. She is currently on immunosuppressive therapy. Based on her INR and PDR values, what is the estimated risk of early death or need for retransplantation in this patient?",
        "choices": {
            "A": "4.4% risk of early death or retransplantation",
            "B": "6.5% risk of early death or retransplantation",
            "C": "12% risk of early death or retransplantation",
            "D": "50% risk of early death or retransplantation",
            "E": "The risk cannot be determined based on the given parameters"
        },
        "answer": "D",
        "pmid": "26569066"
    },
    {
        "question": "A 65-year-old male patient recently underwent liver transplantation. His post-operative course has been uneventful so far. His most recent lab results show an International Normalized Ratio (INR) of 1.9 and a Plasma Disappearance Rate (PDR) of indocyanine green of 8.5%/min. Based on these parameters, what is the patient's risk of early death or need for retransplantation?",
        "choices": {
            "A": "4.4% risk of early death or retransplantation",
            "B": "6.5% risk of early death or retransplantation",
            "C": "12% risk of early death or retransplantation",
            "D": "50% risk of early death or retransplantation",
            "E": "The patient's risk cannot be determined with the given parameters"
        },
        "answer": "C",
        "pmid": "26569066"
    },
    {
        "question": "A 45-year-old male patient presents with a spontaneous type 1 ECG pattern. He has no history of previous cardiac arrest. His ECG shows a number of QRS fragments in inferior leads is 3. The S wave upslope duration ratio is 0.9. The difference between T peak and T end is 110 ms. Based on these findings, what is the patient's risk of major arrhythmic events (MAE)?",
        "choices": {
            "A": "Low risk, with a class specific risk of MAE of 0-1.1%",
            "B": "Moderate risk, with a class specific risk of MAE of 1.2-50%",
            "C": "High risk, with a class specific risk of MAE of 50.1-92.2%",
            "D": "Very high risk, with a class specific risk of MAE of 92.3-100%",
            "E": "Cannot be determined from the given information"
        },
        "answer": "D",
        "pmid": "31082614"
    },
    {
        "question": "A 45-year-old male patient presents to the clinic for a routine check-up. He has no history of previous cardiac arrest. His ECG shows no spontaneous type 1 pattern. The number of QRS fragments in inferior leads is 2. The S wave upslope duration ratio is 0.7. The difference between T peak and T end is 90 ms. Based on these findings, what is the risk of this patient experiencing major arrhythmic events (MAE)?",
        "choices": {
            "A": "High risk, with a class specific risk of MAE of 92.3-100%",
            "B": "Moderate risk, with a class specific risk of MAE of 50-60%",
            "C": "Low risk, with a class specific risk of MAE of 0-1.1%",
            "D": "No risk, the patient is not at risk of MAE",
            "E": "Unable to determine the risk without further testing"
        },
        "answer": "C",
        "pmid": "31082614"
    },
    {
        "question": "A 45-year-old male patient presents with a spontaneous type 1 ECG pattern. He has no history of previous cardiac arrest. His ECG shows the number of QRS fragments in inferior leads is 1. The S wave upslope duration ratio is 0.6. The difference between T peak and T end is 80 ms. His risk of major arrhythmic events (MAE) during follow-up is:",
        "choices": {
            "A": "Between 0-1.1%",
            "B": "Between 1.2-10%",
            "C": "Between 10.1-50%",
            "D": "Between 50.1-92.2%",
            "E": "Between 92.3-100%"
        },
        "answer": "A",
        "pmid": "31082614"
    },
    {
        "question": "A 45-year-old male patient presents with no history of previous cardiac arrest, making him eligible for risk stratification. He does not exhibit a spontaneous type 1 pattern on ECG. His ECG shows 4 QRS fragments in the inferior leads. The S wave upslope duration ratio is calculated to be 0.85, and the difference between T peak and T end is found to be 120 ms. Based on these findings, what is the patient's risk of experiencing major arrhythmic events (MAE) during follow-up?",
        "choices": {
            "A": "Low risk, with a class specific risk of MAE of 0-1.1%",
            "B": "Moderate risk, with a class specific risk of MAE of 1.2-50%",
            "C": "High risk, with a class specific risk of MAE of 50.1-92.2%",
            "D": "High risk, with a class specific risk of MAE of 92.3-100%",
            "E": "Unable to determine risk without further testing"
        },
        "answer": "D",
        "pmid": "31082614"
    },
    {
        "question": "A 45-year-old male patient presents with a spontaneous type 1 ECG pattern. He has no history of previous cardiac arrest. His ECG shows a number of QRS fragments in inferior leads is 5. The S wave upslope duration ratio is 0.95. The difference between T peak and T end is 150 ms. Based on these findings, what is the risk of this patient experiencing major arrhythmic events during follow-up?",
        "choices": {
            "A": "Low risk, with a class specific risk of MAE of 0-1.1%",
            "B": "Moderate risk, with a class specific risk of MAE of 1.2-50%",
            "C": "High risk, with a class specific risk of MAE of 50.1-92.2%",
            "D": "Very high risk, with a class specific risk of MAE of 92.3-100%",
            "E": "Unable to determine risk without further testing"
        },
        "answer": "D",
        "pmid": "31082614"
    },
    {
        "question": "A 75-year-old male patient presents to the emergency department with chest pain. He is diagnosed with ST-segment elevation myocardial infarction (STEMI) and undergoes successful percutaneous intervention. Post-procedure cardiac magnetic resonance (CMR) shows 2 segments with microvascular obstruction. His GRACE score is calculated to be 160 and his left ventricular ejection fraction (LVEF) is 35%. Based on these findings, what is the predicted risk of major adverse cardiac events (MACE) per 100 person-years for this patient?",
        "choices": {
            "A": "0.78 MACE per 100 person-years",
            "B": "5.53 MACE per 100 person-years",
            "C": "11.51 MACE per 100 person-years",
            "D": "78.79 MACE per 100 person-years",
            "E": "Cannot be determined from the given information"
        },
        "answer": "D",
        "pmid": "36436010"
    },
    {
        "question": "A 72-year-old patient presents with ST-segment elevation myocardial infarction (STEMI) and has undergone percutaneous intervention and cardiac magnetic resonance (CMR). The patient's GRACE score is 150, left ventricular ejection fraction (LVEF) is 45%, and there is microvascular obstruction (MVO) in 1 segment. Based on these parameters, what is the predicted risk of major adverse cardiac events (MACE) per 100 person-years for this patient?",
        "choices": {
            "A": "0.78 MACE per 100 person-years",
            "B": "5.53 MACE per 100 person-years",
            "C": "11.51 MACE per 100 person-years",
            "D": "78.79 MACE per 100 person-years",
            "E": "Cannot be determined from the given information"
        },
        "answer": "A",
        "pmid": "36436010"
    },
    {
        "question": "A 78-year-old patient presents with ST-segment elevation myocardial infarction (STEMI) and has undergone percutaneous intervention and cardiac magnetic resonance (CMR). The patient's GRACE score is 160, left ventricular ejection fraction (LVEF) is 50%, and there are no segments with microvascular obstruction (MVO). Based on these parameters, what is the predicted risk of major adverse cardiac events (MACE) per 100 person-years for this patient?",
        "choices": {
            "A": "0.78 MACE per 100 person-years",
            "B": "5.53 MACE per 100 person-years",
            "C": "11.51 MACE per 100 person-years",
            "D": "78.79 MACE per 100 person-years",
            "E": "The risk cannot be determined with the given parameters"
        },
        "answer": "B",
        "pmid": "36436010"
    },
    {
        "question": "An 80-year-old patient presents with ST-segment elevation myocardial infarction (STEMI) and has undergone percutaneous intervention and cardiac magnetic resonance (CMR). The patient's GRACE score is 155, indicating a moderate risk of mortality. The left ventricular ejection fraction (LVEF) is 40%, suggesting a borderline normal heart function. The CMR reveals microvascular obstruction (MVO) in 3 segments of the heart. Based on these findings, what is the predicted risk of major adverse cardiac events (MACE) for this patient per 100 person-years?",
        "choices": {
            "A": "0.78 MACE",
            "B": "5.53 MACE",
            "C": "11.51 MACE",
            "D": "78.79 MACE",
            "E": "Cannot be determined from the given information"
        },
        "answer": "B",
        "pmid": "36436010"
    },
    {
        "question": "A 76-year-old patient presents with ST-segment elevation myocardial infarction (STEMI) and has undergone percutaneous intervention and cardiac magnetic resonance (CMR). The patient's GRACE score is 140, indicating a moderate risk of mortality. The left ventricular ejection fraction (LVEF) is 35%, suggesting a decreased heart function. Additionally, there are 2 segments with microvascular obstruction (MVO), indicating some level of damage to the small vessels in the heart. Based on these findings, what is the predicted risk of major adverse cardiac events (MACE) for this patient per 100 person-years?",
        "choices": {
            "A": "0.78 MACE",
            "B": "5.53 MACE",
            "C": "11.51 MACE",
            "D": "78.79 MACE",
            "E": "Cannot be determined from the given information"
        },
        "answer": "C",
        "pmid": "36436010"
    },
    {
        "question": "A 45-year-old male patient has recently been diagnosed with anti-glomerular basement membrane (GBM) disease. He has been experiencing fatigue, loss of appetite, and weight loss for the past few months. His lab results show that he requires renal replacement therapy at diagnosis. A kidney biopsy was performed, which revealed that only 8% of the glomeruli are normal. Based on these findings, what is the most likely 36-month renal survival rate for this patient?",
        "choices": {
            "A": "96.4%",
            "B": "74.0%",
            "C": "42.3%",
            "D": "14.1%",
            "E": "The patient's renal survival rate cannot be determined"
        },
        "answer": "D",
        "pmid": "36446430"
    },
    {
        "question": "A 45-year-old male patient has recently been diagnosed with anti-glomerular basement membrane (GBM) disease. He does not require renal replacement therapy at the time of diagnosis. A kidney biopsy was performed, which revealed that 15% of the glomeruli are normal. The patient has no other significant medical history. Based on these findings, what is the most likely 36-month renal survival rate for this patient?",
        "choices": {
            "A": "14.1%",
            "B": "42.3%",
            "C": "74.0%",
            "D": "96.4%",
            "E": "The patient's renal survival rate cannot be determined"
        },
        "answer": "D",
        "pmid": "36446430"
    },
    {
        "question": "A 45-year-old male patient has recently been diagnosed with anti-glomerular basement membrane (GBM) disease. He has been experiencing fatigue, loss of appetite, and weight loss for the past few months. His lab results show that he requires renal replacement therapy at the time of diagnosis. A kidney biopsy was performed, which revealed that 12% of the glomeruli are normal. Based on these findings, what is the most likely 36-month renal survival rate for this patient?",
        "choices": {
            "A": "96.4%",
            "B": "74.0%",
            "C": "42.3%",
            "D": "14.1%",
            "E": "The patient's renal survival rate cannot be determined"
        },
        "answer": "C",
        "pmid": "36446430"
    },
    {
        "question": "A 45-year-old male patient has recently been diagnosed with anti-glomerular basement membrane (GBM) disease. He has been experiencing fatigue, hematuria, and edema. His lab results show a creatinine level of 2.5 mg/dL and a BUN of 30 mg/dL. The patient does not require renal replacement therapy at diagnosis. A kidney biopsy was performed, which revealed that only 5% of the glomeruli are normal. Based on these findings, what is the most likely 36-month renal survival rate for this patient?",
        "choices": {
            "A": "96.4%",
            "B": "74.0%",
            "C": "42.3%",
            "D": "14.1%",
            "E": "The patient's renal survival rate cannot be determined"
        },
        "answer": "B",
        "pmid": "36446430"
    },
    {
        "question": "A 45-year-old male patient has recently been diagnosed with anti-glomerular basement membrane (GBM) disease. He has been experiencing fatigue, loss of appetite, and weight loss for the past few months. His laboratory tests show that he requires renal replacement therapy at diagnosis. A kidney biopsy was performed, which revealed that only 9% of the glomeruli are normal. Based on these findings, what is the most likely 36-month renal survival rate for this patient?",
        "choices": {
            "A": "96.4%",
            "B": "74.0%",
            "C": "42.3%",
            "D": "14.1%",
            "E": "The patient's renal survival rate cannot be determined"
        },
        "answer": "D",
        "pmid": "36446430"
    },
    {
        "question": "A 65-year-old male patient is admitted to the ICU with acute kidney injury. He presents with a low Glasgow coma scale, is using a vasopressor, is on mechanical ventilation, and has oliguria. Laboratory findings reveal that his serum creatinine has risen three times the normal value, he has high blood urea nitrogen, and low hematocrit. However, the patient does not have tachypnea or thrombocytopenia. Based on these findings, what is the risk of this patient experiencing Major Adverse Kidney Events (MAKE) within the next 28 days?",
        "choices": {
            "A": "Low risk of Major Adverse Kidney Events (MAKE)",
            "B": "Moderate risk of Major Adverse Kidney Events (MAKE)",
            "C": "High risk of Major Adverse Kidney Events (MAKE)",
            "D": "The patient is not at risk of Major Adverse Kidney Events (MAKE)",
            "E": "Unable to determine the risk of Major Adverse Kidney Events (MAKE)"
        },
        "answer": "C",
        "pmid": "32300902"
    },
    {
        "question": "A 65-year-old male patient is admitted to the ICU due to severe pneumonia. He is critically ill but conscious with a Glasgow coma scale of 15. He presents with tachypnea, high blood urea nitrogen (BUN) of 30 mg/dL, and thrombocytopenia with a platelet count of 100,000 per microliter. He is not on vasopressor support and is breathing spontaneously without the need for mechanical ventilation. His urine output is normal and his serum creatinine level has not risen more than 3 times the baseline. His hematocrit level is within the normal range. Based on these clinical parameters, what is the risk of this patient developing Major Adverse Kidney Events (MAKE) within the next 28 days?",
        "choices": {
            "A": "High risk",
            "B": "Low risk",
            "C": "Moderate risk",
            "D": "Risk cannot be determined",
            "E": "Risk is negligible"
        },
        "answer": "B",
        "pmid": "32300902"
    },
    {
        "question": "A 65-year-old male patient is admitted to the ICU due to acute kidney injury. He presents with a low Glasgow coma scale, indicating a severe impairment of consciousness. He is currently on mechanical ventilation due to respiratory failure. The patient also has oliguria, producing less than 400 mL of urine per day. Laboratory tests reveal a low hematocrit level, suggesting possible anemia or overhydration. However, the patient does not exhibit tachypnea, and there is no use of vasopressors. His serum creatinine level has not risen more than three times the baseline, and his blood urea nitrogen level is within the normal range. Additionally, he does not have thrombocytopenia. Based on these clinical features, what is the most likely prognosis for this patient within the next 28 days?",
        "choices": {
            "A": "Low risk of Major Adverse Kidney Events (MAKE)",
            "B": "High risk of Major Adverse Kidney Events (MAKE)",
            "C": "Moderate risk of Major Adverse Kidney Events (MAKE)",
            "D": "Risk of Major Adverse Kidney Events (MAKE) cannot be determined",
            "E": "No risk of Major Adverse Kidney Events (MAKE)"
        },
        "answer": "B",
        "pmid": "32300902"
    },
    {
        "question": "A 65-year-old male patient is admitted to the ICU with acute kidney injury. He presents with tachypnea and is currently on vasopressor therapy. Laboratory results show that his serum creatinine has risen three times the normal value and he has thrombocytopenia. However, his Glasgow coma scale is normal, he is not on mechanical ventilation, and he does not have oliguria, high blood urea nitrogen, or low hematocrit. Based on these findings, what is the most likely prognosis for this patient within the next 28 days?",
        "choices": {
            "A": "Low risk of Major Adverse Kidney Events (MAKE)",
            "B": "High risk of Major Adverse Kidney Events (MAKE)",
            "C": "Moderate risk of Major Adverse Kidney Events (MAKE)",
            "D": "Risk of Major Adverse Kidney Events (MAKE) cannot be determined",
            "E": "No risk of Major Adverse Kidney Events (MAKE)"
        },
        "answer": "B",
        "pmid": "32300902"
    },
    {
        "question": "A 65-year-old male patient is admitted to the ICU due to acute kidney injury. He presents with a low Glasgow coma scale, tachypnea, oliguria, high blood urea nitrogen, and thrombocytopenia. He is not using a vasopressor, is not on mechanical ventilation, does not have serum creatinine rising \u2265 3 times, and does not have low hematocrit. His Glasgow coma scale is 8, respiratory rate is 28 breaths per minute, urine output is 200 mL in the last 24 hours, blood urea nitrogen is 35 mg/dL, and platelet count is 100,000 per microliter. Based on these findings, what is the most likely prognosis for this patient within the next 28 days?",
        "choices": {
            "A": "Low risk of Major Adverse Kidney Events",
            "B": "Moderate risk of Major Adverse Kidney Events",
            "C": "High risk of Major Adverse Kidney Events",
            "D": "Risk of Major Adverse Kidney Events cannot be determined",
            "E": "No risk of Major Adverse Kidney Events"
        },
        "answer": "C",
        "pmid": "32300902"
    },
    {
        "question": "An 85-year-old patient presents to the emergency department with a Glasgow Coma Scale score of 6. A CT scan reveals a subdural hematoma with a volume of 55 mL. The patient has no history of major trauma. Based on the patient's age, Glasgow Coma Scale score, and subdural hematoma volume, what is the most likely 30-day mortality rate for this patient?",
        "choices": {
            "A": "4.3%",
            "B": "12.2%",
            "C": "36.6%",
            "D": "97.1%",
            "E": "100%"
        },
        "answer": "D",
        "pmid": "35892422"
    },
    {
        "question": "A 70-year-old patient presents to the emergency department with a headache. On examination, the patient is alert and oriented, with a Glasgow Coma Scale score of 13. A CT scan of the head reveals a subdural hematoma with a volume of 40 mL. The patient has no history of trauma. Based on the patient's age, Glasgow Coma Scale score, and subdural hematoma volume, what is the estimated 30-day mortality risk for this patient?",
        "choices": {
            "A": "4.3%",
            "B": "12.2%",
            "C": "36.6%",
            "D": "97.1%",
            "E": "100%"
        },
        "answer": "A",
        "pmid": "35892422"
    },
    {
        "question": "A 90-year-old patient is brought to the emergency department with a decreased level of consciousness. On examination, the Glasgow Coma Scale score is found to be 4. A CT scan of the head reveals a subdural hematoma with a volume of 60 mL. The patient has no history of major trauma. Based on the patient's age, Glasgow Coma Scale score, and the volume of the subdural hematoma, what is the most likely 30-day mortality rate for this patient?",
        "choices": {
            "A": "4.3% mortality rate",
            "B": "12.2% mortality rate",
            "C": "36.6% mortality rate",
            "D": "97.1% mortality rate",
            "E": "100% mortality rate"
        },
        "answer": "E",
        "pmid": "35892422"
    },
    {
        "question": "A 75-year-old patient presents to the emergency department with a headache and confusion. On examination, the patient has a Glasgow Coma Scale score of 10. A CT scan of the head reveals a subdural hematoma with a volume of 45 mL. The patient has no history of major trauma. Based on the patient's age, Glasgow Coma Scale score, and subdural hematoma volume, what is the most likely 30-day mortality rate for this patient?",
        "choices": {
            "A": "4.3%",
            "B": "12.2%",
            "C": "36.6%",
            "D": "97.1%",
            "E": "100%"
        },
        "answer": "B",
        "pmid": "35892422"
    },
    {
        "question": "An 82-year-old patient presents to the emergency department with a headache and confusion. A CT scan reveals an acute subdural hematoma with a volume of 52 mL. The patient's Glasgow Coma Scale score at admission is 8. The patient has no significant past medical history and takes no regular medications. Based on the patient's age, Glasgow Coma Scale score, and subdural hematoma volume, what is the most likely 30-day mortality risk for this patient?",
        "choices": {
            "A": "4.3% 30-day mortality risk",
            "B": "12.2% 30-day mortality risk",
            "C": "36.6% 30-day mortality risk",
            "D": "97.1% 30-day mortality risk",
            "E": "100% 30-day mortality risk"
        },
        "answer": "D",
        "pmid": "35892422"
    },
    {
        "question": "A 55-year-old male patient is being considered for enrollment in a phase I oncology trial. He has a history of non-small cell lung cancer with metastasis to the liver, bone, and brain. His circulating tumor cell count is 4, albumin level is 34 g/L, and lactate dehydrogenase level is above the upper limit of normal. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Good prognosis, with a median overall survival of 63.7 weeks",
            "B": "Intermediate prognosis, with a median overall survival of 37.3 weeks",
            "C": "Poor prognosis, with a median overall survival of 13.4 weeks",
            "D": "Good prognosis, with a median overall survival of 37.3 weeks",
            "E": "Intermediate prognosis, with a median overall survival of 63.7 weeks"
        },
        "answer": "C",
        "pmid": "21531820"
    },
    {
        "question": "A 55-year-old male patient is being considered for enrollment in a phase I oncology trial. He has a history of non-small cell lung cancer. His circulating tumor cell count is 2, albumin level is 36 g/L, lactate dehydrogenase level is within the normal range, and he has 1 metastatic site in the liver. Based on these parameters, what is the patient's prognosis and expected median overall survival?",
        "choices": {
            "A": "Poor prognosis, with a median overall survival of 13.4 weeks",
            "B": "Intermediate prognosis, with a median overall survival of 37.3 weeks",
            "C": "Good prognosis, with a median overall survival of 63.7 weeks",
            "D": "Intermediate prognosis, with a median overall survival of 63.7 weeks",
            "E": "Poor prognosis, with a median overall survival of 37.3 weeks"
        },
        "answer": "C",
        "pmid": "21531820"
    },
    {
        "question": "A 55-year-old male patient is being considered for enrollment in a phase I oncology trial. His medical history reveals a circulating tumor cell count of 1, an albumin level of 38 g/L, a lactate dehydrogenase level within the normal range, and 2 metastatic sites. He has no other significant medical conditions. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Poor prognosis, with a median overall survival of 13.4 weeks",
            "B": "Intermediate prognosis, with a median overall survival of 37.3 weeks",
            "C": "Good prognosis, with a median overall survival of 63.7 weeks",
            "D": "The prognosis cannot be determined based on these parameters",
            "E": "The patient is not eligible for the trial"
        },
        "answer": "C",
        "pmid": "21531820"
    },
    {
        "question": "A 55-year-old male patient is being considered for enrollment in a phase I oncology trial. He has a history of non-small cell lung cancer with metastasis to the liver, bones, and brain. His recent laboratory results show a circulating tumor cell count of 3, an albumin level of 33 g/L, and a lactate dehydrogenase level above the upper limit of normal. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Good prognosis, with a median overall survival of 63.7 weeks",
            "B": "Intermediate prognosis, with a median overall survival of 37.3 weeks",
            "C": "Poor prognosis, with a median overall survival of 13.4 weeks",
            "D": "Good prognosis, with a median overall survival of 37.3 weeks",
            "E": "Intermediate prognosis, with a median overall survival of 63.7 weeks"
        },
        "answer": "C",
        "pmid": "21531820"
    },
    {
        "question": "A 55-year-old male patient is being considered for enrollment in a phase I oncology trial. He has a history of non-small cell lung cancer with 3 metastatic sites. His recent laboratory results show a circulating tumor cell count of 2, an albumin level of 35 g/L, and a lactate dehydrogenase level within the normal range. Based on these parameters, what is the most likely prognosis for this patient if he is enrolled in the trial?",
        "choices": {
            "A": "Median overall survival of 63.7 weeks",
            "B": "Median overall survival of 37.3 weeks",
            "C": "Median overall survival of 13.4 weeks",
            "D": "Median overall survival of less than 10 weeks",
            "E": "Median overall survival of more than 70 weeks"
        },
        "answer": "A",
        "pmid": "21531820"
    },
    {
        "question": "A 78-year-old patient has recently undergone posterior spine surgery. The surgery lasted for 3.5 hours and the estimated blood loss was 1200 ml. The patient has no history of any chronic diseases and has been generally healthy. Based on the patient's age, operative time, and estimated blood loss, what is the risk of postoperative complications for this patient?",
        "choices": {
            "A": "Low risk of postoperative complications",
            "B": "Moderate risk of postoperative complications",
            "C": "High risk of postoperative complications",
            "D": "The patient is not at risk of postoperative complications",
            "E": "The risk cannot be determined based on the given parameters"
        },
        "answer": "B",
        "pmid": "31285117"
    },
    {
        "question": "An 85-year-old patient has recently undergone posterior spine surgery. The surgery lasted for 5 hours and the estimated blood loss was 2000 ml. The patient has a history of hypertension and type 2 diabetes, both of which are well-controlled with medication. The patient is currently stable, but there is concern about potential postoperative complications. Based on the patient's age, operative time, and estimated blood loss, what is the risk of postoperative complications for this patient?",
        "choices": {
            "A": "Low risk of postoperative complications",
            "B": "Moderate risk of postoperative complications",
            "C": "High risk of postoperative complications",
            "D": "The patient's risk cannot be determined based on the given information",
            "E": "The patient is not at risk for postoperative complications"
        },
        "answer": "C",
        "pmid": "31285117"
    },
    {
        "question": "A 65-year-old patient has recently undergone posterior spine surgery. The surgery lasted for 2.5 hours and the estimated blood loss was 800 ml. The patient has no significant past medical history and is currently stable postoperatively. Based on the patient's age, operative time, and estimated blood loss, what is the risk of postoperative complications for this patient?",
        "choices": {
            "A": "Low risk of postoperative complications",
            "B": "Moderate risk of postoperative complications",
            "C": "High risk of postoperative complications",
            "D": "The patient is not at risk of postoperative complications",
            "E": "The risk of postoperative complications cannot be determined"
        },
        "answer": "B",
        "pmid": "31285117"
    },
    {
        "question": "A 72-year-old patient has recently undergone posterior spine surgery. The surgery lasted for 4 hours and the estimated blood loss was 1500 ml. The patient has a history of hypertension and type 2 diabetes, both of which are well-controlled with medication. The patient does not smoke or drink alcohol. Based on the patient's age, operative time, and estimated blood loss, what is the risk of postoperative complications for this patient?",
        "choices": {
            "A": "Low risk of postoperative complications",
            "B": "Moderate risk of postoperative complications",
            "C": "High risk of postoperative complications",
            "D": "The patient is not at risk of postoperative complications",
            "E": "The risk of postoperative complications cannot be determined"
        },
        "answer": "B",
        "pmid": "31285117"
    },
    {
        "question": "An 80-year-old patient has recently undergone posterior spine surgery. The surgery lasted for 3 hours and the estimated blood loss was 1000 ml. The patient has a history of hypertension and type 2 diabetes, both of which are well-controlled with medication. The patient does not smoke or drink alcohol. Based on the patient's age, operative time, and estimated blood loss, what is the risk of postoperative complications for this patient?",
        "choices": {
            "A": "Low risk of postoperative complications",
            "B": "Moderate risk of postoperative complications",
            "C": "High risk of postoperative complications",
            "D": "The patient's risk cannot be determined",
            "E": "The patient is not at risk for postoperative complications"
        },
        "answer": "B",
        "pmid": "31285117"
    },
    {
        "question": "A 50-year-old Caucasian male with a diagnosis of type 1 diabetes for more than 6 months presents for a routine check-up. His waist circumference is 90 cm, insulin requirements are 0.6 IU/kg/d, and triglycerides level is 150 mg/dL. He has no other significant medical history. Based on these parameters, what is the most likely risk level for this patient developing Hypogonadotropic Hypogonadism (HH)?",
        "choices": {
            "A": "Low risk of HH",
            "B": "Moderate risk of HH",
            "C": "High risk of HH",
            "D": "Very high risk of HH",
            "E": "Cannot be determined"
        },
        "answer": "C",
        "pmid": "25394376"
    },
    {
        "question": "A 60-year-old Caucasian male with a diagnosis of type 1 diabetes for more than 6 months presents for a routine check-up. His waist circumference is 100 cm, insulin requirements are 0.8 IU/kg/d, and triglycerides level is 200 mg/dL. He has no other significant medical history. Based on these parameters, what is the most likely risk level for this patient developing Hypogonadotropic Hypogonadism (HH)?",
        "choices": {
            "A": "Low risk of HH",
            "B": "Moderate risk of HH",
            "C": "High risk of HH",
            "D": "Very high risk of HH",
            "E": "Cannot be determined from the given information"
        },
        "answer": "C",
        "pmid": "25394376"
    },
    {
        "question": "A 40-year-old Caucasian male with a diagnosis of type 1 diabetes for more than 6 months presents to your clinic. He has been managing his diabetes with insulin therapy. His current insulin requirement is 0.5 IU/kg/d. He has a waist circumference of 80 cm and a recent lipid panel showed a triglyceride level of 120 mg/dL. Based on these findings, what is the most likely risk for this patient?",
        "choices": {
            "A": "Low risk of Hypogonadotropic Hypogonadism",
            "B": "Moderate risk of Hypogonadotropic Hypogonadism",
            "C": "High risk of Hypogonadotropic Hypogonadism",
            "D": "The patient is not at risk for Hypogonadotropic Hypogonadism",
            "E": "Unable to determine the risk of Hypogonadotropic Hypogonadism without further testing"
        },
        "answer": "C",
        "pmid": "25394376"
    },
    {
        "question": "A 55-year-old Caucasian male with a diagnosis of type 1 diabetes for more than 6 months presents to your clinic. His waist circumference is 95 cm, insulin requirements are 0.7 IU/kg/d, and triglycerides level is 180 mg/dL. Based on these parameters, what is the most likely risk level for this patient developing Hypogonadotropic Hypogonadism?",
        "choices": {
            "A": "Low risk",
            "B": "Moderate risk",
            "C": "High risk",
            "D": "Very high risk",
            "E": "Unable to determine risk"
        },
        "answer": "C",
        "pmid": "25394376"
    },
    {
        "question": "A 65-year-old Caucasian male with a diagnosis of type 1 diabetes for more than 6 months presents to your clinic. His waist circumference is 105 cm, insulin requirements are 0.9 IU/kg/d, and triglycerides level is 220 mg/dL. He has been experiencing fatigue, decreased libido, and has had difficulty maintaining an erection. Based on his risk score of 415.32, what is the most likely diagnosis?",
        "choices": {
            "A": "Low risk of Hypogonadotropic Hypogonadism",
            "B": "Moderate risk of Hypogonadotropic Hypogonadism",
            "C": "High risk of Hypogonadotropic Hypogonadism",
            "D": "The patient does not have Hypogonadotropic Hypogonadism",
            "E": "The patient's risk for Hypogonadotropic Hypogonadism cannot be determined"
        },
        "answer": "C",
        "pmid": "25394376"
    },
    {
        "question": "A 75-year-old male patient has been admitted to the hospital due to a geriatric hip fracture. The patient has a history of hypertension and was admitted to the medicine service. He does not have any history of disseminated cancer. Based on these factors, what is the most likely predicted length of stay for this patient in the hospital?",
        "choices": {
            "A": "Less than 1 day",
            "B": "Approximately 1.77 days",
            "C": "Approximately 3 days",
            "D": "Approximately 5 days",
            "E": "More than 7 days"
        },
        "answer": "B",
        "pmid": "31695265"
    },
    {
        "question": "A 75-year-old female patient has been treated for a hip fracture. She has a medical history of disseminated cancer but does not have hypertension. She was not admitted to the medicine service during her hospital stay. Based on these factors, what is the most likely predicted length of stay for this patient in the hospital?",
        "choices": {
            "A": "Less than 1 day",
            "B": "1.24 days",
            "C": "1.48 days",
            "D": "More than 2 days",
            "E": "The length of stay cannot be predicted"
        },
        "answer": "B",
        "pmid": "31695265"
    },
    {
        "question": "A 78-year-old female patient has been treated for a geriatric hip fracture. She has a medical history of hypertension and disseminated cancer. She was not admitted to the medicine service for her treatment. Based on her medical conditions and treatment, what is the most likely predicted length of stay in the hospital for this patient?",
        "choices": {
            "A": "Less than 1 day",
            "B": "Approximately 1.364 days",
            "C": "Approximately 2 days",
            "D": "Approximately 3 days",
            "E": "More than 3 days"
        },
        "answer": "B",
        "pmid": "31695265"
    },
    {
        "question": "A 75-year-old male patient was admitted to the hospital due to a hip fracture. He was immediately treated for his condition. The patient does not have a history of hypertension or any form of disseminated cancer. He was admitted to the medicine service for further observation and treatment. Based on these factors, what is the most likely predicted length of stay in the hospital for this patient?",
        "choices": {
            "A": "Less than 1 day",
            "B": "Approximately 1.61 days",
            "C": "Approximately 3 days",
            "D": "Approximately 5 days",
            "E": "More than 7 days"
        },
        "answer": "B",
        "pmid": "31695265"
    },
    {
        "question": "A 78-year-old female patient has been admitted to the hospital due to a geriatric hip fracture. She has a medical history of hypertension and disseminated cancer. She was admitted to the medicine service for her treatment. Based on her medical history and current condition, her length of stay in the hospital was calculated. What is the most likely predicted length of stay for this patient?",
        "choices": {
            "A": "Less than 1 day",
            "B": "Approximately 1 day",
            "C": "Approximately 2 days",
            "D": "Approximately 3 days",
            "E": "More than 3 days"
        },
        "answer": "C",
        "pmid": "31695265"
    },
    {
        "question": "A 65-year-old male patient has recently undergone percutaneous coronary intervention (PCI). He is not receiving hemodialysis and has not died within 7 days post-procedure, making him eligible for risk assessment. His score, based on various clinical and procedural factors, is 12. What is the risk category of this patient for developing Contrast-Induced Acute Kidney Injury (CI-AKI) and Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)?",
        "choices": {
            "A": "Low-risk",
            "B": "Medium-risk",
            "C": "High-risk",
            "D": "Very high-risk",
            "E": "The score does not indicate any risk"
        },
        "answer": "C",
        "pmid": "25623482"
    },
    {
        "question": "A 65-year-old male patient recently underwent percutaneous coronary intervention (PCI). He is not receiving hemodialysis and has not died within 7 days post-procedure. His score, based on a set of clinical parameters, is 7. What is the risk category of this patient for developing Contrast-Induced Acute Kidney Injury (CI-AKI) and Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)?",
        "choices": {
            "A": "Low-risk",
            "B": "Medium-risk",
            "C": "High-risk",
            "D": "Very high-risk",
            "E": "The score does not indicate any risk"
        },
        "answer": "B",
        "pmid": "25623482"
    },
    {
        "question": "A 65-year-old male patient has recently undergone percutaneous coronary intervention (PCI). He is not receiving hemodialysis and has survived the first 7 days post-procedure. His clinical score, calculated based on several factors including age, creatinine clearance, and ejection fraction, among others, is 17. What is the risk category of this patient and what are the potential clinical outcomes he might face?",
        "choices": {
            "A": "Low-risk category, with the lowest risk of developing Contrast-Induced Acute Kidney Injury (CI-AKI) and Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)",
            "B": "Medium-risk category, with a moderate risk of developing CI-AKI and MACCE",
            "C": "High-risk category, with a high risk of developing CI-AKI and MACCE",
            "D": "Very high-risk category, with the highest risk of developing CI-AKI and MACCE",
            "E": "The score does not correlate with any risk category"
        },
        "answer": "D",
        "pmid": "25623482"
    },
    {
        "question": "A 65-year-old male patient recently underwent a percutaneous coronary intervention (PCI) procedure. He is not receiving hemodialysis and has not died within 7 days post-procedure. His score, based on a set of clinical parameters, is 4. What is the risk category of this patient for developing Contrast-Induced Acute Kidney Injury (CI-AKI) and Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) following the PCI procedure?",
        "choices": {
            "A": "Very high-risk",
            "B": "High-risk",
            "C": "Medium-risk",
            "D": "Low-risk",
            "E": "The score does not determine the risk category"
        },
        "answer": "D",
        "pmid": "25623482"
    },
    {
        "question": "A 65-year-old male patient recently underwent a percutaneous coronary intervention (PCI) procedure. He is not receiving hemodialysis and has not died within 7 days post-procedure. His risk score is calculated to be 10. Based on this score, what is the patient's risk of developing Contrast-Induced Acute Kidney Injury (CI-AKI) and Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) following the procedure?",
        "choices": {
            "A": "Low risk",
            "B": "Medium risk",
            "C": "High risk",
            "D": "Very high risk",
            "E": "The risk cannot be determined"
        },
        "answer": "B",
        "pmid": "25623482"
    },
    {
        "question": "A 45-year-old male patient presents to the emergency department following a motor vehicle accident. He has a history of smoking. On examination, his Glasgow Coma Scale (GCS) score is 14. Laboratory tests reveal a blood alcohol content (BAC) level of 120 mg/dL and a bicarbonate level of 22 mmol/L. The patient is conscious and cooperative. Based on these findings, what is the risk of alcohol misuse in this patient?",
        "choices": {
            "A": "Low risk of alcohol misuse",
            "B": "Moderate risk of alcohol misuse",
            "C": "High risk of alcohol misuse",
            "D": "The patient does not misuse alcohol",
            "E": "Unable to determine the risk of alcohol misuse"
        },
        "answer": "C",
        "pmid": "36160674"
    },
    {
        "question": "A 30-year-old patient presents to the emergency department following a minor trauma. The patient denies any history of smoking. Laboratory tests reveal a blood alcohol content (BAC) of 0 mg/dL and a bicarbonate level of 18 mmol/L. The patient's Glasgow Coma Scale (GCS) score is below 13. Based on these findings, what is the patient's risk of alcohol misuse?",
        "choices": {
            "A": "The patient is at a high risk of alcohol misuse",
            "B": "The patient is at a moderate risk of alcohol misuse",
            "C": "The patient is at a low risk of alcohol misuse",
            "D": "The patient's risk of alcohol misuse cannot be determined",
            "E": "The patient has no risk of alcohol misuse"
        },
        "answer": "C",
        "pmid": "36160674"
    },
    {
        "question": "A 50-year-old male patient presents to the emergency department following a minor car accident. He has a history of smoking and tests positive for blood alcohol content (BAC). However, his BAC level is below 100 mg/dL and his Glasgow Coma Scale (GCS) score is below 13. His bicarbonate level is 19 mmol/L. Based on these findings, what is the patient's risk of alcohol misuse?",
        "choices": {
            "A": "Low risk of alcohol misuse",
            "B": "Moderate risk of alcohol misuse",
            "C": "High risk of alcohol misuse",
            "D": "The patient does not have a risk of alcohol misuse",
            "E": "Unable to determine the risk of alcohol misuse"
        },
        "answer": "C",
        "pmid": "36160674"
    },
    {
        "question": "A 35-year-old male patient presents to the emergency department following a motor vehicle accident. He is a non-smoker and has no significant past medical history. On examination, his Glasgow Coma Scale (GCS) score is 13. Laboratory tests reveal a blood alcohol content (BAC) level of 100 mg/dL and a bicarbonate level of 21 mmol/L. Based on these findings, what is the risk of alcohol misuse in this patient?",
        "choices": {
            "A": "Low risk of alcohol misuse",
            "B": "Moderate risk of alcohol misuse",
            "C": "High risk of alcohol misuse",
            "D": "The patient does not have any risk of alcohol misuse",
            "E": "Unable to determine the risk of alcohol misuse"
        },
        "answer": "C",
        "pmid": "36160674"
    },
    {
        "question": "A 55-year-old male patient presents to the emergency department following a minor motor vehicle accident. He has a history of smoking but denies any alcohol use. His blood alcohol content (BAC) test comes back negative. His Glasgow Coma Scale (GCS) score is 12, indicating a mild brain injury. His bicarbonate level is measured at 18 mmol/L. Based on these findings, what is the patient's risk of alcohol misuse?",
        "choices": {
            "A": "The patient is at a high risk of alcohol misuse",
            "B": "The patient is at a low risk of alcohol misuse",
            "C": "The patient's risk of alcohol misuse cannot be determined",
            "D": "The patient has no risk of alcohol misuse",
            "E": "The patient's risk of alcohol misuse is moderate"
        },
        "answer": "B",
        "pmid": "36160674"
    },
    {
        "question": "A 70-year-old patient is suspected of having Acute Myeloid Leukemia (AML). Genetic testing reveals the presence of a TP53 mutation, but no FLT3 mutation was detected. The patient has no other significant medical history. Based on the patient's age and gene mutation profiles, which of the following best describes the patient's risk of Acute Myeloid Leukemia with Myelodysplasia-related changes (AML-MRC)?",
        "choices": {
            "A": "The patient is at low risk of AML-MRC.",
            "B": "The patient is at moderate risk of AML-MRC.",
            "C": "The patient is at high risk of AML-MRC.",
            "D": "The patient's risk of AML-MRC cannot be determined.",
            "E": "The patient is not at risk of AML-MRC."
        },
        "answer": "C",
        "pmid": "34481124"
    },
    {
        "question": "A 60-year-old patient presents with fatigue and easy bruising. Blood tests reveal a mutation in the FLT3 gene, but no TP53 mutation is detected. The patient has no significant past medical history and is not currently on any medications. Based on the patient's age and genetic profile, what is the risk of this patient developing Acute Myeloid Leukemia with Myelodysplasia-related changes (AML-MRC)?",
        "choices": {
            "A": "High risk",
            "B": "Moderate risk",
            "C": "Low risk",
            "D": "No risk",
            "E": "Unable to determine risk"
        },
        "answer": "C",
        "pmid": "34481124"
    },
    {
        "question": "A 67-year-old patient presents to the clinic for a routine check-up. The patient has no significant past medical history. Recent genetic testing revealed no TP53 or FLT3 mutations. Based on the patient's age and genetic profile, what is the risk of developing Acute Myeloid Leukemia with Myelodysplasia-related changes (AML-MRC)?",
        "choices": {
            "A": "The patient is at low risk of developing AML-MRC",
            "B": "The patient is at moderate risk of developing AML-MRC",
            "C": "The patient is at high risk of developing AML-MRC",
            "D": "The patient's risk of developing AML-MRC cannot be determined",
            "E": "The patient is not at risk of developing AML-MRC"
        },
        "answer": "C",
        "pmid": "34481124"
    },
    {
        "question": "A 72-year-old patient is suspected of having Acute Myeloid Leukemia (AML). Genetic testing reveals the presence of both TP53 and FLT3 mutations. The patient has no significant past medical history and is currently asymptomatic. Based on the patient's age and gene mutation profiles, what is the risk of the patient developing Acute Myeloid Leukemia with Myelodysplasia-related changes (AML-MRC)?",
        "choices": {
            "A": "The patient is at low risk of developing AML-MRC",
            "B": "The patient is at moderate risk of developing AML-MRC",
            "C": "The patient is at high risk of developing AML-MRC",
            "D": "The patient's risk of developing AML-MRC cannot be determined",
            "E": "The patient is not at risk of developing AML-MRC"
        },
        "answer": "C",
        "pmid": "34481124"
    },
    {
        "question": "A 50-year-old patient suspected of having Acute Myeloid Leukemia (AML) has undergone genetic testing. The results show the presence of a TP53 mutation, but no FLT3 mutation was detected. The patient has no other significant medical history. Based on the patient's age and gene mutation profiles, a risk score was calculated. Which of the following best describes the patient's risk of Acute Myeloid Leukemia with Myelodysplasia-related changes (AML-MRC)?",
        "choices": {
            "A": "The patient is at low risk of AML-MRC",
            "B": "The patient is at moderate risk of AML-MRC",
            "C": "The patient is at high risk of AML-MRC",
            "D": "The patient's risk of AML-MRC cannot be determined",
            "E": "The patient is not at risk of AML-MRC"
        },
        "answer": "C",
        "pmid": "34481124"
    },
    {
        "question": "A 55-year-old woman with advanced epithelial ovarian cancer is scheduled for cytoreductive surgery. Her recent CT and PET/CT scans reveal para-aortic lymph node involvement but no colon involvement. Based on these findings, what is the likelihood of pelvic and/or para-aortic lymph node metastasis (LNM) in this patient?",
        "choices": {
            "A": "Low risk of pelvic and/or para-aortic LNM",
            "B": "High risk of pelvic and/or para-aortic LNM with a probability of 76%",
            "C": "High risk of pelvic and/or para-aortic LNM with a probability of 50%",
            "D": "High risk of pelvic and/or para-aortic LNM with a probability of 25%",
            "E": "No risk of pelvic and/or para-aortic LNM"
        },
        "answer": "B",
        "pmid": "36029956"
    },
    {
        "question": "A 55-year-old woman with advanced epithelial ovarian cancer is scheduled for cytoreductive surgery. Her pre-operative CT and PET/CT scans show no para-aortic lymph node involvement but there is evidence of colon involvement. Based on these findings, what is the likelihood of pelvic and/or para-aortic lymph node metastasis (LNM) in this patient?",
        "choices": {
            "A": "There is a low risk of pelvic and/or para-aortic LNM",
            "B": "There is a moderate risk of pelvic and/or para-aortic LNM",
            "C": "There is a high risk of pelvic and/or para-aortic LNM",
            "D": "There is no risk of pelvic and/or para-aortic LNM",
            "E": "The risk of pelvic and/or para-aortic LNM cannot be determined"
        },
        "answer": "C",
        "pmid": "36029956"
    },
    {
        "question": "A 55-year-old woman with advanced epithelial ovarian cancer is scheduled for cytoreductive surgery. Her recent CT and PET/CT scans reveal para-aortic lymph node involvement and colon involvement. Based on these findings, what is the likelihood of pelvic and/or para-aortic lymph node metastasis (LNM) in this patient?",
        "choices": {
            "A": "There is a low risk of pelvic and/or para-aortic LNM",
            "B": "There is a moderate risk of pelvic and/or para-aortic LNM",
            "C": "There is a high risk of pelvic and/or para-aortic LNM",
            "D": "The risk of pelvic and/or para-aortic LNM cannot be determined",
            "E": "There is no risk of pelvic and/or para-aortic LNM"
        },
        "answer": "C",
        "pmid": "36029956"
    },
    {
        "question": "A 55-year-old woman with advanced epithelial ovarian cancer is scheduled for cytoreductive surgery. Pre-operative CT and PET/CT scans show no evidence of para-aortic lymph node involvement or colon involvement. Based on these findings, what is the patient's risk of pelvic and/or para-aortic lymph node metastasis (LNM)?",
        "choices": {
            "A": "The patient has a high risk of pelvic and/or para-aortic LNM.",
            "B": "The patient has a moderate risk of pelvic and/or para-aortic LNM.",
            "C": "The patient has a low risk of pelvic and/or para-aortic LNM.",
            "D": "The patient's risk of pelvic and/or para-aortic LNM cannot be determined.",
            "E": "The patient has no risk of pelvic and/or para-aortic LNM."
        },
        "answer": "C",
        "pmid": "36029956"
    },
    {
        "question": "A 55-year-old woman with advanced epithelial ovarian cancer is scheduled for cytoreductive surgery. Her recent CT and PET/CT scans show para-aortic lymph node involvement but no colon involvement. Based on these findings, what is the risk of pelvic and/or para-aortic lymph node metastasis (LNM) in this patient?",
        "choices": {
            "A": "Low risk of pelvic and/or para-aortic LNM",
            "B": "High risk of pelvic and/or para-aortic LNM",
            "C": "No risk of pelvic and/or para-aortic LNM",
            "D": "Moderate risk of pelvic and/or para-aortic LNM",
            "E": "The risk cannot be determined"
        },
        "answer": "B",
        "pmid": "36029956"
    },
    {
        "question": "A 65-year-old male patient presents to your clinic. He was recently diagnosed with hepatocellular cancer. His laboratory results show a PIV of 300 and LDH level of 200 U/L, which is above the upper limit of normal (190 U/L). His Eastern Cooperative Oncology Group Performance Status (ECOG PS) is 1, indicating that he is fully active and able to carry on all pre-disease activities without restriction. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median first-line progression-free survival (PFS) of 8 months and overall survival (OS) of 17 months",
            "B": "Median first-line PFS of 3 months and OS of 3 months",
            "C": "Median first-line PFS of 6 months and OS of 12 months",
            "D": "Median first-line PFS of 12 months and OS of 24 months",
            "E": "Median first-line PFS of 5 months and OS of 10 months"
        },
        "answer": "B",
        "pmid": "36314339"
    },
    {
        "question": "A 70-year-old female patient has recently been diagnosed with hepatocellular cancer. She has a Prothrombin Induced by Vitamin K Absence (PIV) of 280, Lactate Dehydrogenase (LDH) level of 180 U/L (upper limit of normal is 190 U/L), and an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 1. She has no other significant medical history. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median first-line progression-free survival (PFS) of 3 months and overall survival (OS) of 3 months",
            "B": "Median first-line PFS of 8 months and OS of 17 months",
            "C": "Median first-line PFS of 6 months and OS of 12 months",
            "D": "Median first-line PFS of 4 months and OS of 9 months",
            "E": "Median first-line PFS of 2 months and OS of 5 months"
        },
        "answer": "B",
        "pmid": "36314339"
    },
    {
        "question": "A 60-year-old male patient presents to your clinic. He has been recently diagnosed with hepatocellular cancer. His laboratory results show a PIV of 290 and LDH level of 200 U/L, which is above the upper limit of normal (ULN is 190 U/L). His Eastern Cooperative Oncology Group Performance Status (ECOG PS) is 2, indicating that he is ambulatory and capable of all self-care but unable to carry out any work activities. He is up and about more than 50% of waking hours. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low-risk group with a median first-line progression-free survival (PFS) of 8 months and overall survival (OS) of 17 months",
            "B": "Low-risk group with a median first-line PFS of 3 months and OS of 3 months",
            "C": "High-risk group with a median first-line PFS of 8 months and OS of 17 months",
            "D": "High-risk group with a median first-line PFS of 3 months and OS of 3 months",
            "E": "Intermediate-risk group with a median first-line PFS of 5 months and OS of 10 months"
        },
        "answer": "D",
        "pmid": "36314339"
    },
    {
        "question": "A 55-year-old female patient presents to your clinic. She was recently diagnosed with hepatocellular cancer. Her laboratory results show a PIV of 275 and LDH level of 180 U/L, which is below the upper limit of normal (ULN) of 190 U/L. Her Eastern Cooperative Oncology Group Performance Status (ECOG PS) is 0, indicating that she is fully active and able to carry on all pre-disease activities without restriction. Based on these findings, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Median first-line progression-free survival (PFS) of 3 months and overall survival (OS) of 3 months",
            "B": "Median first-line PFS of 8 months and OS of 17 months",
            "C": "Median first-line PFS of 6 months and OS of 12 months",
            "D": "Median first-line PFS of 12 months and OS of 24 months",
            "E": "Median first-line PFS of 18 months and OS of 36 months"
        },
        "answer": "B",
        "pmid": "36314339"
    },
    {
        "question": "A 68-year-old male patient presents to your clinic. He has been recently diagnosed with hepatocellular cancer. His laboratory results show a PIV of 300 and LDH level of 195 U/L, which is above the upper limit of normal (ULN) of 190 U/L. His Eastern Cooperative Oncology Group Performance Status (ECOG PS) is 0, indicating that he is fully active and able to carry on all pre-disease activities without restriction. Based on these parameters, what is the most likely prognosis for this patient?",
        "choices": {
            "A": "Low-risk group with a median first-line progression-free survival (PFS) of 8 months and overall survival (OS) of 17 months",
            "B": "High-risk group with a median first-line PFS of 3 months and OS of 3 months",
            "C": "Intermediate-risk group with a median first-line PFS of 5 months and OS of 10 months",
            "D": "Low-risk group with a median first-line PFS of 6 months and OS of 12 months",
            "E": "High-risk group with a median first-line PFS of 2 months and OS of 4 months"
        },
        "answer": "B",
        "pmid": "36314339"
    }
]